10-Q/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q/A

Amendment No. 1

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2022

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from       to       

Commission File Number: 001-38093

Veritone, Inc.

(Exact name of registrant as specified in its charter)

Delaware	47-1161641
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

2420 17^th St., Office 3002, Denver, CO 80202

(Address of principal executive offices, including zip code)

(888) 507-1737

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock, par value $0.001 per share	VERI	The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒  No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes ☒  No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2) of the Exchange Act.  Yes ☐  No ☒

As of April 30, 2022, 36,067,923 shares of the registrant’s common stock were outstanding.

EXPLANATORY NOTE

Veritone, Inc. (the “Company”) is filing this Amendment No. 1 on Form 10-Q/A (this “Amended Report”) to restate the Company’s unaudited condensed consolidated financial statements for the period ended March 31, 2022 included in its Quarterly Report for the quarter ended March 31, 2022, that was originally filed with the U.S. Securities and Exchange Commission (the “SEC”) on May 9, 2022 (the “Original Report”). Unless the context otherwise requires, references in this Amended Report to “the Company,” “Veritone,” “we,” “us” or “our” refer to Veritone, Inc. and its wholly owned subsidiaries.

Background

As disclosed in the Company’s Current Reports on Form 8-K, as furnished or filed, as applicable, with the SEC on August 9, 2022 and August 15, 2022, the Company is restating its previously issued unaudited condensed consolidated financial statements as of and for the three months ended March 31, 2022. On August 9, 2022, the management of the Company and the Audit Committee of the Company’s Board of Directors, after consideration of the relevant facts and circumstances, concluded that the Company’s unaudited condensed consolidated interim financial statements as of March 31, 2022 and for the quarterly period ended March 31, 2022 included in the Original Report should be restated, and that such financial statements previously filed with the SEC should no longer be relied upon due to an error related to the calculation of fair value of contingent consideration at the time of the acquisition of PandoLogic Ltd. (“PandoLogic”), which led to an understatement of goodwill, intangible assets, and contingent consideration at the time of the acquisition, and an overstatement of subsequent changes to the fair value of contingent consideration, and an understatement of subsequent intangible amortization expense in the Original Report (the “Q1 2022 restatement”).

This Amended Report is presented as of the filing date of the Original Report and does not reflect events occurring after that date, or modify or update disclosures in any way other than as required to reflect the Q1 2022 restatement and the full year 2021 adjustment as described below. Accordingly, this Amended Report should be read in conjunction with the Company’s filings with the SEC subsequent to the date on which the Company filed the Original Report.

This Amended Report sets forth the Original Report in its entirety, as amended to reflect the restatement. Among other things, forward-looking statements made in the Original Report have not been revised to reflect events that occurred or facts that became known to the Company after the filing of the Original Report, and such forward-looking statements should be read in their historical context.

In connection with the Q1 2022 restatement and the filing of this Amended Report, the Company has also adjusted its consolidated balance sheet as of December 31, 2021 contained in the Original Report in order to correct for an error that the Company determined was not material to the Company’s  previously issued financial statements included in its Annual Report on Form 10-K as further described in Note 2 “Presentation and Summary of Significant Accounting Policies” (the “full year 2021 adjustment”).

Items Amended in this Amended Report

The following sections in the Original Report are revised in this Amended Report, solely as a result of, and to reflect, the restatement:

• Part I – Item 1. Financial Information

• Part I – Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

• Part I – Item 4. Controls and Procedures

• Part II – Item 1A. Risk Factors

• Part II – Item 6. Exhibits and Signatures

In accordance with applicable SEC rules, this Amended Report includes an updated signature page and certifications of the Company’s Chief Executive Officer and Chief Financial Officer in Exhibits 31.1, 31.2 and 32.1 as required by Rule 12b-15.

Refer to Note 2, “Presentation and Summary of Significant Accounting Policies,” of Notes to the Condensed Consolidated Financial Statements of this Amended Report for additional information and for the summary of the accounting impacts of these adjustments to the Company’s condensed consolidated financial statements.

The Company has also identified a material weakness in its internal control over financial reporting relating to the appropriate oversight and sufficient review of the work performed by third-party specialists on the Company’s behalf and the coordination of work being performed by more than one specialist. In connection with filing of this Amended Report, the Company has reassessed its disclosure controls and procedures and concluded that they were ineffective as of March 31, 2022. See additional discussion included in Part II Item 1A of this Amended Report.

VERITONE, INC.

QUARTERLY REPORT ON FORM 10-Q/A

March 31, 2022

TABLE OF CONTENTS

Special Note Regarding Forward-Looking Statements
PART I.	FINANCIAL INFORMATION	2
Item 1.	Financial Statements (Unaudited)	2
	Condensed Consolidated Balance Sheets as of March 31, 2022 and December 31, 2021	2
	Condensed Consolidated Statements of Operations and Comprehensive Loss for the Three Months Ended March 31, 2022 and 2021	3
	Condensed Consolidated Statements of Stockholders’ Equity for the Three Months Ended March 31, 2022 and 2021	4
	Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2022 and 2021	5
	Notes to the Condensed Consolidated Financial Statements	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	26
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	35
Item 4.	Controls and Procedures	35
PART II.	OTHER INFORMATION	37
Item 1.	Legal Proceedings	37
Item 1A.	Risk Factors	37
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	38
Item 3.	Defaults Upon Senior Securities	38
Item 4.	Mine Safety Disclosures	38
Item 5.	Other Information	38
Item 6.	Exhibits	39
Signatures		40

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q/A contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and we intend that such forward-looking statements be subject to the safe harbors created thereby. For this purpose, any statements made in this Quarterly Report on Form 10-Q/A that are not historical or current facts may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as “anticipates,” “believes,” “seeks,” “estimates,” “expects,” “intends,” “continue,” “can,” “may,” “plans,” “potential,” “projects,” “should,” “could,” “will,” “would” or similar expressions and the negatives of those expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Such forward-looking statements include, but are not limited to, any statements that refer to projections of our future financial condition and results of operations, capital needs and financing plans, competitive position, industry environment, potential growth and market opportunities, acquisition plans and strategies, compensation plans, governance structure and policies and/or the price of our common stock.

The forward-looking statements included herein represent our management’s current expectations and assumptions based on information available as of the date of this report. These statements involve numerous known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Factors that may cause or contribute to such differences include, but are not limited to, those discussed in more detail in Item 2 (Management’s Discussion and Analysis of Financial Condition and Results of Operations) of Part I, and Item 1A (Risk Factors) of Part II, of this Quarterly Report on Form 10-Q/A, and in Item 1 (Business) and Item 1A (Risk Factors) of Part I of our Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on March 17, 2022. Readers should carefully review these risks, as well as the additional risks described in other documents we file from time to time with the Securities and Exchange Commission. In light of the significant risks and uncertainties inherent in the forward-looking information included herein, the inclusion of such information should not be regarded as a representation by us or any other person that such results will be achieved, and readers are cautioned not to place undue reliance on such forward-looking information, which speak only as of the date of this report.

Moreover, we operate in an evolving environment. New risks and uncertainties emerge from time to time and it is not possible for our management to predict all risks and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual future results to be materially different from those expressed or implied by any forward-looking statements.

Except as required by law, we assume no obligation to update any forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. We qualify all of our forward-looking statements by these cautionary statements.

1

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

VERITONE, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except per share and share data)

(Unaudited)

	As of
	March 31,
	2022			December 31,
	(As Restated)			2021
ASSETS
Cash and cash equivalents	$	237,553		$	254,722
Accounts receivable, net		66,975			85,063
Expenditures billable to clients		19,693			27,180
Prepaid expenses and other current assets		12,519			12,117
Total current assets		336,740			379,082
Property, equipment and improvements, net		2,137			1,556
Intangible assets, net		91,867			93,872
Goodwill		44,600			42,028
Long-term restricted cash		856			855
Other assets		6,078			954
Total assets	$	482,278		$	518,347
LIABILITIES AND STOCKHOLDERS' EQUITY
Accounts payable	$	38,345		$	46,711
Accrued media payments		96,327			86,923
Client advances		7,968			10,561
Contingent consideration, current		134			20,053
Other accrued liabilities		22,993			27,093
Total current liabilities		165,767			191,341
Convertible senior notes, non-current		195,381			195,082
Contingent consideration, non-current		35,681			31,533
Other non-current liabilities		17,216			13,891
Total liabilities		414,045			431,847
Commitments and contingencies (Note 9)
Stockholders' equity
Common stock, par value $0.001 per share; 75,000,000 shares authorized; 36,056,839 and 34,972,256 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively		36			35
Additional paid-in capital		435,954			431,606
Accumulated deficit		(367,843	)		(345,037	)
Accumulated other comprehensive income (loss)		86			(104	)
Total stockholders' equity		68,233			86,500
Total liabilities and stockholders' equity	$	482,278		$	518,347

The accompanying notes are an integral part of these condensed consolidated financial statements.

2

VERITONE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

AND COMPREHENSIVE LOSS

(in thousands, except per share and share data)

(Unaudited)

	Three Months Ended
	March 31,
	2022
	(As Restated)			2021
Revenue	$	34,407		$	18,295
Operating expenses:
Cost of revenue		6,923			4,823
Sales and marketing		11,069			6,427
Research and development		9,883			4,960
General and administrative		22,321			31,543
Amortization		5,016			1,078
Total operating expenses		55,212			48,831
Loss from operations		(20,805	)		(30,536	)
Other expense, net		(1,186	)		(9	)
Loss before provision for income taxes		(21,991	)		(30,545	)
Provision for income taxes		138			22
Net loss	$	(22,129	)	$	(30,567	)
Net loss per share:
Basic and diluted	$	(0.62	)	$	(0.95	)
Weighted average shares outstanding:
Basic and diluted		35,476,948			32,172,038
Comprehensive loss:
Net loss	$	(22,129	)	$	(30,567	)
Foreign currency translation gain, net of income taxes		190			7
Total comprehensive loss	$	(21,939	)	$	(30,560	)

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

VERITONE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(in thousands, except share amounts)

(Unaudited)

	Three Months Ended March 31, 2022
												Accumulated
						Additional			Accumulated			Other
	Common Stock					Paid-in			Deficit			Comprehensive			Total
	Shares			Amount		Capital			(As Restated)			Income			(As Restated)
Balance as of December 31, 2021		34,972,256		$	35	$	431,606		$	(345,037	)	$	(104	)	$	86,500
Cumulative-effect of accounting change adopted as of January 1, 2022		—			—		—			(677	)		—			(677	)
Common stock issued under employee stock plans		1,073,543			1		569			—			—			570
Common stock withheld for employee taxes		(457,840	)		—		(9,437	)		—			—			(9,437	)
Common stock issued for acquisitions		116,550			—		1,929			—			—			1,929
Common stock issued as part of contingent consideration		352,330			—		6,440									6,440
Stock-based compensation expense		—			—		4,847			—			—			4,847
Net loss		—			—		—			(22,129	)		—			(22,129	)
Other comprehensive gain		—			—		—			—			190			190
Balance as of March 31, 2022		36,056,839		$	36	$	435,954		$	(367,843	)	$	86		$	68,233

	Three Months Ended March 31, 2021
										Accumulated
					Additional					Other
	Common Stock				Paid-in		Accumulated			Comprehensive
	Shares		Amount		Capital		Deficit			Income		Total
Balance as of December 31, 2020		31,799,354	$	32	$	368,477	$	(280,365	)	$	66	$	88,210
Common stock issued under employee stock plans, net		608,886		1		4,253		—			—		4,254
Common stock issued for services		15,828		—		119		—			—		119
Stock-based compensation expense		—		—		21,491		—			—		21,491
Exercise of warrants		252,218				2,279							2,279
Net loss		—		—		—		(30,567	)		—		(30,567	)
Other comprehensive gain		—		—		—		—			7		7
Balance as of March 31, 2021		32,676,286	$	33	$	396,619	$	(310,932	)	$	73	$	85,793

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

VERITONE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(Unaudited)

	Three Months Ended
	March 31,
	2022
	(As Restated)			2021
Cash flows from operating activities:
Net loss	$	(22,129	)	$	(30,567	)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization		5,214			1,253
Loss on disposal of fixed assets		—			1,894
Provision for doubtful accounts		194			5
Loss on sublease		—			1,211
Stock-based compensation expense		4,847			21,610
Change in fair value of contingent consideration		5,045			—
Change in deferred taxes		(465	)		—
Amortization of debt issuance costs		299			—
Changes in assets and liabilities:
Accounts receivable		18,982			(7,439	)
Expenditures billable to clients		7,487			2,236
Prepaid expenses and other assets		(18	)		1,507
Other assets		(895	)		—
Accounts payable		(8,384	)		3,554
Accrued media payments		8,770			9,517
Client advances		(2,593	)		1,825
Other accrued liabilities		(6,104	)		(103	)
Other liabilities		(116	)		(294	)
Net cash provided by operating activities		10,134			6,209
Cash flows from investing activities:
Minority investment		(2,000	)		—
Capital expenditures		(735	)		(100	)
Acquisitions, net of cash acquired		(1,319	)		—
Net cash used in investing activities		(4,054	)		(100	)
Cash flows from financing activities:
Payment of contingent considerations		(14,376	)		—
Taxes paid related to net share settlement of equity awards		(9,441	)		—
Proceeds from the exercise of warrants		—			2,279
Proceeds from issuances of stock under employee stock plans, net		569			4,254
Net cash (used in) provided by financing activities		(23,248	)		6,533
Net (decrease) increase in cash and cash equivalents and restricted cash		(17,168	)		12,642
Cash and cash equivalents and restricted cash, beginning of period		255,577			115,672
Cash and cash equivalents and restricted cash, end of period	$	238,409		$	128,314
Supplemental Disclosure of Cash Flow Information
Non-cash activities:
Shares issued for acquisition of businesses and earn-out consideration		8,369			—
Lease liabilities arising from right-of-use assets		4,501			—

The accompanying notes are an integral part of these condensed consolidated financial statements.

5

VERITONE, INC.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except share and per share data and percentages)

(Unaudited)

NOTE 1. DESCRIPTION OF BUSINESS

Description of Business

Veritone, Inc., a Delaware corporation (“Veritone”) (together with its wholly owned subsidiaries, the “Company”), is a provider of artificial intelligence (“AI”) computing solutions. The Company’s proprietary AI operating system, aiWARE^TM, uses machine learning algorithms, or AI models, together with a suite of powerful applications, to reveal valuable insights from vast amounts of structured and unstructured data. The aiWARE platform offers capabilities that mimic human cognitive functions such as perception, prediction and problem solving, enabling users to quickly, efficiently and cost effectively transform unstructured data into structured data, and analyze and optimize data to drive business processes and insights.  aiWARE is based on an open architecture that enables new AI models, applications and workflows to be added quickly and efficiently, resulting in a scalable and evolving solution that can be leveraged by organizations across a broad range of business sectors, serving commercial enterprises as well as government and regulated industries.

In addition, the Company operates a full-service advertising agency that leverages the Company’s aiWARE technologies to provide differentiated Managed Services to its clients. The Company’s advertising services include media planning and strategy, advertisement buying and placement, campaign messaging, clearance verification and attribution, and custom analytics, specializing in host-endorsed and influencer advertising across primarily radio, podcasting, streaming audio, social media and other digital media channels. The Company’s advertising services also include its VeriAds Network, which is comprised of programs that enable broadcasters, podcasters and social media influencers to generate incremental advertising revenue. The Company also offers cloud-native digital content management solutions and licensing services, primarily to customers in the media and entertainment market. These offerings leverage the Company’s aiWARE technologies, providing customers with unique capabilities to enrich and drive expanded revenue opportunities from their content.

On March 1, 2022, the Company acquired an influencer-based management company, as discussed in more detail in Note 3. On September 14, 2021, the Company acquired PandoLogic, a company incorporated under the laws of the state of Israel, and a leading provider of intelligent hiring solutions, as discussed in more detail in Note 3. PandoLogic’s software platform, PandoIQ, is an AI-enabled talent acquisition and recruitment platform. 

NOTE 2. PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation and Preparation

The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial statements and the rules and regulations of the SEC. Accordingly, they do not contain all information and footnotes required by GAAP for annual financial statements. Such unaudited condensed consolidated financial statements and accompanying notes are based on the representations of the Company’s management, who is responsible for their integrity and objectivity. The information included in this Form 10-Q/A should be read in conjunction with the information included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on March 17, 2022. Interim results for the three months ended March 31, 2022 are not necessarily indicative of the results the Company will have for the full year ending December 31, 2022.

The accompanying condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, which are normal, recurring and necessary to fairly state the Company’s financial position, results of operations and cash flows. All significant intercompany transactions have been eliminated in consolidation. The financial data and the other information disclosed in these notes to the condensed consolidated financial statements reflected in the three month periods presented are unaudited. The December 31, 2021 balance sheet included herein was derived from the audited financial statements but does not include all disclosures or notes required by GAAP for complete financial statements.

Restatement and Adjustment of Financial Statements

Restatement of Previously Issued Financial Statements

On August 9, 2022, the management of the Company and the Audit Committee of the Board of Directors of the Company, after consideration of the relevant facts and circumstances, determined that the Company’s previously issued financial statements as of and for the three months ended March 31, 2022 should be restated, and that such financial statements should no longer be relied upon due to an error related to the calculation of fair value of contingent consideration at the time of the acquisition of PandoLogic, which led to an understatement of goodwill, intangible assets and contingent consideration at the time of the acquisition, an overstatement of subsequent changes to the fair value of contingent consideration, and an understatement of subsequent intangible amortization expense. The restatement results in a non-cash charge that reduces general and administrative expenses and results in a favorable change to net loss for the three months ended March 31, 2022. The Company has restated its financial statements for the three months ended March 31, 2022 for such errors.

6

Adjustment of Previously Issued Financial Statements

The Company also evaluated the aggregate effects of the errors to its previously issued financial statements in accordance with SEC Staff Accounting Bulletins No. 99 and No. 108 and, based upon quantitative and qualitative factors, determined that the errors were not material to the previously issued financial statements included in its Annual Report on Form 10-K for the year ended December 31, 2021 or for any quarterly periods included therein. However, in order to correctly state equity in connection with the filing of this Form 10-Q/A, the December 31, 2021 consolidated balance sheet has been corrected to reflect the impact of this immaterial error.  The Company will adjust its consolidated financial statements for the year ended December 31, 2021 when it files its Form 10-K for the period ended December 31, 2022.

The following tables present the effects of the aforementioned restatement to the specific line items presented in the Company’s previously reported unaudited condensed consolidated financial statements as of and for the three months ended March 31, 2022 (in thousands, except per share amounts):

Condensed Consolidated Balance Sheet

	As of March 31, 2022
	As Reported			Adjustment		As Restated
Intangible assets, net	$	86,563		$	5,304	$	91,867
Goodwill		36,630			7,970		44,600
Total assets		469,004			13,274		482,278
Contingent consideration, non-current		35,416			265		35,681
Other non-current liabilities		16,440			776		17,216
Total liabilities		413,004			1,041		414,045
Accumulated deficit		(380,076	)		12,233		(367,843	)
Total stockholders' equity		56,000			12,233		68,233
Total liabilities and stockholders' equity		469,004			13,274		482,278

Condensed Consolidated Statement of Operations and Comprehensive Loss

	Three Months Ended
	March 31, 2022
	As Reported			Adjustment			As Restated
General and administrative	$	28,917		$	(6,596	)	$	22,321
Amortization		4,693			323			5,016
Total operating expenses		61,485			(6,273	)		55,212
Loss from operations		(27,078	)		6,273			(20,805	)
Loss before provision for income taxes		(28,264	)		6,273			(21,991	)
Provision for income taxes		177			(39	)		138
Net loss		(28,441	)		6,312			(22,129	)
Basic and diluted net loss per share		(0.80	)		0.18			(0.62	)
Total comprehensive loss		(28,251	)		6,312			(21,939	)

Condensed Consolidated Statement of Stockholders’ Equity

	Accumulated Deficit
	As Reported			Adjustment		As Restated
Balance as of December 31, 2021	$	(350,958	)	$	5,921	$	(345,037	)
Net loss		(28,441	)		6,312		(22,129	)
Balance as of March 31, 2022		(380,076	)		12,233		(367,843	)
	Total Stockholders' Equity
Balance as of December 31, 2021		80,579			5,921		86,500
Net loss		(28,441	)		6,312		(22,129	)
Balance as of March 31, 2022		56,000			12,233		68,233

7

Condensed Consolidated Statement of Cash Flows

	Three Months Ended
	March 31, 2022
	As Reported			Adjustment			As Restated
Cash flows from operating activities:
Net loss	$	(28,441	)	$	6,312		$	(22,129	)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization		4,891			323			5,214
Change in fair value of contingent consideration		11,641			(6,596	)		5,045
Change in deferred taxes		(426	)		(39	)		(465	)

There was no impact on cash flows from investing or financing activities.

The following tables reflect the impact of the adjustments to the specific line items presented in the Company’s previously reported consolidated financial statements as of and for the year-ended December 31, 2021 (in thousands, except per share amounts):

Consolidated Balance Sheet

	As of December 31, 2021
	As Reported			Adjustment		As Adjusted
Intangible assets, net	$	88,247		$	5,625	$	93,872
Goodwill		34,058			7,970	$	42,028
Total assets		504,752			13,595		518,347
Contingent consideration, current		19,988			65		20,053
Total current liabilities		191,276			65		191,341
Contingent consideration, non-current		24,737			6,796		31,533
Other non-current liabilities		13,078			813		13,891
Total liabilities		424,173			7,674		431,847
Accumulated deficit		(350,958	)		5,921		(345,037	)
Total stockholders' equity		80,579			5,921		86,500
Total liabilities and stockholders' equity		504,752			13,595		518,347

Consolidated Statement of Operations and Comprehensive Loss

	Year Ended
	December 31, 2021
	As Reported			Adjustment			As Adjusted
General and administrative	$	97,918		$	(6,251	)	$	91,667
Amortization		8,497			375			8,872
Total operating expenses		182,554			(5,876	)		176,678
Loss from operations		(67,249	)		5,876			(61,373	)
Loss before provision for income taxes		(67,849	)		5,876			(61,973	)
Provision for income taxes		2,744			(45	)		2,699
Net loss		(70,593	)		5,921			(64,672	)
Basic and diluted net loss per share		(2.12	)		0.18			(1.94	)
Total comprehensive loss		(70,763	)		5,921			(64,842	)

Consolidated Statement of Stockholders’ Equity

	Accumulated Deficit
	As Reported			Adjustment		As Adjusted
Net loss	$	(70,593	)	$	5,921	$	(64,672	)
Balance as of December 31, 2021		(350,958	)		5,921		(345,037	)
	Total Stockholders' Equity
Net loss		(70,593	)		5,921		(64,672	)
Balance as of December 31, 2021		80,579			5,921		86,500

8

Consolidated Statement of Cash Flows

	Year Ended
	December 31, 2021
	As Reported			Adjustment			As Adjusted
Cash flows from operating activities:
Net loss	$	(70,593	)	$	5,921		$	(64,672	)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization		9,035			375			9,410
Change in fair value of contingent consideration		18,325			(6,251	)		12,074
Change in deferred taxes		—			(45	)		(45	)

There was no impact on cash flows from investing or financing activities.

The accompanying applicable Notes to the Condensed Consolidated Financial Statements have been updated to reflect the restatement as of and for the three months ended March 31, 2022 and the revision for the year ended December 31, 2021.

Liquidity and Capital Resources

During the years ended December 31, 2021 and 2020, the Company generated cash flows from operations of $7,234 and $1,433, respectively, and incurred net losses of $64,672 and $47,876, respectively. In the three months ended March 31, 2022, the Company generated cash flows from operations of $10,134 and incurred a net loss of $22,129. As of March 31, 2022, the Company had an accumulated deficit of $367,843. Historically, the Company has satisfied its capital needs with the net proceeds from sales of equity securities, issuances of convertible debt, and the exercise of common stock options and warrants. In the first three months of 2022, the Company received net proceeds of $569 from the issuance of common stock under the Company’s employee stock plans, and used $9,441 for taxes paid related to net share settlement of equity awards and $14,376 for payment of the 2021 earnout for PandoLogic.

In 2022, driven by the acquisition of PandoLogic in September 2021, the Company expects to generate positive consolidated cash flows from its operations. As a result, management believes that the Company’s existing balances of cash and cash equivalents, which totaled $237,553 as of March 31, 2021, will be sufficient to meet its anticipated cash requirements for the foreseeable future.

Use of Accounting Estimates

The preparation of the accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the accompanying condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The principal estimates relate to the accounting recognition and presentation of revenue, allowance for doubtful accounts, purchase accounting, impairment of long-lived assets, the valuation of contingent consideration, the valuation of stock awards and stock warrants and income taxes, where applicable.

There has been uncertainty and disruption in the global economy and financial markets due to the COVID-19 pandemic and the war in Ukraine. The Company is not aware of any specific event or circumstance that would require an update to its estimates or assumptions or a revision of the carrying value of its assets or liabilities as of the date of filing of this Quarterly Report on Form 10-Q/A.

These estimates and assumptions may change as new events occur and additional information is obtained. As a result, actual results could differ materially from these estimates and assumptions.

Significant Customers

One individual customer accounted for 10% or more of the Company’s revenue for the three months ended March 31, 2022 and one individual customer accounted for 10% of the Company’s net revenues for the three months ended March 31, 2021. Two individual customers accounted for 10% or more of the Company’s accounts receivable as of March 31, 2022 and two individual customers accounted for 10% or more of the Company’s accounts receivable as December 31, 2021.

Remaining Performance Obligations

As of March 31, 2022, the aggregate amount of the transaction prices under the Company’s contracts allocated to the Company’s remaining performance obligations was $8,798, approximately 57% of which the Company expects to recognize as revenue over the next twelve months, and the remainder thereafter. This aggregate amount excludes amounts allocated to remaining performance obligations under contracts that have an original duration of one year or less and variable consideration that is allocated to remaining performance obligations. Excluded based on this policy are balances related to PandoLogic representing gross purchase orders to be satisfied in less than one year. Revenues will be recognized net of costs to fulfill these orders.

9

Significant Accounting Policies

There have been no material changes in the Company’s significant accounting policies from those disclosed in its Annual Report on Form 10-K for the year ended December 31, 2021, other than those associated with the recently adopted leasing guidance as further described in Note 9.

Recently Adopted Accounting Pronouncements

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). The amendments under this pronouncement change the way all leases with duration of one year or more are treated. Under this guidance, lessees are required to capitalize virtually all leases on the balance sheet as a right-of-use asset and an associated financing lease liability or operating lease liability. On January 1, 2022, the Company adopted the new leasing standard using the modified retrospective transition method applied at the adoption date of the standard. See Note 9 for further details.

In December 2019, the FASB issued ASU No. 2019-12 to simplify the accounting in ASC 740, Income Taxes. This standard removes certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. This guidance also clarifies and simplifies other areas of ASC 740. The Company adopted this guidance on January 1, 2022 using the prospective transition method. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

Recently Issued Accounting Pronouncements

In September 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326) which requires measurement and recognition of expected credit losses for financial assets held. This standard will be effective for the Company beginning in the first quarter of fiscal year 2023, and early adoption is permitted. The Company is currently evaluating the impact that this standard will have on its consolidated financial statements and related disclosures as well as the timing of adoption.

In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires entities to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with ASC Topic 606, Revenue from Contracts with Customers, in order to align the recognition of a contract liability with the definition of a performance obligation. This standard will be effective for the Company beginning in the first quarter of fiscal year 2023, and early adoption is permitted. The Company is currently evaluating the impact that this standard will have on its financial statements and related disclosures as well as the timing of adoption.

NOTE 3. BUSINESS COMBINATIONS

March 2022 Acquisition

On March 1, 2022, the Company acquired 100% of an influencer-based management company, which is a California limited liability company, pursuant to a securities purchase agreement (the “Purchase Agreement”) dated as of March 1, 2022. The entity is an influencer management company that works with a select group of social media influencers to create content and custom marketing campaigns for brand partners and agencies.

The total purchase consideration was $5,844 (the “March Acquisition Consideration”), which consisted of upfront consideration of $1,500 in cash, $1,929 for the fair value of the Company’s 116,550 shares of common stock, and deferred cash payments to be made in 2023 and 2024 totaling $3,000, which was estimated to have a fair value of $2,707 on the acquisition date. The total purchase price was decreased by $976 for the settlement of a preexisting receivable and increased by $684 to adjust for the cash on hand at the time of the transaction closing. The total purchase consideration is preliminary and subject to net working capital adjustments that the Company expects to finalize and settle in the measurement period. In addition, the sellers may receive up to $4,500 in contingent earnout consideration based on achieving certain milestones tied to the entity’s financial performance in fiscal 2022 and 2023, which amount will be paid in cash (the “Earnout”). The fair value of the Earnout was estimated to be $3,015 as of March 1, 2022, all of which was deemed to be compensation to the seller which will be recognized as compensation expense over the earnout period in the general and administrative expenses on the condensed consolidated statement of operations and comprehensive loss. The Company incurred $270 in acquisition-related expenses and has recorded them in general and administrative expenses in the condensed consolidated statement of operations and comprehensive loss.

10

The following table summarizes the fair value of the purchase price consideration (in thousands):

March Acquisition Consideration	Preliminary
Cash consideration at closing	$	1,500
Equity consideration at closing		1,929
Deferred consideration		2,707
Acquired cash		684
Settlement of pre-existing receivable		(976	)
Total	$	5,844

The preliminary allocation of the purchase consideration to tangible and intangible assets acquired and liabilities assumed is based on estimated fair values and is as follows (in thousands):

Preliminary allocation of March Acquisition Consideration**	Preliminary
Cash	$	715
Accounts receivable		1,088
Prepaid and other current assets		120
Property and equipment		53
Intangible assets		3,000
Other assets		247
Total assets acquired		5,223
Accounts payable		18
Accrued expenses and other current liabilities		1,793
Operating lease liabilities, non-current		140
Total liabilities assumed		1,951
Identifiable net assets acquired	$	3,272
Goodwill		2,572
Total purchase consideration	$	5,844

**The excess of the total consideration over the tangible assets, identifiable intangible assets, and assumed liabilities is recorded as goodwill. Goodwill is primarily attributable to opportunities to cross-sell into our Commercial Enterprise customer base. For income tax purposes, the Company elected to treat the transaction as an asset acquisition. Tax deductible goodwill generated from the acquisition is $2,842 (including transaction costs of $270).

Identifiable Intangible Assets

The identifiable intangible assets acquired consisted of the influencer network, trade name and brand relationships with estimated useful lives of 2-10 years. The Company amortizes the fair value of these intangible assets on a straight-line basis over their respective useful lives.

The fair value of the intangible assets has been estimated using an income approach. Under the income approach, the after-tax cash flows associated with the asset are discounted to present value. The key assumptions include the Company’s estimates of the projected cash flows and discount rates.

The valuation of the intangible assets acquired along with their estimated useful lives, is as follows (in thousands):

	Estimated Fair Value		Estimated Useful Lives (in years)
Influencer network	$	1,500		5
Trade name		200		10
Brand relationships		1,300		5
Total intangible assets	$	3,000

11

PandoLogic Acquisition

On September 14, 2021, the Company acquired 100% of PandoLogic., a company incorporated under the laws of the state of Israel, pursuant to an Agreement and Plan of Merger (the “Merger Agreement”) dated as of July 21, 2021. PandoLogic is a leading provider of intelligent hiring solutions and utilizes its proprietary platform to accelerate the time and improve the efficiency in the process for employers hiring at scale for both mass market and difficult-to-source candidates. PandoLogic’s fully autonomous recruiting platform helps employers source talent faster and more efficiently with predictive algorithms, machine learning and AI.

The total purchase consideration for PandoLogic was $135,563 (the “Merger Consideration”), which consisted of upfront consideration of $58,733 in cash and $31,500 for the fair value of the Company’s 1,704,822 shares of common stock, up to $65,000 in contingent consideration based on achieving certain earnouts tied to financial performance of PandoLogic in fiscal 2021 and 2022, which amount will be paid in a combination of cash and common stock (the “Earnout”) and a net working capital adjustment of $5,818 paid in cash. The Company utilized a Monte Carlo simulation model to estimate the fair value of the Earnout. The fair value of the Earnout was estimated to be $44,900 as of September 14, 2021, $39,512 of which was deemed to be purchase consideration and recorded within contingent consideration current and contingent consideration non-current on the condensed consolidated balance sheet. The remaining $5,388 will be recognized as compensation expense over the earnout period in the general and administrative expenses on the condensed consolidated statement of operations and comprehensive loss. Subsequent to the acquisition date, the Company is required to reassess its estimate of the fair value of the Earnout, including certain future Earnout obligations triggered on the employment status of certain PandoLogic management, and record any changes in earnings when the estimate is based on information not known as of the acquisition date (See Note 5). The Company incurred $2,161 in acquisition-related expenses in 2021 and has recorded them in general and administrative expenses in the condensed consolidated statement of operations and comprehensive loss.

The following table summarizes the fair value of the purchase price consideration (in thousands):

Merger Consideration	Amount
Cash consideration at closing	$	58,733
Equity consideration at closing		31,500
Contingent earnout		39,512
Net working capital adjustment		5,818
Total	$	135,563

The preliminary allocation of the purchase consideration to tangible and intangible assets acquired and liabilities assumed is based on estimated fair values and is as follows (in thousands):

Allocation of Merger Consideration**	Amount
Cash	$	11,581
Accounts receivable		21,344
Prepaid and other current assets		8,710
Property and equipment		618
Intangible assets		92,000
Other assets		1,653
Total assets acquired		135,906
Accounts payable		13,183
Accrued expenses and other current liabilities		9,443
Deferred tax liability		12,686
Total liabilities assumed		35,312
Identifiable net assets acquired	$	100,594
Goodwill		34,969
Total purchase consideration	$	135,563

**The excess of the total consideration over the tangible assets, identifiable intangible assets, and assumed liabilities is recorded as goodwill. Goodwill is primarily attributable to operational efficiencies from operating PandoLogic products on aiWARE as well as opportunities to cross-sell into our Commercial Enterprise customer base.

12

 Identifiable Intangible Assets

The identifiable intangible assets acquired consisted of developed technology, customer relationships and tradename with estimated useful lives of 4-7 years. The Company amortizes the fair value of these intangible assets on a straight-line basis over their respective useful lives.

The fair value of the intangible assets has been estimated using a combination of the income and cost approaches. Under the income approach, the after-tax cash flows associated with the asset are discounted to present value. The key assumptions include the Company’s estimates of the projected cash flows and discount rates. Under the cost approach, the replacement cost is used to estimate the value of the asset. The key assumptions include the Company’s estimates of the direct and indirect costs required to replace the asset. The valuation of the intangible assets acquired from PandoLogic along with their estimated useful lives, is as follows (in thousands):

	Estimated Fair Value		Estimated Useful Lives (in years)
Customer relationships	$	70,000	5 - 7
Developed technology		20,000		4
Trade name		2,000		5
Total intangible assets	$	92,000

Taxes

In connection with the acquisition, a net deferred tax liability of $12,686 was established primarily for the differences between the fair value of the acquired non-goodwill intangible assets and PandoLogic’s historical tax basis in these assets. No deferred tax asset or liability is recorded on PandoLogic goodwill, $33,111 of which is not deductible for tax purposes.  In August 2021, PandoLogic obtained the approval for Preferred Technology Enterprise status under which its Israeli tax rate is reduced from the 23% statutory rate to a 12% beneficial rate.  This arrangement is scheduled to expire in December 2025. The acquired Israel deferred tax assets and liabilities are computed based on the tax rate in the year of their expected reversal. No valuation allowance is recorded on the acquired PandoLogic deferred tax assets as it is more likely than not they will be utilized to offset future taxable income.

Unaudited Pro Forma Results

The unaudited pro forma financial information in the table below summarizes the combined results of operations for Veritone and PandoLogic as if the companies were combined for the three-month periods ended March 31, 2021. The unaudited pro forma financial information for all periods presented included the business combination accounting effects resulting from this acquisition, including adjustments to reflect recognition of intangible asset amortization and accretion of contingent consideration. The unaudited pro forma financial information as presented below is for informational purposes only and is not necessarily indicative of the results of operations that would have been achieved if the acquisition had taken place at the beginning of January 1, 2021.

The unaudited pro forma financial information was as follows (in thousands):

	Three Months Ended
	March 31,
	2021
Net revenue	$	23,794
Loss before provision for income taxes	$	(36,392	)
Net loss	$	(35,755	)

NOTE 4. DEBT

Convertible Senior Notes

In November 2021, the Company issued, at par value, $201.3 million aggregate principal amount of 1.75% convertible senior notes due 2026 (the “Convertible Notes”). The issuance included the full exercise of an option granted by the Company to the initial purchasers of the Convertible Notes to purchase an additional $26.25 million aggregate principal amount of Convertible Notes. The Convertible Notes were issued pursuant to and are subject to the terms and conditions of an indenture, which is referred to as the Indenture, between the Company and U.S. Bank National Association, as trustee. The Convertible Notes were offered and sold in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

13

The Convertible Notes are senior, unsecured obligations of the Company and bear interest at a rate of 1.75% per year. Interest accrues from November 19, 2021 and is payable semi-annually in arrears on May 15 and November 15 of each year, beginning on May 15, 2022. The Convertible Notes will mature on November 15, 2026, unless earlier converted, redeemed, or repurchased in accordance with the terms of the Convertible Notes.

Holders of the Convertible Notes may convert all or any portion of their Convertible Notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2026, only under the following conditions: (1) during any calendar quarter commencing after the calendar quarter ending on March 31, 2022 (and only during such calendar quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of Convertible Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate for the Convertible Notes on each such trading day; (3) if the Company calls such Convertible Notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the applicable redemption date; or (4) upon the occurrence of specified corporate events. On or after May 15, 2026, holders may convert all or any portion of their Convertible Notes at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date regardless of the foregoing conditions. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of its common stock or a combination of cash and shares of its common stock, at the Company’s election.

The conversion rate for the Convertible Notes will initially be 27.2068 shares of the Company’s common stock per $1,000 principal amount of Convertible Notes (equivalent to an initial conversion price of approximately $36.76 per share of common stock). The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date or following the Company’s issuance of a notice of redemption, the Company will, in certain circumstances, increase the conversion rate for a holder who elects to convert its Convertible Notes in connection with such a corporate event or who elects to convert its Convertible Notes called (or deemed called) for redemption during the related redemption period, as the case may be.

The Company may not redeem the Convertible Notes prior to November 20, 2024. The Company may redeem for cash all or any portion of the Convertible Notes (subject to certain limitations), at its option, on or after November 20, 2024 if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the Convertible Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No sinking fund is provided for the Convertible Notes.

If the Company undergoes a fundamental change prior to the maturity date, subject to certain conditions, holders may require the Company to repurchase for cash all or any portion of their Convertible Notes. The fundamental change repurchase price will be equal to 100% of the principal amount of the Convertible Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.

The Convertible Notes are the Company’s senior unsecured obligations and rank senior in right of payment to all of the Company’s indebtedness that is expressly subordinated in right of payment to the Convertible Notes; equal in right of payment with all existing and future liabilities of the Company that are not so subordinated; effectively junior to any of secured indebtedness of the Company to the extent of the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities (including trade payables) and any preferred equity of the Company’s current or future subsidiaries.

The net proceeds from the issuance of the Convertible Notes were approximately $194.9 million, after deducting debt issuance costs. The total debt issuance costs incurred and recorded by the Company amounted to $6.3 million, which were recorded as a reduction to the face amount of the Convertible Notes and are being amortized to interest expense using the effective interest method over the contractual term of the Convertible Notes. The Convertible Notes are recorded as a liability within convertible senior notes, non-current.

For the three months ended March 31, 2022, interest expense related to the Convertible Notes and amortization of the issuance costs was $1.2 million. The effective annual interest rate for the three months ended March 31, 2022 was approximately 2.42%. As of March 31, 2022, the if-converted value of the Convertible Notes did not exceed the outstanding principal amount. As of March 31, 2022, the total estimated fair value of the Convertible Notes was $176.3 million, which was determined based on a market approach using actual bids and offers of the Convertible Notes in an over-the-counter market on the last trading day of the period. The Company considers these assumptions to be Level 2 inputs in accordance with the fair value hierarchy described in Note 6.

14

Capped Calls

In connection with the pricing of the Convertible Notes, with the full exercise by the initial purchasers of their option to purchase additional Convertible Notes in November 2021, the Company used approximately $18.6 million of the net proceeds from the issuance of the Convertible Notes to enter into privately negotiated capped call transactions, which are referred to as the capped calls, with various financial institutions.

The capped call transactions will cover, subject to anti-dilution adjustments substantially similar to those applicable to the Convertible Notes, the number of shares of the Company’s common stock underlying the Convertible Notes. The capped call transactions are expected generally to reduce the potential dilution to the Company’s common stock upon conversion of the Convertible Notes and/or offset some or all of any cash payments the Company is required to make in excess of the principal amount of converted Convertible Notes, as the case may be, in the event that the market price per share of the Company’s common stock, as measured under the terms of the capped call transactions, is greater than the strike price of the capped call transactions, which initially corresponds to the conversion price of the Convertible Notes and is subject to anti-dilution adjustments substantially similar to those applicable to the conversion rate of the Convertible Notes. If, however, the market price per share of the Company’s common stock, as measured under the terms of the capped call transactions, exceeds the cap price of the capped call transactions, there would nevertheless be dilution and/or there would not be an offset of such potential cash payments, in each case, to the extent that such market price exceeds the cap price of the capped call transactions. The initial cap price of the capped calls is $48.55 per share of common stock, which represents a premium of 75% over the last reported sale price of the Company’s common stock of $27.74 per share on November 16, 2021, and is subject to certain customary adjustments under the terms of the capped calls; provided that the cap price will not be reduced to an amount less than the strike price of $35.76 per share.

The capped call transactions are separate transactions and are not part of the terms of the Convertible Notes. The capped calls meet the criteria for classification as equity and, as such, are not remeasured each reporting period and are included as a reduction to additional paid-in-capital within stockholders’ equity.

NOTE 5. NET LOSS PER SHARE

The following table presents the computation of basic and diluted net loss per share:

	Three Months Ended
	March 31,
	2022
	(As Restated)			2021
Numerator
Net loss	$	(22,129	)	$	(30,567	)
Denominator
Weighted-average common shares outstanding		35,478,676			32,191,419
Less:  Weighted-average shares subject to repurchase		(1,728	)		(19,381	)
Denominator for basic and diluted net loss per share    attributable to common stockholders		35,476,948			32,172,038
Basic and diluted net loss per share	$	(0.62	)	$	(0.95	)

The Company reported net losses for all periods presented and, as such, all potentially dilutive shares of common stock would have been antidilutive for such periods. The table below presents the weighted-average securities (in common equivalent shares) outstanding during the periods presented that have been excluded from the calculation of diluted net loss per share because their effect would be anti-dilutive:

	Three Months Ended
	March 31,
	2022		2021
Common stock options and restricted stock units		10,025,447		10,274,878
Warrants to purchase common stock		496,612		639,169
Common stock issuable in connection with convertible senior notes		5,475,369		—
		15,997,428		10,914,047

15

NOTE 6. FINANCIAL INSTRUMENTS

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs that may be used to measure fair value. Level 1 and Level 2 are considered observable and Level 3 is considered unobservable, as follows:

• Level 1—quoted prices (unadjusted) in active markets for identical assets or liabilities;

• Level 2—inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or

• Level 3—unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

Cash and Cash Equivalents

The Company’s money market funds are categorized as Level 1 within the fair value hierarchy. As of March 31, 2022, the Company’s cash and cash equivalents were as follows:

			Gross				Cash and
			Unrealized		Fair		Cash
	Cost		Losses		Value		Equivalents
Cash	$	236,524	$	—	$	236,524	$	236,524
Level 1:
Money market funds		1,029		—		1,029		1,029
Total	$	237,553	$	—	$	237,553	$	237,553

As of December 31, 2021, the Company’s cash and cash equivalents balances were as follows:

			Gross				Cash and
			Unrealized		Fair		Cash
	Cost		Losses		Value		Equivalents
Cash	$	253,693	$	—	$	253,693	$	253,693
Level 1:
Money market funds		1,029		—		1,029		1,029
Total	$	254,722	$	—	$	254,722	$	254,722

Contingent Consideration

All of the Company’s contingent consideration liabilities are categorized as Level 3 within the fair value hierarchy. Contingent consideration for the PandoLogic acquisition was valued at the time of acquisition using Monte Carlo simulation models. These models incorporate contractual terms and assumptions regarding financial forecasts for PandoLogic, discount rates, and volatility of forecasted revenue. The value of the Company’s contingent consideration would increase if a lower discount rate was used and would decrease if a higher discount rate was used. Similarly, a higher revenue volatility assumption would increase the value of the contingent consideration, and a lower revenue volatility assumption would decrease the value of the contingent consideration. Contingent consideration for the March 2022 acquisition was valued using a simple probability of achievement model, with the probability of achievement based on management’s forecasted outcomes for 2022 and 2023 fiscal year results for the acquired entity. The development and determination of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company’s management with the assistance of a third-party valuation specialist. 

As of March 31, 2022, the Company’s contingent consideration liabilities current and non-current balances were as follows:

			Changes in					Fair		Contingent
	Cost		Fair Value		Amount Paid			Value		Consideration
	(As Restated)		(As Restated)		In Period			(As Restated)		(As Restated)
Level 3:
Contingent consideration, current	$	18,128	$	2,822	$	(20,816	)	$	134	$	134
Contingent consideration, non-current		21,384		14,297		—			35,681		35,681
Total	$	39,512	$	17,119	$	(20,816	)	$	35,815	$	35,815

16

As of December 31, 2021, the Company’s contingent consideration liabilities current and non-current balances were as follows:

			Changes in		Fair		Contingent
	Cost		Fair Value		Value		Consideration
Level 3:
Contingent consideration, current	$	18,128	$	1,925	$	20,053	$	20,053
Contingent consideration, non-current		21,384		10,149		31,533		31,533
Total	$	39,512	$	12,074	$	51,586	$	51,586

Stock Warrants

All of the Company’s outstanding stock warrants are categorized as Level 3 within the fair value hierarchy. Stock warrants have been recorded at their fair value using either a probability weighted expected return model, the Monte Carlo simulation model or the Black-Scholes option-pricing model. These models incorporate contractual terms, maturity, risk-free interest rates and volatility. The value of the Company’s stock warrants would increase if a higher risk-free interest rate was used and would decrease if a lower risk-free interest rate was used. Similarly, a higher volatility assumption would increase the value of the stock warrants, and a lower volatility assumption would decrease the value of the stock warrants. The development and determination of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company’s management with the assistance of a third-party valuation specialist. 

Investments

During the three months ended March 31, 2022, the Company invested $2,000 in a strategic investment in a technology company that was determined to not have a readily determinable fair value. This investment is carried initially at cost of $2,000 on our condensed consolidated balance sheet within other assets. The Company will monitor this investment to determine whether an other-than-temporary decline in value indicates that impairment charges may be required. The Company will also re-measure its investment if there is an observable transaction in a similar class of security to our investment.

NOTE 7. GOODWILL AND INTANGIBLE ASSETS, NET

Goodwill

The carrying amount of goodwill was $44,600 as of March 31, 2022 and $42,028 December 31, 2021.

	Goodwill
Balance at December 31, 2021	$	42,028
March 2022 acquisition		2,572
Balance at March 31, 2022	$	44,600

Intangible Assets

The following table sets forth the Company’s finite-lived intangible assets resulting from business acquisitions and other purchases, which continue to be amortized: 

			March 31, 2022
			(As Restated)							December 31, 2021
	Weighted Average Remaining Useful Life (in years)		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
Software and technology		0.0	$	3,582	$	(3,555	)	$	27	$	3,582	$	(3,515	)	$	67
Licensed technology		0.0		500		(500	)		—		500		(500	)		—
Developed technology		3.1		29,600		(9,201	)		20,399		29,600		(7,647	)		21,953
Customer and supplier relationships		5.9		82,100		(12,715	)		69,385		79,300		(9,449	)		69,851
Noncompete agreements		0.3		800		(727	)		73		800		(683	)		117
Trade names		4.6		2,300		(317	)		1,983		2,100		(216	)		1,884
Total		5.4	$	118,882	$	(27,015	)	$	91,867	$	115,882	$	(22,010	)	$	93,872

17

The following table presents future amortization of the Company’s finite-lived intangible assets at March 31, 2022:

	(As Restated)
2022 (9 months)	$	15,496
2023		19,177
2024		17,365
2025		14,074
2026		10,574
Thereafter		15,181
Total	$	91,867

NOTE 8. CONSOLIDATED FINANCIAL STATEMENTS DETAILS

Consolidated Balance Sheets Details

Cash and cash equivalents

As of March 31, 2022 and December 31, 2021, the Company had cash and cash equivalents of $237,553 and $254,722, respectively, including $69,496 and $66,401, respectively, of cash received from advertising customers and content licensees for future payments to vendors. 

Accounts Receivable, Net

Accounts receivable consisted of the following:

	As of
	March 31,			December 31,
	2022			2021
Accounts receivable — Managed Services(1)	$	35,648		$	21,347
Accounts receivable — Software Products & Services(2)		25,847			59,568
Accounts receivable — Other		6,452			4,926
		67,947			85,841
Less: allowance for doubtful accounts		(972	)		(778	)
Accounts receivable, net	$	66,975		$	85,063

⁽¹⁾ Accounts receivable – Managed Services reflects the amounts due from the Company’s advertising customers.

⁽²⁾ Accounts receivable – Software Products & Services reflects the amounts due from the Company’s PandoLogic customers.

Property, Equipment and Improvements, Net

Property, equipment and improvements, net consisted of the following:

	As of
	March 31,			December 31,
	2022			2021
Property and equipment	$	5,088		$	4,262
Leasehold improvements		167			167
		5,255			4,429
Less: accumulated depreciation		(3,118	)		(2,873	)
Property, equipment and improvements, net	$	2,137		$	1,556

Depreciation expense was $198 and $175 for the three months ended March 31, 2022 and 2021, respectively.

Accounts Payable

Accounts payable consisted of the following:

	As of
	March 31,		December 31,
	2022		2021
Accounts payable — Managed Services(1)	$	27,440	$	23,613
Accounts payable — Other		10,905		23,098
Total	$	38,345	$	46,711

18

⁽¹⁾ Accounts payable – Managed Services reflects the amounts due to media vendors for advertisements placed on behalf of the Company’s advertising clients.

Consolidated Statement of Operations and Comprehensive Loss Details

Revenue

Revenue for the periods presented were comprised of the following:

	Three Months Ended
	March 31,
	2022		2021
Commercial Enterprise	$	33,626	$	17,005
Government & Regulated Entities		781		1,290
Total revenue	$	34,407	$	18,295

In the third quarter of fiscal year 2021, the Company realigned its organization to improve focus and growth into two customer groups: (1) Commercial Enterprise (“CE”), which today consists of customers in the commercial sector, including media and entertainment customers, advertising customers, content licensing customers and PandoLogic customers; and (2) Government & Regulated Industries (“GRI”), which today consists of customers in the government and regulated industries sectors, including state, local and federal government, legal, compliance and energy customers.

Software Products & Services consists of revenue generated from the Company’s aiWARE platform and PandoLogic’s talent acquisition solutions, any related support and maintenance services, and any related professional services associated with the deployment and or implementation of such solutions.

Managed Services consists of revenues generated from content licensing customers and advertising agency customers and related services.

The table below illustrates the presentation of our revenues based on the above definitions:

	Three Months Ended
	March 31, 2022
			Government &
	Commercial		Regulated
	Enterprise		Industries		Total
Total Software Products & Services(1)	$	17,386	$	781	$	18,167
Managed Services
Advertising		10,968		—		10,968
Licensing		5,272		—		5,272
Total Managed Services		16,240		—		16,240
Total Revenue	$	33,626	$	781	$	34,407

⁽¹⁾ Software Products & Services consists of aiWARE revenues of $3,371 and PandoLogic revenues of $14,796.

19

	Three Months Ended
	March 31, 2021
			Government &
	Commercial		Regulated
	Enterprise		Industries		Total
Total Software Products & Services	$	3,395	$	1,290	$	4,685
Managed Services
Advertising		10,327		—		10,327
Licensing		3,283		—		3,283
Total Managed Services		13,610		—		13,610
Total Revenue	$	17,005	$	1,290	$	18,295

Other Expense, Net

Other expense, net for the periods presented was comprised of the following:

	Three Months Ended
	March 31,
	2022			2021
Interest (expense) income, net	$	(1,182	)	$	2
Other		(4	)		(11	)
Other expense, net	$	(1,186	)	$	(9	)

Provision for Income Taxes

The provision or benefit from income taxes for interim periods is determined using an estimate of the Company’s annual effective tax rate, adjusted for discrete items, if any, that are taken into account in the relevant period. Each quarter, the Company updates the estimate of the annual effective tax rate, and if the estimated tax rate changes, the Company records a cumulative adjustment. 

The income tax expense for the three months ended March 31, 2022 and 2021 resulted in an effective tax rate of (0.6)% and (0.1)%, respectively. The difference between the effective tax rate and the U.S. federal statutory rate is primarily due to a valuation allowance established on the majority of the Company’s federal and state net deferred tax assets and certain of its foreign operations. Due to tax losses and an offsetting valuation allowance against a majority of the U.S deferred tax assets, the Company recorded a tax provision in the amount of $138 for the three months ended March 31, 2022 as compared to $22 for the three months ended March 31, 2021. The increase is mainly attributed to the US and foreign income taxes resulted from the profitability of PandoLogic.

As of March 31, 2022, the Company continues to provide a valuation allowance against certain federal and state deferred tax assets. The Company continues to evaluate the realizability of deferred tax assets and the related valuation allowance. If the Company’s assessment of the deferred tax assets or the corresponding valuation allowance were to change, the Company would record the related adjustment to income during the period in which the determination is made.

The Company is subject to taxation in the U.S. and various foreign jurisdictions. The tax years subsequent to 2016 remain open and subject to examination by federal, state, and foreign taxing authorities in which the Company is subject to tax. The Company is not under examination in any other jurisdictions.

NOTE 9. LEASES, COMMITMENTS AND CONTINGENCIES

Leases

Adoption of the New Lease Accounting Standard

On January 1, 2022, the Company adopted ASU No. 2016-02, Leases (Topic 842), using the modified retrospective transition method applied at the adoption date of the standard. Results for reporting periods beginning after January 1, 2022 are presented under the new leasing standard, while prior period amounts are not adjusted and continue to be reported in accordance with the Company’s historic accounting. The Company has elected to utilize the package of practical expedients at the time of adoption, which allows the Company to (1) not reassess whether any expired or existing contracts are or contain leases, (2) not reassess the lease classification of any expired or existing leases, and (3) not reassess initial direct costs for any existing leases. The Company also has elected to utilize the short-term lease recognition exemption and, for those leases that qualified, the Company did not recognize right-of-use (“ROU”) assets or lease liabilities.

20

As a result of adoption, the Company recorded ROU assets related to office facility leases which are recognized on the consolidated balance sheet within “other assets” and the associated lease liabilities are recognized on the consolidated balance sheet within “other accrued liabilities” and “other non-current liabilities.” The present value of the Company’s remaining lease payments, which comprise the lease liabilities, was estimated using the incremental borrowing rate as of the adoption date.

The cumulative effects of the changes made to the Company’s January 1, 2022 consolidated balance sheet were as follows:

	December 31, 2021			Adjustments Due to Adoption of New Leasing Standard			January 1, 2022
Assets
Prepaid expenses and other current assets	$	12,117		$	71		$	12,188
Other assets		954			1,983			2,937
								-
Liabilities								-
Other accrued liabilities	$	27,093		$	1,675		$	28,768
Other non-current liabilities		13,891			1,057			14,948
								-
Stockholders' Equity								-
Accumulated deficit	$	(345,037	)	$	(678	)	$	(345,715	)

New Lease Accounting Policies

The Company determines if an arrangement is a lease at inception and determine the classification of the lease, as either operating or finance, at commencement. The Company has various operating leases for its offices. These existing leases have remaining lease terms ranging from 1 to 5 years. Certain lease agreements contain options to renew, with renewal terms that generally extend the lease terms by 1 to 5 years for each option. The Company determined that none of its current leases are reasonably certain to renew. For short-term leases with expected terms of less than 1 year, the Company does not recognize ROU assets or lease liabilities. The Company does not have any finance leases.

ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As the rate implicit in the Company’s leases is not readily determinable, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. The Company estimates the incremental borrowing rate to reflect the profile of secured borrowing over the expected term of the leases based on the information available at the later of the initial date of adoption or the lease commencement date.

The operating lease ROU asset also includes any lease payments made and excludes lease incentives received at or before lease commencement. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Sublease rental income is recognized as a reduction to the related lease expense on a straight-line basis over the sublease term.

Lease Costs

As of March 31, 2022, on its condensed consolidated balance sheet the Company has right-of-use assets of $2,556 recorded within other assets, the current portion of operating lease liabilities of $2,106 recorded within other accrued liabilities, and the non-current portion of operating lease liabilities of $2,851 recorded within other non-current liabilities.

The Company made cash payments for its operating leases of $652 for the three months ended March 31, 2022, all of which were included in cash flows from operating activities within the condensed consolidated statements of cash flows. The Company’s operating leases have a weighted average remaining lease term of 2.7 years and weighted average discount rate of 7.8%.

In February 2021, the Company entered into an office sublease (the “Sublease”) with a third party (the “Subtenant”), pursuant to which the Company has subleased its former office space located in Costa Mesa, California, consisting of approximately 37,875 square feet, which the Company leases pursuant to an existing lease agreement expiring in 2024 (the “Lease”). The term of the Sublease commenced in March 2021 and will continue through December 31, 2024, coterminous with the Lease. Pursuant to the Sublease, the Subtenant will pay to the Company monthly base rent, which is subject to annual rent escalations, as well as a portion of the operating expenses and taxes payable by the Company under the Lease. The Company recognized contract termination costs as a liability when it ceased using the rights conveyed under the Lease. During the three months ended March 31, 2021, the Company recorded approximately $3,367 in charges resulting from the Sublease, consisting of $1,894 loss on disposal of property and equipment and leasehold improvements, $1,211 loss on sublease, and $262 in initial direct costs.

21

The total rent expense for all operating leases, excluding the charges related to the Sublease discussed above, was $506 and $571 for the three months ended March 31, 2022 and 2021, respectively, with short-term leases making up an immaterial portion of such expenses. For its sublease, the Company recorded sublease income of $277 for the three months ended March 31, 2022.

Lease Commitments

 Future undiscounted lease payments for the Company’s operating lease liabilities, a reconciliation of these payments to its operating lease liabilities, and related sublease income at December 31, 2021 are as follows:

Years ended December 31,
2022 (nine months)	$	2,095
2023		2,241
2024		1,792
Total future minimum lease payments, including short-term leases		6,128
Less: future minimum lease payments for short-term leases		(602	)
Less: imputed interest		(569	)
Present value of future minimum lease payments, excluding short-term leases	$	4,957
Less: current portion of operating lease liabilities		(2,106	)
Non-current portion of operating lease liabilities		2,851
Years ended December 31,	Sublease Income
2022 (nine months)	$	782
2023		1,297
2024		1,034
Total sublease income	$	3,113

22

As previously disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 under the previous lease accounting standard, future minimum lease payments at December 31, 2021, on an undiscounted basis, were as follows:    

2022	$	2,532
2023		2,091
2024		1,730
Total minimum payments	$	6,353

As of December 31, 2021, minimum sublease rental income to be received in the future under noncancelable subleases was approximately $3,402 and the total rent expense for all operating leases was $4,668 for the year ended December 31, 2021.

Sales Taxes

The Company collects and remits sales tax in jurisdictions in which it has a physical presence or it believes tax nexus exists, which therefore obligates the Company to collect and remit sales tax. During the three months ended March 31, 2022 and 2021, the Company recorded a $134 liability and a $138 liability, respectively, for potential exposure in several states where there is uncertainty about the point in time at which the Company established a sufficient business connection to create nexus.

Purchase Consideration

In connection with its March 2022 acquisition, the Company committed to make purchase consideration payments of $1,500 within ten days of the first anniversary of the closing date of the acquisition and an additional $1,500 within ten days of the second anniversary of the closing date of the acquisition. Refer to Note 3 for further details.

Other Contingencies

From time to time, the Company may be involved in litigation relating to claims arising out of its operations in the normal course of business. The Company currently is not a party to any legal proceedings, the adverse outcome of which, in management’s opinion, individually or in the aggregate, would have a material adverse effect on the Company’s results of operations, financial position or cash flows.

NOTE 10. STOCKHOLDERS’ EQUITY

Common Stock Issuances

During the three months ended March 31, 2022 and 2021, the Company issued an aggregate of 615,703 and 608,886 shares of its common stock, respectively, in connection with the exercise of stock options, issuance of stock awards and vesting of restricted stock units under its stock incentive plans and purchases under its Employee Stock Purchase Plan (the “ESPP”).

During the three months ended March 31, 2022, the Company issued a total of 116,550 shares of its common stock in connection with its March 2022 acquisition. During the three months ended March 31, 2022, the Company issued a total of 352,330 shares of its common stock in connection with the contingent consideration arrangement related to the acquisition of PandoLogic.

During the three months ended March 31, 2021, the Company issued a total of 167,495 shares of its common stock upon the exercise of warrants for an aggregate exercise price of $2,279 and issued an aggregate of 84,723 shares of its common stock upon exercises of warrants to purchase an aggregate of 91,833 shares of its common stock, which were effected on a net exercise basis without cash payment of the exercise price.

During the three months ended March 31, 2021, the Company issued an aggregate of 15,828 shares of its common stock for services provided to the Company.

NOTE 11. STOCK PLANS

Stock-Based Compensation

During the three months ended March 31, 2022, the Company granted options to purchase an aggregate of 480,850 shares of its common stock that are subject to time-based vesting conditions.

23

The Company valued these stock options using the Black-Scholes Merton option pricing model. The following assumptions were used to compute the grant date fair values of the stock options granted during the three months ended March 31, 2022:

Expected term (in years)	6.1
Expected volatility	82	%
Risk-free interest rate	1.8	%
Expected dividend yield	—

The assumptions used in calculating the fair values of purchase rights granted under the ESPP during the three months ended March 31, 2022 are set forth in the table below:

Expected term (in years)	0.5 - 2.0
Expected volatility	71% - 88%
Risk-free interest rate	0.2% - 2.4%
Expected dividend yield		—

The Company’s stock-based compensation expense by type of award and by operating expense grouping are presented below:

	Three Months Ended
	March 31,
	2022		2021
Stock-based compensation expense by type of award:
Restricted stock units	$	3,432	$	4,171
Stock awards		—		19
Performance-based stock options		—		16,314
Stock options		1,273		837
Employee stock purchase plan		92		150
Common stock issued for services		19		119
Total	$	4,816	$	21,610
Stock-based compensation expense by operating expense grouping:
Cost of revenue	$	20	$	-
Sales and marketing		463		898
Research and development		1,004		1,019
General and administrative		3,329		19,693
	$	4,816	$	21,610

Equity Award Activity Under Stock Plans

Restricted Stock Units

The Company’s restricted stock unit activity for the three months ended March 31, 2022 was as follows:

				Weighted
				Average Grant
	Shares			Date Fair Value
Unvested at December 31, 2021		886,461		$	32.56
Granted		402,811		$	16.47
Forfeited		(28,824	)	$	23.20
Vested		(328,956	)	$	46.65
Unvested at March 31, 2022		931,492		$	21.01

As of March 31, 2022, total unrecognized compensation cost related to restricted stock units was $14,362, which is expected to be recognized over a weighted average period of 2.18 years.

24

Performance-Based Stock Options

The activity during the three months ended March 31, 2022 related to stock options that are subject to performance-based vesting conditions tied to the achievement of stock price goals by the Company was as follows:

				Weighted-Average
						Remaining		Aggregate
				Exercise		Contractual		Intrinsic
	Options			Price		Term		Value
Outstanding at December 31, 2021		3,834,441		$	11.05
Exercised		(21,713	)	$	5.55
Expired		(7,277	)	$	4.94
Outstanding at March 31, 2022		3,805,451		$	11.09		6.3	$	27,350
Exercisable at March 31, 2022		3,805,451		$	11.09		6.3	$	27,350

The aggregate intrinsic value of the options exercised during the three months ended March 31, 2022 and 2021 was $221 and $5,815, respectively. No performance-based stock options were granted during the three months ended March 31, 2022 and 2021 and no performance-based stock options vested during the three months ended March 31, 2022. During the three months ended March 31, 2021, the Company achieved all of the stock price milestones applicable to substantially all of the performance-based stock options and, as a result, such performance-based stock options vested and all associated unrecognized compensation was accelerated and recognized in full as a one-time expense of $16,268. 

Stock Options

The activity during the three months ended March 31, 2022 related to all other stock options was as follows:

				Weighted-Average
						Remaining		Aggregate
				Exercise		Contractual		Intrinsic
	Options			Price		Term		Value
Outstanding at December 31, 2021		5,508,608		$	15.10
Granted		291,850		$	16.13
Exercised		(20,222	)	$	7.33
Forfeited		(57,134	)	$	13.07
Expired		(8,425	)	$	21.61
Outstanding at March 31, 2022		5,714,677		$	15.23		6.2	$	25,419
Exercisable at March 31, 2022		4,289,264		$	13.76		5.4	$	20,201

The weighted average grant date fair value of stock options granted during the three months ended March 31, 2022 and 2021 was $11.36 and $32.68 per share, respectively. The aggregate intrinsic value of the stock options exercised during the three months ended March 31, 2022 and 2021 was $163 and $7,848, respectively. The total grant date fair value of stock options vested during the three months ended March 31, 2022 and 2021 was $1,085 and $733, respectively. At March 31, 2022, total unrecognized compensation expense related to stock options was $15,080 and is expected to be recognized over a weighted average period of 3.3 years.

The aggregate intrinsic values in the tables above represent the difference between the fair market value of the Company’s common stock and the average option exercise price of in-the-money options, multiplied by the number of such stock options.

Employee Stock Purchase Plan

During the three months ended March 31, 2022, a total of 67 shares of common stock were purchased under the Company’s ESPP. As of March 31, 2022, accrued employee contributions for future purchases under the ESPP totaled $191.

NOTE 12. RELATED PARTY TRANSACTIONS

There were no related party transactions as of or during the three months ended March 31, 2022 and 2021.

25

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

The following discussion and analysis of our financial condition and results of operations should be read together with the condensed consolidated financial statements and related notes that are included elsewhere in this Quarterly Report on Form 10-Q/A and in our Annual Report on Form 10-K for the year ended December 31, 2021. This discussion contains forward-looking statements based upon current expectations that involve risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those discussed under “Risk Factors,” set forth in Part II, Item 1A of this Quarterly Report on Form 10-Q/A and in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2021. See “Special Note Regarding Forward-Looking Statements” above at page 1.

The following information has been adjusted to reflect the Q1 2022 restatement and full year 2021 adjustment of our condensed consolidated financial statements as described in the “Explanatory Note” at the beginning of this Amended Report and in Note 2, “Presentation and Summary of Significant Accounting Policies,” in the Notes to the Condensed Consolidated Financial Statements of this Amended Report.

Overview

We are a provider of AI solutions, powered by our proprietary AI operating system, aiWARE™, to deliver differentiated products and solutions to our Commercial Enterprise and Government & Regulated Industries customers.

During the three months ended March 31, 2022, we generated revenue of $34.4 million as compared to $18.3 million during the three months ended March 31, 2021. Our Software Products & Services grew 288% year over year, and represented 53% and 26% of our consolidated revenue during the three months ended March 31, 2022 and 2021, respectively, and our Managed Services grew 19% year over year, and represented 47% and 74% of our consolidated revenue during the three months ended March 31, 2022 and 2021, respectively.  During the three months ended March 31, 2022 our largest customer represented 31% of our consolidated revenue and during the three months ended March 31, 2021 a different customer was our largest customer, with revenues representing 10% of our consolidated revenue.

Significant Transactions

In March 2022, we completed an acquisition of an influencer-based management services company for total consideration of $5.8 million (the “March Acquisition Consideration”). The March Acquisition Consideration consists of upfront payments of $2.0 million in cash and $1.9 million in common stock (0.1 million shares) and deferred compensation of $3.0 million payable in fiscal 2022 and 2023.

Opportunities, Challenges and Risks

During the three months ended March 31, 2022 and 2021, we derived our revenue primarily through our Commercial Enterprise customers, and secondarily through our Government & Regulated Industries customers.

We are a leader in AI-based Software Products & Services. Our proprietary AI operating system, aiWARE, uses machine learning algorithms, or AI models, together with a suite of powerful applications, to reveal valuable insights from vast amounts of structured and unstructured data. In addition to the year-over-year growth of 288% in our Software Products & Services during the three months ended March 31, 2022 as compared to the prior year, we have also demonstrated our ability to grow our AI-based Managed Services, with our revenue from these Managed Services increasing 19% during the three months ended March 31, 2022 as compared to the prior year. Historically, we have derived a large portion of our Software Product & Services revenue from applications we internally developed from our aiWARE platform and actively sold across various customers. Beginning in the second half of 2021, we realigned our organization to also focus on enterprise sales and opportunities across existing and newer markets. In September 2021, we acquired PandoLogic, an intelligent hiring platform. Based in Israel, PandoLogic serves high-volume hiring and enterprise level customers today, including the second largest employer in the U.S., Amazon. While management believes there is a substantial opportunity to increase revenue longer term, there is no certainty that any future investments, which could be significant and include future potential acquisitions, will result in significant enterprise revenue realization or revenue growth when compared with historical revenue. We also continue to see significant opportunities for growth in cross-selling PandoLogic and aiWARE to existing and newly acquired customers, and where our AI solutions could add tremendous value in content creation and distribution, including in the news, television and film industries.

We believe there will be significant near and long-term opportunities for revenue growth from Government & Regulated Industries markets due to customer adoption of our products and services related to AI technologies and more recently with our official Authorization to Operate, or ATO, of our aiWARE platform across the entire U.S. Department of Justice and progress with the Joint Artificial Intelligence Commission (“JAIC”) and Department of Defense (“DOD”). However, many enterprise-level opportunities with GRI customers can involve long sales cycles, during which we must invest significant time and resources without a guarantee of success. We may seek to acquire businesses with deep relationships and greater scale within the U.S. government and within regulated industries such as energy to further accelerate our pursuit of the growth opportunities we see in this market.

During the second half of 2020, we launched our Veritone energy solutions as part of our GRI solutions to help utilities increase profitability and improve grid reliability as they make the transition to renewables. Today, our energy solutions are in production at a major

26

utility and being deployed across global manufactures. We believe that our patented technology is uniquely suited to solving some of the most difficult challenges facing utilities today, and we see significant near and long-term opportunities to grow our revenue within this market. Our aiWARE platform is in the early stages of deployment in the energy market, and we expect to continue making significant investments in product, sales and engineering over the next 12 to 24 months to further develop our current and future solutions to address the opportunities in this market.

Growing our existing and new Software Products & Services customer base is critical for our success. During the first quarter of 2022, our largest customer, Amazon, represented 31% of our consolidated revenue, as compared to 16% in the same quarter of 2021 on a pro forma basis (pro forma basis meaning the inclusion of PandoLogic as if owned by us since January 1, 2021). Approximately 25% of the first quarter 2022 Amazon revenue was from new services, part of our land-and-expand strategy and helped to drive our customer net retention above 120% in the quarter ended March 31, 2022 as compared to the same quarter of 2021. Moreover, we continue to grow our Software Products & Services customer base.  At the end of the first quarter of 2022, we reported 559 Software Product & Services customers, which grew 45% from March 31, 2021 on a pro forma basis. On a pro forma basis, we also grew PandoLogic’s customer base as of March 31, 2022 over 100% year over year, and non-volume hiring revenue for the quarter ended March 31, 2022, which excludes Amazon, grew over 200% year over year. To continue to grow our Software Product & Services and diversify our customer base, and drive increased sales within our existing customer base, we plan to continue to increase our sales and marketing spending throughout 2022 as compared with prior periods.

Our business has seasonality, driven mostly by hiring patterns across PandoLogic. Typically, hiring patterns are lowest during the first and second quarters, then increase sequentially each quarter in the second half of the year.  During the quarter ended March 31, 2022, one of our largest customers accelerated hiring in part to manage the January 2022 Omicron virus outbreak. As a result of this, we do not expect our intelligent hiring platform revenues to sequentially improve substantially from the first quarter of 2022 to the second quarter of 2022, as part of the first half of 2022 planned revenues from this customer accelerated into early 2022. However, we do expect the platform to normalize starting in the third quarter of 2022, and to grow comparably with prior years’ seasonality trends and in accordance with our prior expectations.

We believe our Software Products & Services will extend the capabilities of many third-party software platforms and products that are widely used today. For example, we believe that, when integrated with aiWARE, PandoLogic customers will be given greater visibility and transparency in their hiring processes. In addition, we have historically integrated aiWARE across many platforms, including Alteryx and the NVIDIA® CUDA® GPU-based platform, enabling dramatic increases in aiWARE’s processing speed and providing a wide range of new use cases for our technology. We are in the process of developing and marketing more specific use cases for these and future integrations, which we believe will open up new markets for our products and accelerate our near and long term revenue growth opportunities. We plan to hire additional engineers and business development resources in the near term to further accelerate our pursuit of these potential opportunities, as well as other third-party technology integrations.

For the three months ended March 31, 2022, our non-GAAP gross margin (calculated as described in “Non-GAAP Financial Measures” below) improved to 80%, compared with 74% for the three months ended March 31, 2021, driven by growth of new customers across our Software Products & Services and the addition of PandoLogic in late 2021, which generated incremental non-GAAP gross margins in excess of 80% during the three months ended March 31, 2022. Our non-GAAP gross margin is impacted significantly by the mix of our Software Products & Services and our Managed Services revenue in any given period because our Managed Services revenue typically has a lower overall non-GAAP gross margin than our Software Products & Services revenue. With the acquisition of PandoLogic in September 2021, we expect our consolidated non-GAAP gross margin and related non-GAAP gross profit to improve in each subsequent quarter in 2022 as the mix of PandoLogic revenue becomes seasonally larger throughout 2022. Our non-GAAP gross profit (see “Non-GAAP Financial Measures” below) is also dependent upon our ability to grow our revenue by expanding our customer base and increasing business with existing customers, and to manage our costs by negotiating favorable economic terms with cloud computing providers such as AWS and Microsoft Azure. While we are focused on continuing to improve our non-GAAP gross profit, our ability to attract and retain customers to grow our revenue will be highly dependent on our ability to implement and continually improve upon our technology and services and improve our technology infrastructure and operations as we experience increased network capacity constraints due to our growth.

  We believe our operating results and performance are, and will continue to be, driven by various factors that affect our industry. Our ability to attract, grow and retain customers for our aiWARE platform is highly sensitive to rapidly changing technology and is dependent on our ability to maintain the attractiveness of our platform, content and services to our customers. Moreover, we have historically reported GAAP operating losses, driven by certain non-cash and non-recurring items such as stock-based compensation and purchase accounting; however, we expect to report substantial improvements in our consolidated operating results for the year ending December 31, 2022 as compared to the year ended December 31, 2021, driven by the growth in our software offerings and customers and the growth of PandoLogic. Our future revenue and operating growth will rely heavily on our ability to grow and retain our Software Products & Services customer base, continue to develop and deploy quality and innovative AI-driven applications and enterprise-level offerings, provide unique and attractive content and advertising services to our customers, continue to grow in newer markets such as Government & Regulated Industries, expand aiWARE into larger and more expansive enterprise engagements and manage our corporate overhead costs. While we believe we will be successful in these endeavors, we cannot guarantee that we will succeed in generating substantial long term operating growth and profitability.

We expect to pursue a strategy of acquiring companies to help accelerate our organic growth. We believe there are strategic acquisition targets that can accelerate our entry into key strategic markets, as well as our ability to grow our business. As a result, we are continuing to prioritize corporate development efforts throughout 2022. Our acquisition strategy is threefold: (i) to increase the scale of our business in markets we are in today, (ii) to accelerate growth in new markets and product categories, including expanding our existing engineering and

27

sales resources, and (iii) to accelerate the adoption of aiWARE as the universal AI operating system through venture or market-driven opportunities.    

During the three months ended March 31, 2022, we reported a non-GAAP net loss of $5.2 million as compared to $3.9 million during the three months ended March 31, 2021. While we forecast our full year 2022 to be profitable on a non-GAAP net income basis, we do expect seasonality in our revenue and more losses in operating performance throughout the quarter ended June 30, with increased profitability during the quarters ended September 30 and December 31, driven partly from PandoLogic services. Moreover, and to continue to grow our revenue in 2022, we will continue to make substantial investments in people, namely software engineers and sales personnel. Through April 2022, our headcount grew approximately 25% since the beginning of 2022. In addition, we have made substantial investments in our existing people, including higher annual raises and increased benefits, in order to compete in a challenging and constrained labor environment. Lastly, we are making investments in our corporate infrastructure, including new ERP and workforce systems to help us better manage the scale and growth of our business. These investments in people and infrastructure will weigh heavier on our financial results beginning in Q2 2022 and beyond.  If we cannot hire or retain people in a timely manner, and or are incapable of managing the scale of our operations, our growth and ultimate profitability could be accelerated or delayed.

In the three months ended March 31, 2022 and 2021, substantially all of our revenue was derived from customers located in the United States. We believe that there is a substantial opportunity over time for us to significantly expand our service offerings and customer base in countries outside of the United States. In the long term, we plan to expand our business further internationally in places such as Europe, Asia Pacific and Latin America, and as a result, we expect to continue to incur significant incremental upfront expenses associated with these expansion opportunities.

Impact of the COVID-19 Pandemic

The COVID-19 outbreak emerged in late 2019 and was declared a global pandemic by the World Health Organization in March 2020. The COVID-19 pandemic, and the actions being taken by governments worldwide to mitigate the public health consequences of the pandemic, significantly impacted the global economy. Beginning in March 2020, we began to experience fluctuations in demand for certain services, particularly our Managed Services, a significant amount of revenue from which is typically driven by major live sporting events that were cancelled or postponed in the United States due to COVID-19. While many major sporting events have resumed, future cancellations of live sporting events could have a material adverse impact on our revenue generated from our Managed Services in future quarters.

The pandemic has affected and may continue to affect some of our customers, which may further reduce the demand and/or delay purchase decisions for our products and services and may additionally impact the creditworthiness of our customers. We have assessed the potential credit deterioration of our customers due to changes in the macroeconomic environment and have determined that no additional allowance for doubtful accounts was necessary due to credit deterioration as of March 31, 2022.

The extent to which the COVID-19 pandemic and the related macroeconomic conditions may continue to affect our financial condition or results of operations is uncertain. The severity and duration of the pandemic and the resulting macroeconomic conditions are difficult to predict, and our revenue and operating results may be adversely impacted in future periods. Due to the nature of our business, the effect of the COVID-19 pandemic may not be fully reflected in its results of operations until future periods. The most significant risks to our business and results of operations arising from the COVID-19 pandemic are discussed in Part I, Item 1A (Risk Factors) of our Annual Report on Form 10-K for the year ended December 31, 2021.

In response to the COVID-19, we took actions to control expenses, including temporarily discontinuing non-essential services and instituting controls on travel, entertainment and other expenses. In addition, we have initiated a remote work from home policy. We expect to continue to enforce these and other actions we deem appropriate until or when the COVID-19 pandemic is officially no longer declared a pandemic by the World Health Organization.

Non-GAAP Financial Measure

In evaluating our cash flows and financial performance, we use certain non-GAAP financial measures, including “non-GAAP gross profit,” “non-GAAP gross margin,” “non-GAAP net income (loss),” and “non-GAAP net income (loss) per share.” Non-GAAP gross profit is the Company’s revenue less its cost of revenue. Non-GAAP net income (loss) and non-GAAP net income (loss) per share is the Company’s net income (loss) and net income (loss) per share, adjusted to exclude interest expense, provision for income taxes, depreciation expense, amortization expense, stock-based compensation expense, changes in fair value of warrant liability, changes in fair value of contingent consideration, a reserve for state sales taxes, charges related to a facility sublease, gain on sale of asset, warrant expense, acquisition and due diligence costs, and severance and executive search costs. The results for non-GAAP net income (loss), are presented below for the three months ended March 31, 2022 and 2021. The items excluded from these non-GAAP financial measures, as well as a breakdown of GAAP net loss, non-GAAP net income (loss) and these excluded items between our Core Operations and Corporate, are detailed in the reconciliation below.

In addition, we have provided additional supplemental non-GAAP measures of gross profit, operating expenses, loss from operations, other (expense) income, net, and loss before income taxes, excluding the items excluded from non-GAAP net loss as noted above, and reconciling such non-GAAP measures to the most directly comparable GAAP measures.

28

We present these non-GAAP financial measures because management believes such information to be important supplemental measures of performance that are commonly used by securities analysts, investors and other interested parties in the evaluation of companies in our industry. Management also uses this information internally for forecasting and budgeting.

These non-GAAP financial measures are not calculated and presented in accordance with GAAP and should not be considered as an alternative to net income (loss), operating income (loss) or any other financial measures so calculated and presented, nor as an alternative to cash flow from operating activities as a measure of liquidity. Other companies (including our competitors) may define these non-GAAP financial measures differently. These non-GAAP measures may not be indicative of our historical operating results or predictive of potential future results. Investors should not consider this supplemental non-GAAP financial information in isolation or as a substitute for analysis of our results as reported in accordance with GAAP.

(in thousands)
	Three Months Ended March 31,
	2022
	(As Restated)									2021
	Core Operations(1)			Corporate(2)			Total			Core Operations(1)			Corporate(2)			Total
Net loss	$	(6,100	)	$	(16,029	)	$	(22,129	)	$	(2,825	)	$	(27,742	)	$	(30,567	)
Provision for income taxes		134			4			138			—			22			22
Depreciation and amortization		5,098			116			5,214			1,083			170			1,253
Stock-based compensation expense		1,983			2,833			4,816			2,695			18,915			21,610
Change in fair value of Contingent consideration		—			5,045			5,045			—			—			—
Interest expense		—			1,182			1,182			—			—			—
Acquisition and due diligence costs		—			561			561			—			—			—
State sales tax reserve		—			—			—			—			138			138
Charges related to sublease		—			—			—			—			3,367			3,367
Severance and executive search		—			—			—			250			7			257
Non-GAAP Net Income (Loss)	$	1,115		$	(6,288	)	$	(5,173	)	$	1,203		$	(5,123	)	$	(3,920	)
(1) Core operations consists of our aiWARE operating platform of software, SaaS and related services; content, licensing and advertising agency services; and their supporting operations, including direct costs of sales as well as operating expenses for sales, marketing and product development and certain general and administrative costs dedicated to these operations.
(2) Corporate consists of general and administrative functions such as executive, finance, legal, people operations, fixed overhead expenses (including facilities and information technology expenses), other income (expenses) and taxes, and other expenses that support the entire company, including public company driven costs.

The following tables set forth the calculation of our gross profit and gross margin, followed by a reconciliation of non-GAAP to GAAP financial information presented in our condensed consolidated financial statements for three months ended March 31, 2022 and 2021.

	Three Months Ended
(dollars in thousands)	March 31,
	2022			2021
Revenue	$	34,407		$	18,295
Cost of revenue		6,923			4,823
Non-GAAP gross profit		27,484			13,472
Non-GAAP gross margin		79.9	%		73.6	%

29

	Three Months Ended
	March 31,
	2022
	(As Restated)			2021
Revenue	$	34,407		$	18,295
Cost of revenue		6,923			4,823
Non-GAAP gross profit		27,484			13,472
GAAP cost of revenue		6,923			4,823
Stock-based compensation expense		(20	)		—
Non-GAAP cost of revenue		6,903			4,823
GAAP sales and marketing expenses		11,069			6,427
Stock-based compensation expense		(463	)		(898	)
Severance and executive search		—			(236	)
Non-GAAP sales and marketing expenses		10,606			5,293
GAAP research and development expenses		9,883			4,960
Stock-based compensation expense		(1,004	)		(1,019	)
Severance and executive search		—			(14	)
Non-GAAP research and development expenses		8,879			3,927
GAAP general and administrative expenses		22,321			31,543
Depreciation		(198	)		(175	)
Stock-based compensation expense		(3,329	)		(19,693	)
Warrant expense		—			—
Change in fair value of contingent consideration		(5,045	)		—
Charges related to sublease		—			(3,367	)
State sales tax reserve		—			(138	)
Acquisition and due diligence costs		(561	)		—
Severance and executive search		—			(7	)
Non-GAAP general and administrative expenses		13,188			8,163
GAAP amortization		(5,016	)		(1,078	)
GAAP loss from operations		(20,805	)		(30,536	)
Total non-GAAP adjustments (1)		15,636			26,625
Non-GAAP loss from operations		(5,169	)		(3,911	)
GAAP other expense, net		(1,186	)		(9	)
Interest expense		1,182			—
Non-GAAP other expense, net		(4	)		(9	)
GAAP loss before income taxes		(21,991	)		(30,545	)
Total non-GAAP adjustments (1)		16,818			26,625
Non-GAAP loss before income taxes		(5,173	)		(3,920	)
Income tax provision	138			22
GAAP net loss		(22,129	)		(30,567	)
Total non-GAAP adjustments (1)		16,956			26,647
Non-GAAP net loss	$	(5,173	)	$	(3,920	)
Shares used in computing non-GAAP basic and diluted net loss per share		35,477			32,172
Non-GAAP diluted net loss per share	$	(0.15	)	$	(0.12	)
(1) Adjustments are comprised of the adjustments to GAAP cost of revenue, sales and marketing expenses, research and development expenses and general and administrative expenses and other (expense) income, net (where applicable) listed above.

30

Supplemental Financial Information

We are providing the following unaudited supplemental financial information regarding our Software Products & Services and Managed Services as a lookback of the prior year to explain our recent historical and year-over-year performance. The Software Products & Services supplemental financial information is presented on a pro forma basis, as further described below.

The supplemental financial information for our Software Products & Services include: (i) Software Revenue – Pro Forma, (ii) Ending Customers, (iii) Average Annual Revenue (AAR), (iv) Total New Bookings, and (iv) Gross Revenue Retention, in each case as defined in the footnotes to the table below. The supplemental financial information for our Managed Services includes: (i) average gross billings per active agency client, and (ii) revenue.

Software Products & Services Supplemental Financial Information

The following table sets forth the results for each of our Software Products & Services supplemental financial information.

	Quarter Ended
	Mar 31,		Jun 30,		Sept 30,		Dec 31,		Mar 31,
	2021		2021		2021		2021		2022
Software Revenue - Pro Forma (in 000's) (1)	$	10,183	$	20,072	$	21,860	$	40,223	$	18,167
Ending Customers (2)	385		419		433		529		559
Average Annual Revenue (AAR) (in 000's) (3)	$	199	$	203	$	208	$	209	$	207
Total New Bookings (in 000's) (4)	$	2,442	$	4,896	$	3,356	$	8,317	$	9,574
Gross Revenue Retention (5)	>90%		>90%		>90%		>90%		>90%

⁽¹⁾ “Software Revenue - Pro Forma” includes historical Software Products & Services revenue from the past five (5) fiscal quarters of each of Veritone, Inc. and PandoLogic (unaudited) and presents such revenue on a combined pro forma basis treating PandoLogic as owned by Veritone, Inc. since January 1, 2020.

⁽²⁾ “Ending Customers” includes Software Products & Services customers as of the end of each respective quarter set forth above with trailing twelve-month revenues in excess of $2,400 for both Veritone, Inc. and PandoLogic and/or deemed by us to be under an active contract for the applicable periods.

⁽³⁾ “Average Annual Revenue (AAR)” is calculated as the aggregate of trailing twelve-month Software Products & Services revenue divided by the average number of customers over the same period for both Veritone, Inc. and PandoLogic.

⁽⁴⁾ “Total New Bookings” represents the total fees payable during the full contract term for new contracts received in the quarter (including fees payable during any cancellable portion and an estimate of license fees that may fluctuate over the term), excluding any variable fees under the contract (e.g., fees for cognitive processing, storage, professional services and other variable services).

⁽⁵⁾ “Gross Revenue Retention”: We calculate our dollar-based gross retention rate as of the period end by starting with the revenue from Ending Customers for Software Products & Services as of the 3 months in the prior year quarter to such period, or Prior Year Quarter Revenue. We then deduct from the Prior Year Quarter Revenue any revenue from Ending Customers who are no longer customers as of the current period end, or Current Period Ending Customer Revenue. We then divide the total Current Period Ending Customer Revenue by the total Prior Year Quarter Revenue to arrive at our dollar-based gross retention rate, which is the percentage of revenue from all Ending Customers from our Software Products & Services as of the year prior that is not lost to customer churn.

As we grow our business for our Software Products & Services, we expect that our supplemental financial information will be impacted in different ways based on our customer profiles and the nature of target markets. For example, our PandoLogic business has significant revenue concentration in a single customer which has a material impact on the average contract value and gross retention. As a result, we have shown the supplemental financial information on a pro forma basis for comparability.

Managed Services Supplemental Financial Information

The following table sets forth the results for each of the KPIs for our Managed Services.

	Quarter Ended
	Mar 31,		Jun 30,		Sept 30,		Dec 31,		Mar 31,
	2021		2021		2021		2021		2022
Avg billings per active Managed Services client (in 000's) (6)	$	582	$	622	$	615	$	625	$	684
Revenue during quarter (in 000's) (7)	$	10,327	$	9,968	$	9,647	$	10,857	$	10,735

⁽⁶⁾ Avg billings per active Managed Services customer for each quarter reflects the average quarterly billings per active Managed Services customer over the twelve-month period through the end of such quarter for Managed Services customers that are active during such quarter.

⁽⁷⁾ Managed Services revenue and metrics exclude content licensing and media services.

We have experienced and may continue to experience volatility in revenue from our Managed Services due to a number of factors, including: (i) the timing of new large customer agreements; (ii) loss of customers who choose to replace our services with new providers or by bringing their advertising placement in-house; (iii) customers who experience reductions in their advertising budgets due to issues with their own businesses; and (iv) the seasonality of the campaigns for certain large customers. We have historically generated a significant portion of our revenue from a few major customers. As we continue to grow and diversify our customer base, we expect that our dependency on a limited number of large customers will be minimized.

31

Results of Operations

The following tables set forth our results of operations for the three months ended March 31, 2022 and 2021, in dollars and as a percentage of our revenue for those periods. The period-to-period comparisons of our historical results are not necessarily indicative of the results that may be expected in the future.

	Three Months Ended
(dollars in thousands)	March 31,
	2022
	(As Restated)			2021
Revenue	$	34,407		$	18,295
Operating expenses:
Cost of revenue		6,923			4,823
Sales and marketing		11,069			6,427
Research and development		9,883			4,960
General and administrative		22,321			31,543
Amortization		5,016			1,078
Total operating expenses		55,212			48,831
Loss from operations		(20,805	)		(30,536	)
Other expense, net		(1,186	)		(9	)
Loss before provision for income taxes		(21,991	)		(30,545	)
Provision for income taxes		138			22
Net loss	$	(22,129	)	$	(30,567	)

	Three Months Ended
	March 31,
	2022
	(As Restated)			2021
Revenue		100.0	%		100.0	%
Operating expenses:
Cost of revenue		20.1			26.4
Sales and marketing		32.2			35.1
Research and development		28.7			27.1
General and administrative		64.9			172.4
Amortization		14.6			6.0
Total operating expenses		160.5			267.0
Loss from operations		(60.5	)		(167.0	)
Other expense, net		(3.4	)		-
Loss before provision for income taxes		(63.9	)		(167.0	)
Provision for income taxes		0.4			0.1
Net loss		(64.3	)		(167.1	)

Three Months Ended March 31, 2022 Compared with Three Months Ended March 31, 2021

Revenue

	Three Months Ended						Three Months Ended
	March 31, 2022						March 31, 2021
	Commercial		Government &				Commercial		Government &
	Enterprise		Regulated		Total		Enterprise		Regulated		Total
Software Products & Services (1)	$	17,386	$	781	$	18,167	$	3,395	$	1,290	$	4,685
Managed Services		16,240		-		16,240		13,610		-		13,610
Revenue	$	33,626	$	781	$	34,407	$	17,005	$	1,290	$	18,295

⁽¹⁾ Software Products & Services consists of aiWARE SaaS Solutions revenues of $3.4 million and $4.7 million for the three months ended March 31, 2022 and 2021, respectively, as well PandoLogic revenues of $14.8 million for the three months ended March 31, 2022.

Commercial Enterprise (“CE”)

CE Software Products & Services revenue increased $14.0 million, or 412%, in the three months ended March 31, 2022 compared to the corresponding prior year period due primarily due to our acquisition of PandoLogic in September 2021 coupled with expanded services we provided to existing media and entertainment customers. CE Managed Services increased $2.6 million, or 19%, in the three months ended

32

March 31, 2022 compared to the corresponding prior year period due to growth of our licensing platform, in new advertising customers and in expanded services for existing advertising customers.

Government & Regulated Industries (“GRI”)

GRI Software Products & Services revenue decreased $0.5 million or 39% in the three months ended March 31, 2022 compared to the corresponding prior year period primarily due to timing of early stage energy deliverables. GRI Software Products & Services revenue from customers in certain markets, particularly government and energy customers, is often project-based and is impacted by the timing of projects. As such, we expect that our revenue from these markets could fluctuate significantly from period to period.

Non-GAAP Gross Profit

As noted above, our non-GAAP gross profit is calculated as our revenue less our cost of revenue, as follows:

	Three Months Ended
(dollars in thousands)	March 31,
	2022			2021			$ Change		% Change
Revenue	$	34,407		$	18,295		$	16,112		88.1	%
Cost of revenue		6,923			4,823			2,100		43.5	%
Non-GAAP gross profit		27,484			13,472			14,012		104.0	%
Non-GAAP gross margin		79.9	%		73.6	%

The increase in non-GAAP gross profit and non-GAAP gross margin in the three months ended March 31, 2022 compared to the three months ended March 31, 2021 was due primarily to growth in Software Products & Services revenue, including our acquisition of PandoLogic in September 2021, which collectively generated incremental non-GAAP gross margins in excess of 80% during the three months ended March 31, 2022.

Operating Expenses

	Three Months Ended
(dollars in thousands)	March 31,
	2022
	(As Restated)		2021		$ Change			% Change
Cost of revenue	$	6,923	$	4,823	$	2,100			43.5	%
Sales and marketing		11,069		6,427		4,642			72.2	%
Research and development		9,883		4,960		4,923			99.3	%
General and administrative		22,321		31,543		(9,222	)		-29.2	%
Amortization		5,016		1,078		3,938			365.3	%
Total operating expenses	$	55,212	$	48,831	$	6,381			13.1	%

Cost of Revenue. The increase in cost of revenue in the three months ended March 31, 2022 compared with the corresponding prior year periods was due primarily to our higher revenue level, as discussed above. Cost of revenue increased at a lower rate than the increase in revenues due to the introduction of new products with higher non-GAAP gross margin contribution in the second half of 2021, including the addition of PandoLogic.

Sales and Marketing. The increase in sales and marketing expenses of $4.6 million or 72% in the three months ended March 31, 2022 compared with the corresponding prior year period was primarily due to our acquisition of PandoLogic in September 2021, coupled with a $0.8 million increase in personnel-related costs from the addition of new sales and marketing resources.  As a percentage of revenue, sales and marketing expenses decreased to 32% in 2022 from 35% in 2021.

Research and Development. The increase in research and development expenses of $4.9 million or 99% in the three months ended March 31, 2022 compared with the corresponding prior year period was primarily due to an increase of $2.2 million in personnel-related costs from the addition of new engineering resources and our September 2021 acquisition of PandoLogic in September 2021. As a percentage of revenue, research and development expenses increased to 29% in 2022 from 27% in 2021.

General and Administrative. General and administrative expenses decreased $9.2 million or 29% in the three months ended March 31, 2022 compared with the corresponding prior year period principally due to a one-time expense in the prior year period associated with the vesting of performance-based stock options. As a percentage of revenue, general and administrative expenses declined to 65% in 2022 from 172% in 2021.

33

Amortization Expense. Amortization expense increased in the three months ended March 31, 2022 compared with the corresponding prior year period due to the addition of PandoLogic amortization expense.

Other (Expense) Income, Net

Other expense, net for the three months ended March 31, 2022 was comprised primarily of interest expense of $1.2 million due to the Convertible Notes we issued in November 2021.

Liquidity and Capital Resources

We have historically financed our business through the sale of equity and debt securities.  Our principal sources of liquidity are our cash and cash equivalents, which totaled $237.6 million as of March 31, 2022, compared with total cash and cash equivalents of $254.7 million as of December 31, 2021. The decrease in our cash and cash equivalents in the three months ended March 31, 2022 as compared with December 31, 2021 was primarily due to investments made during the period, taxes paid related to net share settlement of equity awards, and the payment of the PandoLogic 2021 earnout. We generated $10.1 million through cash provided by operating activities and also generated cash through proceeds from issuances of stock under employee stock incentive plans and stock purchases made under the ESPP of $0.6 million.

Cash Flows

A summary of cash flows from our operating, investing and financing activities is shown in the table below.

	Three Months Ended
(in thousands)	March 31,
	2022			2021
Cash provided by operating activities	$	10,134		$	6,209
Cash used in investing activities		(4,054	)		(100	)
Cash (used in) provided by financing activities		(23,248	)		6,533
Net (decrease) increase in cash, cash equivalents and restricted cash	$	(17,168	)	$	12,642

Operating Activities

Our operating activities provided cash of $10.1 million in the three months ended March 31, 2022, due primarily to our net loss of $22.1 million, adjusted by $15.2 million in non-cash expenses, including $5.0 million from a change in the fair value of contingent consideration and $4.8 million in stock-based compensation expense, offset in part by the net working capital increase of $17.1 million, primarily due to decreases in our accounts receivable of $19.0 million. Our business strategy includes streamlining operational costs while investing in the development of our AI capabilities and enhancement of our Software Products & Services to grow our business and future revenue. We gauge the amount of cash utilized in these efforts using the Non-GAAP net loss measure, as presented under the heading “Non-GAAP Financial Measures” above. Our use of cash as measured by Non-GAAP net loss decreased to $5.2 million for the three months ended March 31, 2022 from $3.9 million for the three months ended March 31, 2021, due primarily to the increase in our revenues, partially offset by an increase in non-GAAP expenses.

Our operating activities provided cash of $6.2 million in the three months ended March 31, 2021, due primarily to the net increase of $11.1 million of cash received from advertising clients for future payments to vendors, offset in part by the effect of our net loss of $30.6 million, adjusted by $26.0 million in non-cash expenses, including $21.6 million in stock-based compensation expense. Our business strategy includes streamlining operational costs while investing in the development of our AI capabilities and enhancement of our Software Products & Services to grow our business and future revenue.

Investing Activities

Our investing activities for the three months ended March 31, 2022 used cash of $4.1 million primarily for an equity investment of $2.0 million in a strategic partner, $1.3 million to fund a portion of the consideration for the March 2022 acquisition, and $0.7 million in capital expenditures.

Our investing activities consisted of minimal amounts used for capital expenditures and proceeds from the sale of equipment in the three months ended March 31, 2021.

Financing Activities

Our financing activities for the three months ended March 31, 2022 used cash of $23.2 million, consisting of $14.4 million to pay the 2021 earnout for PandoLogic and $9.4 million to pay taxes paid related to the net share settlement of equity awards, partially offset by $0.6 million in proceeds received from the exercise of stock options and purchases of shares under our ESPP.

Our financing activities provided cash of $6.5 million for the three months ended March 31, 2021, consisting of $4.3 million in proceeds received from the exercise of stock options and purchases of shares under our ESPP and $2.3 million in proceeds received from the exercise of stock warrants.

34

Capital Resources

As of March 31, 2022, our only debt obligations were the Convertible Notes issued in the fourth quarter of fiscal year 2021. We have $3.0 million in purchase consideration commitments related to our March 2022 acquisition that will be paid 50% in 2023 and 50% in 2024. We have no other present agreements or commitments with respect to any material acquisitions of businesses or technologies or any other material capital expenditures.

We have generated significant losses since inception; however, we do expect to begin generating profits in the foreseeable future. With the acquisition of PandoLogic, we believe we have an opportunity to significantly improve our operating income/(loss) in 2022 as compared to 2021. We believe that our current cash and cash equivalents balance will be sufficient to fund our operations in the ordinary course of business for at least the next twelve months from the date of this filing. We have not entered into any off-balance sheet arrangements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

As a smaller reporting company, we are not required to provide the information required by Item 305 of Regulation S-K.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Our disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives of ensuring that information we are required to disclose in the reports we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to enable timely decisions regarding required disclosures, and is recorded, processed, summarized, and reported within the time periods specified in the rules and forms promulgated by the SEC. Our management recognizes that any disclosure controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and there is no assurance that our disclosure controls and procedures will operate effectively under all circumstances. Based on this evaluation, at the time of our Original Report on May 9, 2022, our Chief Executive Officer and Chief Financial Officer concluded that, as of March 31, 2022, our disclosure controls and procedures were effective at the reasonable assurance level. Subsequent to that evaluation, a material weakness was identified in our internal control over financial reporting. Our Chief Executive Officer and Chief Financial Officer re-evaluated the effectiveness of our disclosure controls and procedures and concluded that, as of March 31, 2022, our disclosure controls and procedures were not effective at the reasonable assurance level due to the following material weakness in internal control over financial reporting.

Material Weakness in Internal Control over Financial Reporting

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis. Management identified a material weakness in internal control over financial reporting relating to the appropriate oversight and sufficient review of the work performed by third-party specialists on the Company’s behalf and the coordination of work being performed by more than one specialist.  Such third-party specialists were used in the preparation of (i) our valuation of Contingent Consideration, (ii) our valuation of certain identified intangible assets and (iii) our purchase price allocation pursuant to ASC 805, Business Combinations, in connection with the acquisition of PandoLogic Ltd. The material weakness resulted in the restatement of the unaudited condensed consolidated financial statements as of and for the three months ended March 31, 2022 and immaterial misstatements to the consolidated financial statements for the year ended December 31, 2021. Additionally, this material weakness could have resulted in a misstatement of certain accounting estimates or disclosures that would have resulted in a material misstatement of our annual consolidated financial statements that would not have been prevented or detected on a timely basis.

Remediation of Material Weakness in Internal Control Over Financial Reporting

In order to remediate the material weakness, management is implementing financial reporting control changes to address the material weakness relating to the process for evaluating the qualifications of third-party specialists, defining the scope of work to be performed by such specialists and reviewing all estimates and other work product prepared by specialists. Management is taking steps to enhance its evaluation of the qualifications of third-party specialists, more accurately defining the scope of work to be performed by such specialists and improving the review process for all estimates and other work product prepared by specialists, including a detailed review of all work performed by specialists, by our employees with the appropriate level of experience and knowledge and review the specialists’ work for compliance with accounting standards.

To further remediate the material weakness identified herein, the management team, including the Chief Executive Officer and Chief Financial Officer, have reaffirmed and re-emphasized the importance of internal controls, control consciousness and a strong control environment. We are committed to maintaining a strong control environment and believe that these remediation efforts represent continued improvement in our control environment.  We also expect to continue to review, optimize and enhance our financial reporting controls and

35

procedures. This material weakness will not be considered remediated until the applicable remediated control operates for a sufficient period of time and management has concluded, through testing, that this enhanced control is operating effectively.

Changes in Internal Control over Financial Reporting

Other than the remediation efforts described above, there have been no changes in our internal control over financial reporting during the quarter ended March 31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Inherent Limitations on Effectiveness of Controls

Management recognizes that a control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud or error, if any, have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

36

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business. We currently are not a party to any legal proceedings, the adverse outcome of which, in management’s opinion, individually or in the aggregate, would have a material adverse effect on our results of operations, financial position or cash flows. Regardless of the outcome, any litigation could have an adverse impact on us due to defense and settlement costs, diversion of management resources and other factors.

Item 1A. Risk Factors

Our Annual Report on Form 10-K for the year ended December 31, 2021 contains a discussion of the material risks associated with our business. There have been no material changes to the risks described in such Annual Report on Form 10-K, except as follows:

We have identified a material weakness in our internal control over financial reporting. If we are unable to develop and maintain effective internal control over financial reporting, we may not be able to accurately report our financial results in a timely manner, which may adversely affect investor confidence in us; materially and adversely affect our business and operating results; and expose us to potential litigation.

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim consolidated financial statements will not be prevented or detected and corrected on a timely basis.

Management identified that a material weakness in internal control over financial reporting existed relating to the appropriate oversight and sufficient review of the work performed by third-party specialists on our behalf and the coordination of work being performed by more than one specialist.  Such third-party specialists were used in the preparation of (i) our valuation of Contingent Consideration, (ii) our valuation of certain identified intangible assets and (iii) our purchase price allocation pursuant to ASC 805, Business Combinations, in connection with our acquisition of PandoLogic Ltd.  The material weakness resulted in the restatement of the unaudited condensed consolidated financial statements as of and for the three months ended March 31, 2022 and immaterial misstatements to the consolidated financial statements for the year ended December 31, 2021.  Additionally, this material weakness could have resulted in a misstatement of certain accounting estimates or disclosures that would have resulted in a material misstatement of our annual consolidated financial statements that would not have been prevented or detected on a timely basis.

Effective internal control over financial reporting is necessary for us to provide reliable financial reports and prevent fraud. We continue to evaluate steps to remediate the material weakness. These remediation measures may be time consuming and costly and there is no assurance that these measures will ultimately have the intended effects.

In order to remediate the material weakness, we are implementing financial reporting control changes to address the material weakness relating to the process for evaluating the qualifications of third-party specialists, defining the scope of work to be performed by such specialists and reviewing all estimates and other work product prepared by specialists. Management is taking steps to enhance our evaluation of the qualifications of third-party specialists, more accurately define the scope of work to be performed by such specialists and improve the review process for all estimates and other work product prepared by specialists, by our employees with the appropriate level of experience and knowledge and review the specialists’ work for compliance with accounting standards.  To further remediate the material weakness identified herein, the management team, including the Chief Executive Officer and Chief Financial Officer, have reaffirmed and re-emphasized the importance of internal controls, control consciousness and a strong control environment.

If we are not able to remediate the material weakness, or if we identify any new material weaknesses in the future, we may be unable to maintain compliance with the requirements of securities laws, stock exchange listing rules, or debt instrument covenants regarding timely filing of information; we could lose access to sources of capital or liquidity; and investors may lose confidence in our financial reporting and our stock price may decline as a result. Though we are taking steps to remediate the material weakness, we cannot be assured that the measures we have taken to date, or any measures we may take in the future, will be sufficient to remediate the material weakness or avoid potential future material weaknesses.

As a result of the material weakness described above and other related matters raised or that may in the future be identified, we face potential for adverse regulatory consequences, including investigations, penalties or suspensions by the SEC or NASDAQ, litigation or other disputes which may include, among others, claims invoking the federal and state securities laws, contractual claims or other claims arising from the restatement and material weakness in our internal control over financial reporting and the preparation of our consolidated financial statements. As of the date of this filing, we have no knowledge of any such regulatory consequences, litigation, claim or dispute. However, we can provide no assurance that such regulatory consequences, litigation, claim or dispute will not arise in the future. Any such regulatory consequences, litigation, claim or dispute, whether successful or not, could subject us to additional costs, divert the attention of our management, or impair our reputation. Each of these consequences could have a material adverse effect on our business, results of operations and financial condition.

37

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On March 1, 2022, we issued 116,550 shares of our common stock as partial consideration in connection with an acquisition of an influencer-based management company. These shares of common stock were issued in a private placement under Section 4(2) of the Securities Act.

Item 3. Defaults Upon Senior Securities

None

Item 4. Mine Safety Disclosures

Not applicable

Item 5. Other Information

None

38

Item 6. Exhibits

Exhibit No.	Description of Exhibit
31.1	Certification pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act.
31.2	Certification pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act.
32.1*	Certifications pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Exchange Act and 18 U.S.C. Section 1350.
101.INS	Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH	Inline XBRL Taxonomy Extension Schema Document.
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104	The cover page from the Company’s Quarterly Report on Form 10-Q/A for the quarter ended March 31, 2022, has been formatted in Inline XBRL.

* The certifications furnished in Exhibit 32.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (including this Quarterly Report on Form 10-Q/A), unless the Company specifically incorporates the foregoing information into those documents by reference.

39

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Veritone, Inc.
August 15, 2022	By:	/s/ Chad Steelberg
		Chad Steelberg
		Chief Executive Officer and Chairman of the Board
		(Principal Executive Officer)
August 15, 2022	By:	/s/ Michael L. Zemetra
		Michael L. Zemetra
		Executive Vice President, Chief Financial Officer and Treasurer
		(Principal Financial and Accounting Officer)

40

EX-31.1

EXHIBIT 31.1

CERTIFICATION PURSUANT TO

RULE 13a-14(a) OR RULE 15d-14(a) OF THE

SECURITIES EXCHANGE ACT OF 1934

I, Chad Steelberg, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q/A of Veritone, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant ‘s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 15, 2022	By:	/s/ Chad Steelberg
		Chad Steelberg
		Chief Executive Officer and Chairman of the Board
		(Principal Executive Officer)

EX-31.2

EXHIBIT 31.2

CERTIFICATION PURSUANT TO

RULE 13a-14(a) OR RULE 15d-14(a) OF THE

SECURITIES EXCHANGE ACT OF 1934

I, Michael L. Zemetra, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q/A of Veritone, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 15, 2022	By:	/s/ Michael L. Zemetra
		Michael L. Zemetra
		Executive Vice President, Chief Financial Officer and Treasurer
		(Principal Financial and Accounting Officer)

EX-32.1

EXHIBIT 32.1

CERTIFICATIONS PURSUANT TO RULE 13a-14(b) OR RULE 15d-14(b)
OF THE SECURITIES EXCHANGE ACT OF 1934

AND 18 U.S.C. SECTION 1350

Each of the undersigned hereby certifies, pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, in his capacity as an officer of Veritone, Inc., that, to his knowledge, the Quarterly Report on Form 10-Q/A of Veritone, Inc. for the period ended March 31, 2022 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of Veritone, Inc.

Date: August 15, 2022	By:	/s/ Chad Steelberg
		Chad Steelberg
		Chief Executive Officer and Chairman of the Board
		(Principal Executive Officer)
Date: August 15, 2022	By:	/s/ Michael L. Zemetra
		Michael L. Zemetra
		Executive Vice President, Chief Financial Officer and Treasurer
		(Principal Financial and Accounting Officer)

A signed original of this written statement required by 18 U.S.C. Section 1350 has been provided to Veritone, Inc. and will be retained by Veritone, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2022	Apr. 30, 2022
Cover [Abstract]
Document Type	10-Q/A
Amendment Flag	true
Document Period End Date	Mar. 31, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Trading Symbol	VERI
Entity Registrant Name	Veritone, Inc.
Entity Central Index Key	0001615165
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity File Number	001-38093
Entity Tax Identification Number	47-1161641
Entity Address, Address Line One	2420 17th St.
Entity Address, Address Line Two	Office 3002
Entity Address, City or Town	Denver
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80202
City Area Code	888
Local Phone Number	507-1737
Entity Common Stock, Shares Outstanding		36,067,923
Entity Interactive Data Current	Yes
Entity Incorporation, State or Country Code	DE
Document Quarterly Report	true
Document Transition Report	false
Title of 12(b) Security	Common Stock, par value $0.001 per share
Security Exchange Name	NASDAQ
Amendment Description	Veritone, Inc. (the “Company”) is filing this Amendment No. 1 on Form 10-Q/A (this “Amended Report”) to restate the Company’s unaudited condensed consolidated financial statements for the period ended March 31, 2022 included in its Quarterly Report for the quarter ended March 31, 2022, that was originally filed with the U.S. Securities and Exchange Commission (the “SEC”) on May 9, 2022 (the “Original Report”). Unless the context otherwise requires, references in this Amended Report to “the Company,” “Veritone,” “we,” “us” or “our” refer to Veritone, Inc. and its wholly owned subsidiaries.

XML

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
ASSETS
Cash and cash equivalents	$ 237,553	$ 254,722
Accounts receivable, net	66,975	85,063
Expenditures billable to clients	19,693	27,180
Prepaid expenses and other current assets	12,519	12,117
Total current assets	336,740	379,082
Property, equipment and improvements, net	2,137	1,556
Intangible assets, net	91,867	93,872
Goodwill	44,600	42,028
Long-term restricted cash	856	855
Other assets	6,078	954
Total assets	482,278	518,347
LIABILITIES AND STOCKHOLDERS' EQUITY
Accounts payable	38,345	46,711
Accrued media payments	96,327	86,923
Client advances	7,968	10,561
Contingent consideration, current	134	20,053
Other accrued liabilities	22,993	27,093
Total current liabilities	165,767	191,341
Convertible senior notes, non-current	195,381	195,082
Contingent consideration, non-current	35,681	31,533
Other non-current liabilities	17,216	13,891
Total liabilities	414,045	431,847
Commitments and contingencies (Note 9)
Stockholders' equity
Common stock, par value $0.001 per share; 75,000,000 shares authorized; 36,056,839 and 34,972,256 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively	36	35
Additional paid-in capital	435,954	431,606
Accumulated deficit	(367,843)	(345,037)
Accumulated other comprehensive income (loss)	86	(104)
Total stockholders' equity	68,233	86,500
Total liabilities and stockholders' equity	$ 482,278	$ 518,347

XML

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2022	Dec. 31, 2021
Statement Of Financial Position [Abstract]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	75,000,000	75,000,000
Common stock, shares issued	36,056,839	34,972,256
Common stock, shares outstanding	36,056,839	34,972,256

XML

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Revenue	$ 34,407	$ 18,295
Operating expenses:
Cost of revenue	6,923	4,823
Sales and marketing	11,069	6,427
Research and development	9,883	4,960
General and administrative	22,321	31,543
Amortization	5,016	1,078
Total operating expenses	55,212	48,831
Loss from operations	(20,805)	(30,536)
Other expense, net	(1,186)	(9)
Loss before provision for income taxes	(21,991)	(30,545)
Provision for income taxes	138	22
Net loss	$ (22,129)	$ (30,567)
Net loss per share:
Basic and diluted	$ (0.62)	$ (0.95)
Weighted average shares outstanding:
Basic and diluted	35,476,948	32,172,038
Comprehensive loss:
Net loss	$ (22,129)	$ (30,567)
Foreign currency translation gain, net of income taxes	190	7
Total comprehensive loss	$ (21,939)	$ (30,560)

XML

Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Cumulative-effect of Accounting Change Adopted [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Accumulated Deficit [Member] Cumulative-effect of Accounting Change Adopted [Member]	Accumulated Other Comprehensive Income [Member]
Beginning balance at Dec. 31, 2020	$ 88,210		$ 32	$ 368,477	$ (280,365)		$ 66
Beginning balance, shares at Dec. 31, 2020			31,799,354
Common stock issued under employee stock plans, net	4,254		$ 1	4,253
Common stock issued under employee stock plans, net, shares			608,886
Common stock issued for services	119			119
Common stock issued for services, shares			15,828
Stock-based compensation expense	21,491			21,491
Exercise of warrants	2,279		$ 2,279	2,279
Exercise of warrants, shares			252,218
Net loss	(30,567)				(30,567)
Other comprehensive gain	7						7
Ending balance at Mar. 31, 2021	85,793		$ 33	396,619	(310,932)		73
Ending balance, shares at Mar. 31, 2021			32,676,286
Beginning balance at Dec. 31, 2020	88,210		$ 32	368,477	(280,365)		66
Beginning balance, shares at Dec. 31, 2020			31,799,354
Net loss	(64,672)				(64,672)
Ending balance at Dec. 31, 2021	86,500	$ (677)	$ 35	431,606	(345,037)	$ (677)	(104)
Ending balance, shares at Dec. 31, 2021			34,972,256
Common stock issued under employee stock plans, net	570		$ 1	569
Common stock issued under employee stock plans, net, shares			1,073,543
Common stock withheld for employee taxes	(9,437)			(9,437)
Common stock withheld for employee taxes, shares			(457,840)
Common stock issued for acquisitions	1,929			1,929
Common stock issued for acquisitions, shares			116,550
Common stock issued as part of contingent consideration	6,440			6,440
Common stock issued as part of contingent consideration, shares			352,330
Stock-based compensation expense	4,847			4,847
Net loss	(22,129)				(22,129)
Other comprehensive gain	190						190
Ending balance at Mar. 31, 2022	$ 68,233		$ 36	$ 435,954	$ (367,843)		$ 86
Ending balance, shares at Mar. 31, 2022			36,056,839

XML

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net loss	$ (22,129)	$ (30,567)	$ (64,672)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	5,214	1,253	9,410
Loss on disposal of fixed assets		1,894
Provision for doubtful accounts	194	5
Loss on sublease		1,211
Stock-based compensation expense	4,847	21,610
Change in fair value of contingent consideration	5,045		12,074
Change in deferred taxes	(465)		(45)
Amortization of debt issuance costs	299
Changes in assets and liabilities:
Accounts receivable	18,982	(7,439)
Expenditures billable to clients	7,487	2,236
Prepaid expenses and other assets	(18)	1,507
Other assets	(895)
Accounts payable	(8,384)	3,554
Accrued media payments	8,770	9,517
Client advances	(2,593)	1,825
Other accrued liabilities	(6,104)	(103)
Other liabilities	(116)	(294)
Net cash provided by operating activities	10,134	6,209	7,234	$ 1,433
Cash flows from investing activities:
Minority investment	(2,000)
Capital expenditures	(735)	(100)
Acquisitions, net of cash acquired	(1,319)
Net cash used in investing activities	(4,054)	(100)
Cash flows from financing activities:
Payment of contingent considerations	(14,376)
Taxes paid related to net share settlement of equity awards	(9,441)
Proceeds from the exercise of warrants		2,279
Proceeds from issuances of stock under employee stock plans, net	569	4,254
Net cash (used in) provided by financing activities	(23,248)	6,533
Net (decrease) increase in cash and cash equivalents and restricted cash	(17,168)	12,642
Cash and cash equivalents and restricted cash, beginning of period	255,577	115,672	115,672
Cash and cash equivalents and restricted cash, end of period	238,409	$ 128,314	$ 255,577	$ 115,672
Non-cash activities:
Shares issued for acquisition of businesses and earn-out consideration	8,369
Lease liabilities arising from right-of-use assets	$ 4,501

XML

Description of Business

3 Months Ended

Mar. 31, 2022

Accounting Policies [Abstract]

Description of Business

NOTE 1. DESCRIPTION OF BUSINESS

Description of Business

Veritone, Inc., a Delaware corporation (“Veritone”) (together with its wholly owned subsidiaries, the “Company”), is a provider of artificial intelligence (“AI”) computing solutions. The Company’s proprietary AI operating system, aiWARE^TM, uses machine learning algorithms, or AI models, together with a suite of powerful applications, to reveal valuable insights from vast amounts of structured and unstructured data. The aiWARE platform offers capabilities that mimic human cognitive functions such as perception, prediction and problem solving, enabling users to quickly, efficiently and cost effectively transform unstructured data into structured data, and analyze and optimize data to drive business processes and insights.  aiWARE is based on an open architecture that enables new AI models, applications and workflows to be added quickly and efficiently, resulting in a scalable and evolving solution that can be leveraged by organizations across a broad range of business sectors, serving commercial enterprises as well as government and regulated industries.

In addition, the Company operates a full-service advertising agency that leverages the Company’s aiWARE technologies to provide differentiated Managed Services to its clients. The Company’s advertising services include media planning and strategy, advertisement buying and placement, campaign messaging, clearance verification and attribution, and custom analytics, specializing in host-endorsed and influencer advertising across primarily radio, podcasting, streaming audio, social media and other digital media channels. The Company’s advertising services also include its VeriAds Network, which is comprised of programs that enable broadcasters, podcasters and social media influencers to generate incremental advertising revenue. The Company also offers cloud-native digital content management solutions and licensing services, primarily to customers in the media and entertainment market. These offerings leverage the Company’s aiWARE technologies, providing customers with unique capabilities to enrich and drive expanded revenue opportunities from their content.

On March 1, 2022, the Company acquired an influencer-based management company, as discussed in more detail in Note 3. On September 14, 2021, the Company acquired PandoLogic, a company incorporated under the laws of the state of Israel, and a leading provider of intelligent hiring solutions, as discussed in more detail in Note 3. PandoLogic’s software platform, PandoIQ, is an AI-enabled talent acquisition and recruitment platform. 

XML

Presentation and Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2022

Accounting Policies [Abstract]

Presentation and Summary of Significant Accounting Policies

NOTE 2. PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation and Preparation

The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial statements and the rules and regulations of the SEC. Accordingly, they do not contain all information and footnotes required by GAAP for annual financial statements. Such unaudited condensed consolidated financial statements and accompanying notes are based on the representations of the Company’s management, who is responsible for their integrity and objectivity. The information included in this Form 10-Q/A should be read in conjunction with the information included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on March 17, 2022. Interim results for the three months ended March 31, 2022 are not necessarily indicative of the results the Company will have for the full year ending December 31, 2022.

The accompanying condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, which are normal, recurring and necessary to fairly state the Company’s financial position, results of operations and cash flows. All significant intercompany transactions have been eliminated in consolidation. The financial data and the other information disclosed in these notes to the condensed consolidated financial statements reflected in the three month periods presented are unaudited. The December 31, 2021 balance sheet included herein was derived from the audited financial statements but does not include all disclosures or notes required by GAAP for complete financial statements.

Restatement and Adjustment of Financial Statements

Restatement of Previously Issued Financial Statements

On August 9, 2022, the management of the Company and the Audit Committee of the Board of Directors of the Company, after consideration of the relevant facts and circumstances, determined that the Company’s previously issued financial statements as of and for the three months ended March 31, 2022 should be restated, and that such financial statements should no longer be relied upon due to an error related to the calculation of fair value of contingent consideration at the time of the acquisition of PandoLogic, which led to an understatement of goodwill, intangible assets and contingent consideration at the time of the acquisition, an overstatement of subsequent changes to the fair value of contingent consideration, and an understatement of subsequent intangible amortization expense. The restatement results in a non-cash charge that reduces general and administrative expenses and results in a favorable change to net loss for the three months ended March 31, 2022. The Company has restated its financial statements for the three months ended March 31, 2022 for such errors.

Adjustment of Previously Issued Financial Statements

The Company also evaluated the aggregate effects of the errors to its previously issued financial statements in accordance with SEC Staff Accounting Bulletins No. 99 and No. 108 and, based upon quantitative and qualitative factors, determined that the errors were not material to the previously issued financial statements included in its Annual Report on Form 10-K for the year ended December 31, 2021 or for any quarterly periods included therein. However, in order to correctly state equity in connection with the filing of this Form 10-Q/A, the December 31, 2021 consolidated balance sheet has been corrected to reflect the impact of this immaterial error.  The Company will adjust its consolidated financial statements for the year ended December 31, 2021 when it files its Form 10-K for the period ended December 31, 2022.

The following tables present the effects of the aforementioned restatement to the specific line items presented in the Company’s previously reported unaudited condensed consolidated financial statements as of and for the three months ended March 31, 2022 (in thousands, except per share amounts):

Condensed Consolidated Balance Sheet

	As of March 31, 2022
	As Reported			Adjustment		As Restated
Intangible assets, net	$	86,563		$	5,304	$	91,867
Goodwill		36,630			7,970		44,600
Total assets		469,004			13,274		482,278
Contingent consideration, non-current		35,416			265		35,681
Other non-current liabilities		16,440			776		17,216
Total liabilities		413,004			1,041		414,045
Accumulated deficit		(380,076	)		12,233		(367,843	)
Total stockholders' equity		56,000			12,233		68,233
Total liabilities and stockholders' equity		469,004			13,274		482,278

Condensed Consolidated Statement of Operations and Comprehensive Loss

	Three Months Ended
	March 31, 2022
	As Reported			Adjustment			As Restated
General and administrative	$	28,917		$	(6,596	)	$	22,321
Amortization		4,693			323			5,016
Total operating expenses		61,485			(6,273	)		55,212
Loss from operations		(27,078	)		6,273			(20,805	)
Loss before provision for income taxes		(28,264	)		6,273			(21,991	)
Provision for income taxes		177			(39	)		138
Net loss		(28,441	)		6,312			(22,129	)
Basic and diluted net loss per share		(0.80	)		0.18			(0.62	)
Total comprehensive loss		(28,251	)		6,312			(21,939	)

Condensed Consolidated Statement of Stockholders’ Equity

	Accumulated Deficit
	As Reported			Adjustment		As Restated
Balance as of December 31, 2021	$	(350,958	)	$	5,921	$	(345,037	)
Net loss		(28,441	)		6,312		(22,129	)
Balance as of March 31, 2022		(380,076	)		12,233		(367,843	)
	Total Stockholders' Equity
Balance as of December 31, 2021		80,579			5,921		86,500
Net loss		(28,441	)		6,312		(22,129	)
Balance as of March 31, 2022		56,000			12,233		68,233

Condensed Consolidated Statement of Cash Flows

	Three Months Ended
	March 31, 2022
	As Reported			Adjustment			As Restated
Cash flows from operating activities:
Net loss	$	(28,441	)	$	6,312		$	(22,129	)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization		4,891			323			5,214
Change in fair value of contingent consideration		11,641			(6,596	)		5,045
Change in deferred taxes		(426	)		(39	)		(465	)

There was no impact on cash flows from investing or financing activities.

The following tables reflect the impact of the adjustments to the specific line items presented in the Company’s previously reported consolidated financial statements as of and for the year-ended December 31, 2021 (in thousands, except per share amounts):

Consolidated Balance Sheet

	As of December 31, 2021
	As Reported			Adjustment		As Adjusted
Intangible assets, net	$	88,247		$	5,625	$	93,872
Goodwill		34,058			7,970	$	42,028
Total assets		504,752			13,595		518,347
Contingent consideration, current		19,988			65		20,053
Total current liabilities		191,276			65		191,341
Contingent consideration, non-current		24,737			6,796		31,533
Other non-current liabilities		13,078			813		13,891
Total liabilities		424,173			7,674		431,847
Accumulated deficit		(350,958	)		5,921		(345,037	)
Total stockholders' equity		80,579			5,921		86,500
Total liabilities and stockholders' equity		504,752			13,595		518,347

Consolidated Statement of Operations and Comprehensive Loss

	Year Ended
	December 31, 2021
	As Reported			Adjustment			As Adjusted
General and administrative	$	97,918		$	(6,251	)	$	91,667
Amortization		8,497			375			8,872
Total operating expenses		182,554			(5,876	)		176,678
Loss from operations		(67,249	)		5,876			(61,373	)
Loss before provision for income taxes		(67,849	)		5,876			(61,973	)
Provision for income taxes		2,744			(45	)		2,699
Net loss		(70,593	)		5,921			(64,672	)
Basic and diluted net loss per share		(2.12	)		0.18			(1.94	)
Total comprehensive loss		(70,763	)		5,921			(64,842	)

Consolidated Statement of Stockholders’ Equity

	Accumulated Deficit
	As Reported			Adjustment		As Adjusted
Net loss	$	(70,593	)	$	5,921	$	(64,672	)
Balance as of December 31, 2021		(350,958	)		5,921		(345,037	)
	Total Stockholders' Equity
Net loss		(70,593	)		5,921		(64,672	)
Balance as of December 31, 2021		80,579			5,921		86,500

Consolidated Statement of Cash Flows

	Year Ended
	December 31, 2021
	As Reported			Adjustment			As Adjusted
Cash flows from operating activities:
Net loss	$	(70,593	)	$	5,921		$	(64,672	)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization		9,035			375			9,410
Change in fair value of contingent consideration		18,325			(6,251	)		12,074
Change in deferred taxes		—			(45	)		(45	)

There was no impact on cash flows from investing or financing activities.

The accompanying applicable Notes to the Condensed Consolidated Financial Statements have been updated to reflect the restatement as of and for the three months ended March 31, 2022 and the revision for the year ended December 31, 2021.

Liquidity and Capital Resources

During the years ended December 31, 2021 and 2020, the Company generated cash flows from operations of $7,234 and $1,433, respectively, and incurred net losses of $64,672 and $47,876, respectively. In the three months ended March 31, 2022, the Company generated cash flows from operations of $10,134 and incurred a net loss of $22,129. As of March 31, 2022, the Company had an accumulated deficit of $367,843. Historically, the Company has satisfied its capital needs with the net proceeds from sales of equity securities, issuances of convertible debt, and the exercise of common stock options and warrants. In the first three months of 2022, the Company received net proceeds of $569 from the issuance of common stock under the Company’s employee stock plans, and used $9,441 for taxes paid related to net share settlement of equity awards and $14,376 for payment of the 2021 earnout for PandoLogic.

In 2022, driven by the acquisition of PandoLogic in September 2021, the Company expects to generate positive consolidated cash flows from its operations. As a result, management believes that the Company’s existing balances of cash and cash equivalents, which totaled $237,553 as of March 31, 2021, will be sufficient to meet its anticipated cash requirements for the foreseeable future.

Use of Accounting Estimates

The preparation of the accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the accompanying condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The principal estimates relate to the accounting recognition and presentation of revenue, allowance for doubtful accounts, purchase accounting, impairment of long-lived assets, the valuation of contingent consideration, the valuation of stock awards and stock warrants and income taxes, where applicable.

There has been uncertainty and disruption in the global economy and financial markets due to the COVID-19 pandemic and the war in Ukraine. The Company is not aware of any specific event or circumstance that would require an update to its estimates or assumptions or a revision of the carrying value of its assets or liabilities as of the date of filing of this Quarterly Report on Form 10-Q/A.

These estimates and assumptions may change as new events occur and additional information is obtained. As a result, actual results could differ materially from these estimates and assumptions.

Significant Customers

One individual customer accounted for 10% or more of the Company’s revenue for the three months ended March 31, 2022 and one individual customer accounted for 10% of the Company’s net revenues for the three months ended March 31, 2021. Two individual customers accounted for 10% or more of the Company’s accounts receivable as of March 31, 2022 and two individual customers accounted for 10% or more of the Company’s accounts receivable as December 31, 2021.

Remaining Performance Obligations

As of March 31, 2022, the aggregate amount of the transaction prices under the Company’s contracts allocated to the Company’s remaining performance obligations was $8,798, approximately 57% of which the Company expects to recognize as revenue over the next twelve months, and the remainder thereafter. This aggregate amount excludes amounts allocated to remaining performance obligations under contracts that have an original duration of one year or less and variable consideration that is allocated to remaining performance obligations. Excluded based on this policy are balances related to PandoLogic representing gross purchase orders to be satisfied in less than one year. Revenues will be recognized net of costs to fulfill these orders.

Significant Accounting Policies

There have been no material changes in the Company’s significant accounting policies from those disclosed in its Annual Report on Form 10-K for the year ended December 31, 2021, other than those associated with the recently adopted leasing guidance as further described in Note 9.

Recently Adopted Accounting Pronouncements

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). The amendments under this pronouncement change the way all leases with duration of one year or more are treated. Under this guidance, lessees are required to capitalize virtually all leases on the balance sheet as a right-of-use asset and an associated financing lease liability or operating lease liability. On January 1, 2022, the Company adopted the new leasing standard using the modified retrospective transition method applied at the adoption date of the standard. See Note 9 for further details.

In December 2019, the FASB issued ASU No. 2019-12 to simplify the accounting in ASC 740, Income Taxes. This standard removes certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. This guidance also clarifies and simplifies other areas of ASC 740. The Company adopted this guidance on January 1, 2022 using the prospective transition method. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

Recently Issued Accounting Pronouncements

In September 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326) which requires measurement and recognition of expected credit losses for financial assets held. This standard will be effective for the Company beginning in the first quarter of fiscal year 2023, and early adoption is permitted. The Company is currently evaluating the impact that this standard will have on its consolidated financial statements and related disclosures as well as the timing of adoption.

In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires entities to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with ASC Topic 606, Revenue from Contracts with Customers, in order to align the recognition of a contract liability with the definition of a performance obligation. This standard will be effective for the Company beginning in the first quarter of fiscal year 2023, and early adoption is permitted. The Company is currently evaluating the impact that this standard will have on its financial statements and related disclosures as well as the timing of adoption.

XML

Business Combinations

3 Months Ended

Mar. 31, 2022

Business Combinations [Abstract]

Business Combinations

NOTE 3. BUSINESS COMBINATIONS

March 2022 Acquisition

On March 1, 2022, the Company acquired 100% of an influencer-based management company, which is a California limited liability company, pursuant to a securities purchase agreement (the “Purchase Agreement”) dated as of March 1, 2022. The entity is an influencer management company that works with a select group of social media influencers to create content and custom marketing campaigns for brand partners and agencies.

The total purchase consideration was $5,844 (the “March Acquisition Consideration”), which consisted of upfront consideration of $1,500 in cash, $1,929 for the fair value of the Company’s 116,550 shares of common stock, and deferred cash payments to be made in 2023 and 2024 totaling $3,000, which was estimated to have a fair value of $2,707 on the acquisition date. The total purchase price was decreased by $976 for the settlement of a preexisting receivable and increased by $684 to adjust for the cash on hand at the time of the transaction closing. The total purchase consideration is preliminary and subject to net working capital adjustments that the Company expects to finalize and settle in the measurement period. In addition, the sellers may receive up to $4,500 in contingent earnout consideration based on achieving certain milestones tied to the entity’s financial performance in fiscal 2022 and 2023, which amount will be paid in cash (the “Earnout”). The fair value of the Earnout was estimated to be $3,015 as of March 1, 2022, all of which was deemed to be compensation to the seller which will be recognized as compensation expense over the earnout period in the general and administrative expenses on the condensed consolidated statement of operations and comprehensive loss. The Company incurred $270 in acquisition-related expenses and has recorded them in general and administrative expenses in the condensed consolidated statement of operations and comprehensive loss.

The following table summarizes the fair value of the purchase price consideration (in thousands):

March Acquisition Consideration	Preliminary
Cash consideration at closing	$	1,500
Equity consideration at closing		1,929
Deferred consideration		2,707
Acquired cash		684
Settlement of pre-existing receivable		(976	)
Total	$	5,844

The preliminary allocation of the purchase consideration to tangible and intangible assets acquired and liabilities assumed is based on estimated fair values and is as follows (in thousands):

Preliminary allocation of March Acquisition Consideration**	Preliminary
Cash	$	715
Accounts receivable		1,088
Prepaid and other current assets		120
Property and equipment		53
Intangible assets		3,000
Other assets		247
Total assets acquired		5,223
Accounts payable		18
Accrued expenses and other current liabilities		1,793
Operating lease liabilities, non-current		140
Total liabilities assumed		1,951
Identifiable net assets acquired	$	3,272
Goodwill		2,572
Total purchase consideration	$	5,844

**The excess of the total consideration over the tangible assets, identifiable intangible assets, and assumed liabilities is recorded as goodwill. Goodwill is primarily attributable to opportunities to cross-sell into our Commercial Enterprise customer base. For income tax purposes, the Company elected to treat the transaction as an asset acquisition. Tax deductible goodwill generated from the acquisition is $2,842 (including transaction costs of $270).

Identifiable Intangible Assets

The identifiable intangible assets acquired consisted of the influencer network, trade name and brand relationships with estimated useful lives of 2-10 years. The Company amortizes the fair value of these intangible assets on a straight-line basis over their respective useful lives.

The fair value of the intangible assets has been estimated using an income approach. Under the income approach, the after-tax cash flows associated with the asset are discounted to present value. The key assumptions include the Company’s estimates of the projected cash flows and discount rates.

The valuation of the intangible assets acquired along with their estimated useful lives, is as follows (in thousands):

	Estimated Fair Value		Estimated Useful Lives (in years)
Influencer network	$	1,500		5
Trade name		200		10
Brand relationships		1,300		5
Total intangible assets	$	3,000

PandoLogic Acquisition

On September 14, 2021, the Company acquired 100% of PandoLogic., a company incorporated under the laws of the state of Israel, pursuant to an Agreement and Plan of Merger (the “Merger Agreement”) dated as of July 21, 2021. PandoLogic is a leading provider of intelligent hiring solutions and utilizes its proprietary platform to accelerate the time and improve the efficiency in the process for employers hiring at scale for both mass market and difficult-to-source candidates. PandoLogic’s fully autonomous recruiting platform helps employers source talent faster and more efficiently with predictive algorithms, machine learning and AI.

The total purchase consideration for PandoLogic was $135,563 (the “Merger Consideration”), which consisted of upfront consideration of $58,733 in cash and $31,500 for the fair value of the Company’s 1,704,822 shares of common stock, up to $65,000 in contingent consideration based on achieving certain earnouts tied to financial performance of PandoLogic in fiscal 2021 and 2022, which amount will be paid in a combination of cash and common stock (the “Earnout”) and a net working capital adjustment of $5,818 paid in cash. The Company utilized a Monte Carlo simulation model to estimate the fair value of the Earnout. The fair value of the Earnout was estimated to be $44,900 as of September 14, 2021, $39,512 of which was deemed to be purchase consideration and recorded within contingent consideration current and contingent consideration non-current on the condensed consolidated balance sheet. The remaining $5,388 will be recognized as compensation expense over the earnout period in the general and administrative expenses on the condensed consolidated statement of operations and comprehensive loss. Subsequent to the acquisition date, the Company is required to reassess its estimate of the fair value of the Earnout, including certain future Earnout obligations triggered on the employment status of certain PandoLogic management, and record any changes in earnings when the estimate is based on information not known as of the acquisition date (See Note 5). The Company incurred $2,161 in acquisition-related expenses in 2021 and has recorded them in general and administrative expenses in the condensed consolidated statement of operations and comprehensive loss.

The following table summarizes the fair value of the purchase price consideration (in thousands):

Merger Consideration	Amount
Cash consideration at closing	$	58,733
Equity consideration at closing		31,500
Contingent earnout		39,512
Net working capital adjustment		5,818
Total	$	135,563

The preliminary allocation of the purchase consideration to tangible and intangible assets acquired and liabilities assumed is based on estimated fair values and is as follows (in thousands):

Allocation of Merger Consideration**	Amount
Cash	$	11,581
Accounts receivable		21,344
Prepaid and other current assets		8,710
Property and equipment		618
Intangible assets		92,000
Other assets		1,653
Total assets acquired		135,906
Accounts payable		13,183
Accrued expenses and other current liabilities		9,443
Deferred tax liability		12,686
Total liabilities assumed		35,312
Identifiable net assets acquired	$	100,594
Goodwill		34,969
Total purchase consideration	$	135,563

**The excess of the total consideration over the tangible assets, identifiable intangible assets, and assumed liabilities is recorded as goodwill. Goodwill is primarily attributable to operational efficiencies from operating PandoLogic products on aiWARE as well as opportunities to cross-sell into our Commercial Enterprise customer base.

 Identifiable Intangible Assets

The identifiable intangible assets acquired consisted of developed technology, customer relationships and tradename with estimated useful lives of 4-7 years. The Company amortizes the fair value of these intangible assets on a straight-line basis over their respective useful lives.

The fair value of the intangible assets has been estimated using a combination of the income and cost approaches. Under the income approach, the after-tax cash flows associated with the asset are discounted to present value. The key assumptions include the Company’s estimates of the projected cash flows and discount rates. Under the cost approach, the replacement cost is used to estimate the value of the asset. The key assumptions include the Company’s estimates of the direct and indirect costs required to replace the asset. The valuation of the intangible assets acquired from PandoLogic along with their estimated useful lives, is as follows (in thousands):

	Estimated Fair Value		Estimated Useful Lives (in years)
Customer relationships	$	70,000	5 - 7
Developed technology		20,000		4
Trade name		2,000		5
Total intangible assets	$	92,000

Taxes

In connection with the acquisition, a net deferred tax liability of $12,686 was established primarily for the differences between the fair value of the acquired non-goodwill intangible assets and PandoLogic’s historical tax basis in these assets. No deferred tax asset or liability is recorded on PandoLogic goodwill, $33,111 of which is not deductible for tax purposes.  In August 2021, PandoLogic obtained the approval for Preferred Technology Enterprise status under which its Israeli tax rate is reduced from the 23% statutory rate to a 12% beneficial rate.  This arrangement is scheduled to expire in December 2025. The acquired Israel deferred tax assets and liabilities are computed based on the tax rate in the year of their expected reversal. No valuation allowance is recorded on the acquired PandoLogic deferred tax assets as it is more likely than not they will be utilized to offset future taxable income.

Unaudited Pro Forma Results

The unaudited pro forma financial information in the table below summarizes the combined results of operations for Veritone and PandoLogic as if the companies were combined for the three-month periods ended March 31, 2021. The unaudited pro forma financial information for all periods presented included the business combination accounting effects resulting from this acquisition, including adjustments to reflect recognition of intangible asset amortization and accretion of contingent consideration. The unaudited pro forma financial information as presented below is for informational purposes only and is not necessarily indicative of the results of operations that would have been achieved if the acquisition had taken place at the beginning of January 1, 2021.

The unaudited pro forma financial information was as follows (in thousands):

	Three Months Ended
	March 31,
	2021
Net revenue	$	23,794
Loss before provision for income taxes	$	(36,392	)
Net loss	$	(35,755	)

XML

Debt

3 Months Ended

Mar. 31, 2022

Debt Disclosure [Abstract]

Debt

NOTE 4. DEBT

Convertible Senior Notes

In November 2021, the Company issued, at par value, $201.3 million aggregate principal amount of 1.75% convertible senior notes due 2026 (the “Convertible Notes”). The issuance included the full exercise of an option granted by the Company to the initial purchasers of the Convertible Notes to purchase an additional $26.25 million aggregate principal amount of Convertible Notes. The Convertible Notes were issued pursuant to and are subject to the terms and conditions of an indenture, which is referred to as the Indenture, between the Company and U.S. Bank National Association, as trustee. The Convertible Notes were offered and sold in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

The Convertible Notes are senior, unsecured obligations of the Company and bear interest at a rate of 1.75% per year. Interest accrues from November 19, 2021 and is payable semi-annually in arrears on May 15 and November 15 of each year, beginning on May 15, 2022. The Convertible Notes will mature on November 15, 2026, unless earlier converted, redeemed, or repurchased in accordance with the terms of the Convertible Notes.

Holders of the Convertible Notes may convert all or any portion of their Convertible Notes at their option at any time prior to the close of business on the business day immediately preceding May 15, 2026, only under the following conditions: (1) during any calendar quarter commencing after the calendar quarter ending on March 31, 2022 (and only during such calendar quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of Convertible Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate for the Convertible Notes on each such trading day; (3) if the Company calls such Convertible Notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the applicable redemption date; or (4) upon the occurrence of specified corporate events. On or after May 15, 2026, holders may convert all or any portion of their Convertible Notes at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date regardless of the foregoing conditions. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of its common stock or a combination of cash and shares of its common stock, at the Company’s election.

The conversion rate for the Convertible Notes will initially be 27.2068 shares of the Company’s common stock per $1,000 principal amount of Convertible Notes (equivalent to an initial conversion price of approximately $36.76 per share of common stock). The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date or following the Company’s issuance of a notice of redemption, the Company will, in certain circumstances, increase the conversion rate for a holder who elects to convert its Convertible Notes in connection with such a corporate event or who elects to convert its Convertible Notes called (or deemed called) for redemption during the related redemption period, as the case may be.

The Company may not redeem the Convertible Notes prior to November 20, 2024. The Company may redeem for cash all or any portion of the Convertible Notes (subject to certain limitations), at its option, on or after November 20, 2024 if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the Convertible Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No sinking fund is provided for the Convertible Notes.

If the Company undergoes a fundamental change prior to the maturity date, subject to certain conditions, holders may require the Company to repurchase for cash all or any portion of their Convertible Notes. The fundamental change repurchase price will be equal to 100% of the principal amount of the Convertible Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date.

The Convertible Notes are the Company’s senior unsecured obligations and rank senior in right of payment to all of the Company’s indebtedness that is expressly subordinated in right of payment to the Convertible Notes; equal in right of payment with all existing and future liabilities of the Company that are not so subordinated; effectively junior to any of secured indebtedness of the Company to the extent of the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities (including trade payables) and any preferred equity of the Company’s current or future subsidiaries.

The net proceeds from the issuance of the Convertible Notes were approximately $194.9 million, after deducting debt issuance costs. The total debt issuance costs incurred and recorded by the Company amounted to $6.3 million, which were recorded as a reduction to the face amount of the Convertible Notes and are being amortized to interest expense using the effective interest method over the contractual term of the Convertible Notes. The Convertible Notes are recorded as a liability within convertible senior notes, non-current.

For the three months ended March 31, 2022, interest expense related to the Convertible Notes and amortization of the issuance costs was $1.2 million. The effective annual interest rate for the three months ended March 31, 2022 was approximately 2.42%. As of March 31, 2022, the if-converted value of the Convertible Notes did not exceed the outstanding principal amount. As of March 31, 2022, the total estimated fair value of the Convertible Notes was $176.3 million, which was determined based on a market approach using actual bids and offers of the Convertible Notes in an over-the-counter market on the last trading day of the period. The Company considers these assumptions to be Level 2 inputs in accordance with the fair value hierarchy described in Note 6.

Capped Calls

In connection with the pricing of the Convertible Notes, with the full exercise by the initial purchasers of their option to purchase additional Convertible Notes in November 2021, the Company used approximately $18.6 million of the net proceeds from the issuance of the Convertible Notes to enter into privately negotiated capped call transactions, which are referred to as the capped calls, with various financial institutions.

The capped call transactions will cover, subject to anti-dilution adjustments substantially similar to those applicable to the Convertible Notes, the number of shares of the Company’s common stock underlying the Convertible Notes. The capped call transactions are expected generally to reduce the potential dilution to the Company’s common stock upon conversion of the Convertible Notes and/or offset some or all of any cash payments the Company is required to make in excess of the principal amount of converted Convertible Notes, as the case may be, in the event that the market price per share of the Company’s common stock, as measured under the terms of the capped call transactions, is greater than the strike price of the capped call transactions, which initially corresponds to the conversion price of the Convertible Notes and is subject to anti-dilution adjustments substantially similar to those applicable to the conversion rate of the Convertible Notes. If, however, the market price per share of the Company’s common stock, as measured under the terms of the capped call transactions, exceeds the cap price of the capped call transactions, there would nevertheless be dilution and/or there would not be an offset of such potential cash payments, in each case, to the extent that such market price exceeds the cap price of the capped call transactions. The initial cap price of the capped calls is $48.55 per share of common stock, which represents a premium of 75% over the last reported sale price of the Company’s common stock of $27.74 per share on November 16, 2021, and is subject to certain customary adjustments under the terms of the capped calls; provided that the cap price will not be reduced to an amount less than the strike price of $35.76 per share.

The capped call transactions are separate transactions and are not part of the terms of the Convertible Notes. The capped calls meet the criteria for classification as equity and, as such, are not remeasured each reporting period and are included as a reduction to additional paid-in-capital within stockholders’ equity.

XML

Net Loss Per Share

3 Months Ended

Mar. 31, 2022

Earnings Per Share [Abstract]

Net Loss Per Share

NOTE 5. NET LOSS PER SHARE

The following table presents the computation of basic and diluted net loss per share:

	Three Months Ended
	March 31,
	2022
	(As Restated)			2021
Numerator
Net loss	$	(22,129	)	$	(30,567	)
Denominator
Weighted-average common shares outstanding		35,478,676			32,191,419
Less:  Weighted-average shares subject to repurchase		(1,728	)		(19,381	)
Denominator for basic and diluted net loss per share    attributable to common stockholders		35,476,948			32,172,038
Basic and diluted net loss per share	$	(0.62	)	$	(0.95	)

The Company reported net losses for all periods presented and, as such, all potentially dilutive shares of common stock would have been antidilutive for such periods. The table below presents the weighted-average securities (in common equivalent shares) outstanding during the periods presented that have been excluded from the calculation of diluted net loss per share because their effect would be anti-dilutive:

	Three Months Ended
	March 31,
	2022		2021
Common stock options and restricted stock units		10,025,447		10,274,878
Warrants to purchase common stock		496,612		639,169
Common stock issuable in connection with convertible senior notes		5,475,369		—
		15,997,428		10,914,047

XML

Financial Instruments

3 Months Ended

Mar. 31, 2022

Investments All Other Investments [Abstract]

Financial Instruments

NOTE 6. FINANCIAL INSTRUMENTS

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs that may be used to measure fair value. Level 1 and Level 2 are considered observable and Level 3 is considered unobservable, as follows:

• Level 1—quoted prices (unadjusted) in active markets for identical assets or liabilities;

• Level 2—inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or

• Level 3—unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

Cash and Cash Equivalents

The Company’s money market funds are categorized as Level 1 within the fair value hierarchy. As of March 31, 2022, the Company’s cash and cash equivalents were as follows:

			Gross				Cash and
			Unrealized		Fair		Cash
	Cost		Losses		Value		Equivalents
Cash	$	236,524	$	—	$	236,524	$	236,524
Level 1:
Money market funds		1,029		—		1,029		1,029
Total	$	237,553	$	—	$	237,553	$	237,553

As of December 31, 2021, the Company’s cash and cash equivalents balances were as follows:

			Gross				Cash and
			Unrealized		Fair		Cash
	Cost		Losses		Value		Equivalents
Cash	$	253,693	$	—	$	253,693	$	253,693
Level 1:
Money market funds		1,029		—		1,029		1,029
Total	$	254,722	$	—	$	254,722	$	254,722

Contingent Consideration

All of the Company’s contingent consideration liabilities are categorized as Level 3 within the fair value hierarchy. Contingent consideration for the PandoLogic acquisition was valued at the time of acquisition using Monte Carlo simulation models. These models incorporate contractual terms and assumptions regarding financial forecasts for PandoLogic, discount rates, and volatility of forecasted revenue. The value of the Company’s contingent consideration would increase if a lower discount rate was used and would decrease if a higher discount rate was used. Similarly, a higher revenue volatility assumption would increase the value of the contingent consideration, and a lower revenue volatility assumption would decrease the value of the contingent consideration. Contingent consideration for the March 2022 acquisition was valued using a simple probability of achievement model, with the probability of achievement based on management’s forecasted outcomes for 2022 and 2023 fiscal year results for the acquired entity. The development and determination of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company’s management with the assistance of a third-party valuation specialist. 

As of March 31, 2022, the Company’s contingent consideration liabilities current and non-current balances were as follows:

			Changes in					Fair		Contingent
	Cost		Fair Value		Amount Paid			Value		Consideration
	(As Restated)		(As Restated)		In Period			(As Restated)		(As Restated)
Level 3:
Contingent consideration, current	$	18,128	$	2,822	$	(20,816	)	$	134	$	134
Contingent consideration, non-current		21,384		14,297		—			35,681		35,681
Total	$	39,512	$	17,119	$	(20,816	)	$	35,815	$	35,815

As of December 31, 2021, the Company’s contingent consideration liabilities current and non-current balances were as follows:

			Changes in		Fair		Contingent
	Cost		Fair Value		Value		Consideration
Level 3:
Contingent consideration, current	$	18,128	$	1,925	$	20,053	$	20,053
Contingent consideration, non-current		21,384		10,149		31,533		31,533
Total	$	39,512	$	12,074	$	51,586	$	51,586

Stock Warrants

All of the Company’s outstanding stock warrants are categorized as Level 3 within the fair value hierarchy. Stock warrants have been recorded at their fair value using either a probability weighted expected return model, the Monte Carlo simulation model or the Black-Scholes option-pricing model. These models incorporate contractual terms, maturity, risk-free interest rates and volatility. The value of the Company’s stock warrants would increase if a higher risk-free interest rate was used and would decrease if a lower risk-free interest rate was used. Similarly, a higher volatility assumption would increase the value of the stock warrants, and a lower volatility assumption would decrease the value of the stock warrants. The development and determination of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company’s management with the assistance of a third-party valuation specialist. 

Investments

During the three months ended March 31, 2022, the Company invested $2,000 in a strategic investment in a technology company that was determined to not have a readily determinable fair value. This investment is carried initially at cost of $2,000 on our condensed consolidated balance sheet within other assets. The Company will monitor this investment to determine whether an other-than-temporary decline in value indicates that impairment charges may be required. The Company will also re-measure its investment if there is an observable transaction in a similar class of security to our investment.

XML

Goodwill and Intangible Assets, Net

3 Months Ended

Mar. 31, 2022

Goodwill And Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets, Net

NOTE 7. GOODWILL AND INTANGIBLE ASSETS, NET

Goodwill

The carrying amount of goodwill was $44,600 as of March 31, 2022 and $42,028 December 31, 2021.

	Goodwill
Balance at December 31, 2021	$	42,028
March 2022 acquisition		2,572
Balance at March 31, 2022	$	44,600

Intangible Assets

The following table sets forth the Company’s finite-lived intangible assets resulting from business acquisitions and other purchases, which continue to be amortized: 

			March 31, 2022
			(As Restated)							December 31, 2021
	Weighted Average Remaining Useful Life (in years)		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
Software and technology		0.0	$	3,582	$	(3,555	)	$	27	$	3,582	$	(3,515	)	$	67
Licensed technology		0.0		500		(500	)		—		500		(500	)		—
Developed technology		3.1		29,600		(9,201	)		20,399		29,600		(7,647	)		21,953
Customer and supplier relationships		5.9		82,100		(12,715	)		69,385		79,300		(9,449	)		69,851
Noncompete agreements		0.3		800		(727	)		73		800		(683	)		117
Trade names		4.6		2,300		(317	)		1,983		2,100		(216	)		1,884
Total		5.4	$	118,882	$	(27,015	)	$	91,867	$	115,882	$	(22,010	)	$	93,872

The following table presents future amortization of the Company’s finite-lived intangible assets at March 31, 2022:

	(As Restated)
2022 (9 months)	$	15,496
2023		19,177
2024		17,365
2025		14,074
2026		10,574
Thereafter		15,181
Total	$	91,867

XML

Consolidated Financial Statements Details

3 Months Ended

Mar. 31, 2022

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Consolidated Financial Statements Details

NOTE 8. CONSOLIDATED FINANCIAL STATEMENTS DETAILS

Consolidated Balance Sheets Details

Cash and cash equivalents

As of March 31, 2022 and December 31, 2021, the Company had cash and cash equivalents of $237,553 and $254,722, respectively, including $69,496 and $66,401, respectively, of cash received from advertising customers and content licensees for future payments to vendors. 

Accounts Receivable, Net

Accounts receivable consisted of the following:

	As of
	March 31,			December 31,
	2022			2021
Accounts receivable — Managed Services(1)	$	35,648		$	21,347
Accounts receivable — Software Products & Services(2)		25,847			59,568
Accounts receivable — Other		6,452			4,926
		67,947			85,841
Less: allowance for doubtful accounts		(972	)		(778	)
Accounts receivable, net	$	66,975		$	85,063

⁽¹⁾ Accounts receivable – Managed Services reflects the amounts due from the Company’s advertising customers.

⁽²⁾ Accounts receivable – Software Products & Services reflects the amounts due from the Company’s PandoLogic customers.

Property, Equipment and Improvements, Net

Property, equipment and improvements, net consisted of the following:

	As of
	March 31,			December 31,
	2022			2021
Property and equipment	$	5,088		$	4,262
Leasehold improvements		167			167
		5,255			4,429
Less: accumulated depreciation		(3,118	)		(2,873	)
Property, equipment and improvements, net	$	2,137		$	1,556

Depreciation expense was $198 and $175 for the three months ended March 31, 2022 and 2021, respectively.

Accounts Payable

Accounts payable consisted of the following:

	As of
	March 31,		December 31,
	2022		2021
Accounts payable — Managed Services(1)	$	27,440	$	23,613
Accounts payable — Other		10,905		23,098
Total	$	38,345	$	46,711

⁽¹⁾ Accounts payable – Managed Services reflects the amounts due to media vendors for advertisements placed on behalf of the Company’s advertising clients.

Consolidated Statement of Operations and Comprehensive Loss Details

Revenue

Revenue for the periods presented were comprised of the following:

	Three Months Ended
	March 31,
	2022		2021
Commercial Enterprise	$	33,626	$	17,005
Government & Regulated Entities		781		1,290
Total revenue	$	34,407	$	18,295

In the third quarter of fiscal year 2021, the Company realigned its organization to improve focus and growth into two customer groups: (1) Commercial Enterprise (“CE”), which today consists of customers in the commercial sector, including media and entertainment customers, advertising customers, content licensing customers and PandoLogic customers; and (2) Government & Regulated Industries (“GRI”), which today consists of customers in the government and regulated industries sectors, including state, local and federal government, legal, compliance and energy customers.

Software Products & Services consists of revenue generated from the Company’s aiWARE platform and PandoLogic’s talent acquisition solutions, any related support and maintenance services, and any related professional services associated with the deployment and or implementation of such solutions.

Managed Services consists of revenues generated from content licensing customers and advertising agency customers and related services.

The table below illustrates the presentation of our revenues based on the above definitions:

	Three Months Ended
	March 31, 2022
			Government &
	Commercial		Regulated
	Enterprise		Industries		Total
Total Software Products & Services(1)	$	17,386	$	781	$	18,167
Managed Services
Advertising		10,968		—		10,968
Licensing		5,272		—		5,272
Total Managed Services		16,240		—		16,240
Total Revenue	$	33,626	$	781	$	34,407

⁽¹⁾ Software Products & Services consists of aiWARE revenues of $3,371 and PandoLogic revenues of $14,796.

	Three Months Ended
	March 31, 2021
			Government &
	Commercial		Regulated
	Enterprise		Industries		Total
Total Software Products & Services	$	3,395	$	1,290	$	4,685
Managed Services
Advertising		10,327		—		10,327
Licensing		3,283		—		3,283
Total Managed Services		13,610		—		13,610
Total Revenue	$	17,005	$	1,290	$	18,295

Other Expense, Net

Other expense, net for the periods presented was comprised of the following:

	Three Months Ended
	March 31,
	2022			2021
Interest (expense) income, net	$	(1,182	)	$	2
Other		(4	)		(11	)
Other expense, net	$	(1,186	)	$	(9	)

Provision for Income Taxes

The provision or benefit from income taxes for interim periods is determined using an estimate of the Company’s annual effective tax rate, adjusted for discrete items, if any, that are taken into account in the relevant period. Each quarter, the Company updates the estimate of the annual effective tax rate, and if the estimated tax rate changes, the Company records a cumulative adjustment. 

The income tax expense for the three months ended March 31, 2022 and 2021 resulted in an effective tax rate of (0.6)% and (0.1)%, respectively. The difference between the effective tax rate and the U.S. federal statutory rate is primarily due to a valuation allowance established on the majority of the Company’s federal and state net deferred tax assets and certain of its foreign operations. Due to tax losses and an offsetting valuation allowance against a majority of the U.S deferred tax assets, the Company recorded a tax provision in the amount of $138 for the three months ended March 31, 2022 as compared to $22 for the three months ended March 31, 2021. The increase is mainly attributed to the US and foreign income taxes resulted from the profitability of PandoLogic.

As of March 31, 2022, the Company continues to provide a valuation allowance against certain federal and state deferred tax assets. The Company continues to evaluate the realizability of deferred tax assets and the related valuation allowance. If the Company’s assessment of the deferred tax assets or the corresponding valuation allowance were to change, the Company would record the related adjustment to income during the period in which the determination is made.

The Company is subject to taxation in the U.S. and various foreign jurisdictions. The tax years subsequent to 2016 remain open and subject to examination by federal, state, and foreign taxing authorities in which the Company is subject to tax. The Company is not under examination in any other jurisdictions.

XML

Leases, Commitments and Contingencies

3 Months Ended

Mar. 31, 2022

Leases Commitments And Contingencies [Abstract]

Leases, Commitments and Contingencies

NOTE 9. LEASES, COMMITMENTS AND CONTINGENCIES

Leases

Adoption of the New Lease Accounting Standard

On January 1, 2022, the Company adopted ASU No. 2016-02, Leases (Topic 842), using the modified retrospective transition method applied at the adoption date of the standard. Results for reporting periods beginning after January 1, 2022 are presented under the new leasing standard, while prior period amounts are not adjusted and continue to be reported in accordance with the Company’s historic accounting. The Company has elected to utilize the package of practical expedients at the time of adoption, which allows the Company to (1) not reassess whether any expired or existing contracts are or contain leases, (2) not reassess the lease classification of any expired or existing leases, and (3) not reassess initial direct costs for any existing leases. The Company also has elected to utilize the short-term lease recognition exemption and, for those leases that qualified, the Company did not recognize right-of-use (“ROU”) assets or lease liabilities.

As a result of adoption, the Company recorded ROU assets related to office facility leases which are recognized on the consolidated balance sheet within “other assets” and the associated lease liabilities are recognized on the consolidated balance sheet within “other accrued liabilities” and “other non-current liabilities.” The present value of the Company’s remaining lease payments, which comprise the lease liabilities, was estimated using the incremental borrowing rate as of the adoption date.

The cumulative effects of the changes made to the Company’s January 1, 2022 consolidated balance sheet were as follows:

	December 31, 2021			Adjustments Due to Adoption of New Leasing Standard			January 1, 2022
Assets
Prepaid expenses and other current assets	$	12,117		$	71		$	12,188
Other assets		954			1,983			2,937
								-
Liabilities								-
Other accrued liabilities	$	27,093		$	1,675		$	28,768
Other non-current liabilities		13,891			1,057			14,948
								-
Stockholders' Equity								-
Accumulated deficit	$	(345,037	)	$	(678	)	$	(345,715	)

New Lease Accounting Policies

The Company determines if an arrangement is a lease at inception and determine the classification of the lease, as either operating or finance, at commencement. The Company has various operating leases for its offices. These existing leases have remaining lease terms ranging from 1 to 5 years. Certain lease agreements contain options to renew, with renewal terms that generally extend the lease terms by 1 to 5 years for each option. The Company determined that none of its current leases are reasonably certain to renew. For short-term leases with expected terms of less than 1 year, the Company does not recognize ROU assets or lease liabilities. The Company does not have any finance leases.

ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As the rate implicit in the Company’s leases is not readily determinable, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. The Company estimates the incremental borrowing rate to reflect the profile of secured borrowing over the expected term of the leases based on the information available at the later of the initial date of adoption or the lease commencement date.

The operating lease ROU asset also includes any lease payments made and excludes lease incentives received at or before lease commencement. Lease expense for lease payments is recognized on a straight-line basis over the lease term. Sublease rental income is recognized as a reduction to the related lease expense on a straight-line basis over the sublease term.

Lease Costs

As of March 31, 2022, on its condensed consolidated balance sheet the Company has right-of-use assets of $2,556 recorded within other assets, the current portion of operating lease liabilities of $2,106 recorded within other accrued liabilities, and the non-current portion of operating lease liabilities of $2,851 recorded within other non-current liabilities.

The Company made cash payments for its operating leases of $652 for the three months ended March 31, 2022, all of which were included in cash flows from operating activities within the condensed consolidated statements of cash flows. The Company’s operating leases have a weighted average remaining lease term of 2.7 years and weighted average discount rate of 7.8%.

In February 2021, the Company entered into an office sublease (the “Sublease”) with a third party (the “Subtenant”), pursuant to which the Company has subleased its former office space located in Costa Mesa, California, consisting of approximately 37,875 square feet, which the Company leases pursuant to an existing lease agreement expiring in 2024 (the “Lease”). The term of the Sublease commenced in March 2021 and will continue through December 31, 2024, coterminous with the Lease. Pursuant to the Sublease, the Subtenant will pay to the Company monthly base rent, which is subject to annual rent escalations, as well as a portion of the operating expenses and taxes payable by the Company under the Lease. The Company recognized contract termination costs as a liability when it ceased using the rights conveyed under the Lease. During the three months ended March 31, 2021, the Company recorded approximately $3,367 in charges resulting from the Sublease, consisting of $1,894 loss on disposal of property and equipment and leasehold improvements, $1,211 loss on sublease, and $262 in initial direct costs.

The total rent expense for all operating leases, excluding the charges related to the Sublease discussed above, was $506 and $571 for the three months ended March 31, 2022 and 2021, respectively, with short-term leases making up an immaterial portion of such expenses. For its sublease, the Company recorded sublease income of $277 for the three months ended March 31, 2022.

Lease Commitments

 Future undiscounted lease payments for the Company’s operating lease liabilities, a reconciliation of these payments to its operating lease liabilities, and related sublease income at December 31, 2021 are as follows:

Years ended December 31,
2022 (nine months)	$	2,095
2023		2,241
2024		1,792
Total future minimum lease payments, including short-term leases		6,128
Less: future minimum lease payments for short-term leases		(602	)
Less: imputed interest		(569	)
Present value of future minimum lease payments, excluding short-term leases	$	4,957
Less: current portion of operating lease liabilities		(2,106	)
Non-current portion of operating lease liabilities		2,851
Years ended December 31,	Sublease Income
2022 (nine months)	$	782
2023		1,297
2024		1,034
Total sublease income	$	3,113

As previously disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 under the previous lease accounting standard, future minimum lease payments at December 31, 2021, on an undiscounted basis, were as follows:    

2022	$	2,532
2023		2,091
2024		1,730
Total minimum payments	$	6,353

As of December 31, 2021, minimum sublease rental income to be received in the future under noncancelable subleases was approximately $3,402 and the total rent expense for all operating leases was $4,668 for the year ended December 31, 2021.

Sales Taxes

The Company collects and remits sales tax in jurisdictions in which it has a physical presence or it believes tax nexus exists, which therefore obligates the Company to collect and remit sales tax. During the three months ended March 31, 2022 and 2021, the Company recorded a $134 liability and a $138 liability, respectively, for potential exposure in several states where there is uncertainty about the point in time at which the Company established a sufficient business connection to create nexus.

Purchase Consideration

In connection with its March 2022 acquisition, the Company committed to make purchase consideration payments of $1,500 within ten days of the first anniversary of the closing date of the acquisition and an additional $1,500 within ten days of the second anniversary of the closing date of the acquisition. Refer to Note 3 for further details.

Other Contingencies

From time to time, the Company may be involved in litigation relating to claims arising out of its operations in the normal course of business. The Company currently is not a party to any legal proceedings, the adverse outcome of which, in management’s opinion, individually or in the aggregate, would have a material adverse effect on the Company’s results of operations, financial position or cash flows.

XML

Stockholders' Equity

3 Months Ended

Mar. 31, 2022

Equity [Abstract]

Stockholders' Equity

NOTE 10. STOCKHOLDERS’ EQUITY

Common Stock Issuances

During the three months ended March 31, 2022 and 2021, the Company issued an aggregate of 615,703 and 608,886 shares of its common stock, respectively, in connection with the exercise of stock options, issuance of stock awards and vesting of restricted stock units under its stock incentive plans and purchases under its Employee Stock Purchase Plan (the “ESPP”).

During the three months ended March 31, 2022, the Company issued a total of 116,550 shares of its common stock in connection with its March 2022 acquisition. During the three months ended March 31, 2022, the Company issued a total of 352,330 shares of its common stock in connection with the contingent consideration arrangement related to the acquisition of PandoLogic.

During the three months ended March 31, 2021, the Company issued a total of 167,495 shares of its common stock upon the exercise of warrants for an aggregate exercise price of $2,279 and issued an aggregate of 84,723 shares of its common stock upon exercises of warrants to purchase an aggregate of 91,833 shares of its common stock, which were effected on a net exercise basis without cash payment of the exercise price.

During the three months ended March 31, 2021, the Company issued an aggregate of 15,828 shares of its common stock for services provided to the Company.

XML

Stock Plans

3 Months Ended

Mar. 31, 2022

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Stock Plans

NOTE 11. STOCK PLANS

Stock-Based Compensation

During the three months ended March 31, 2022, the Company granted options to purchase an aggregate of 480,850 shares of its common stock that are subject to time-based vesting conditions.

The Company valued these stock options using the Black-Scholes Merton option pricing model. The following assumptions were used to compute the grant date fair values of the stock options granted during the three months ended March 31, 2022:

Expected term (in years)	6.1
Expected volatility	82	%
Risk-free interest rate	1.8	%
Expected dividend yield	—

The assumptions used in calculating the fair values of purchase rights granted under the ESPP during the three months ended March 31, 2022 are set forth in the table below:

Expected term (in years)	0.5 - 2.0
Expected volatility	71% - 88%
Risk-free interest rate	0.2% - 2.4%
Expected dividend yield		—

The Company’s stock-based compensation expense by type of award and by operating expense grouping are presented below:

	Three Months Ended
	March 31,
	2022		2021
Stock-based compensation expense by type of award:
Restricted stock units	$	3,432	$	4,171
Stock awards		—		19
Performance-based stock options		—		16,314
Stock options		1,273		837
Employee stock purchase plan		92		150
Common stock issued for services		19		119
Total	$	4,816	$	21,610
Stock-based compensation expense by operating expense grouping:
Cost of revenue	$	20	$	-
Sales and marketing		463		898
Research and development		1,004		1,019
General and administrative		3,329		19,693
	$	4,816	$	21,610

Equity Award Activity Under Stock Plans

Restricted Stock Units

The Company’s restricted stock unit activity for the three months ended March 31, 2022 was as follows:

				Weighted
				Average Grant
	Shares			Date Fair Value
Unvested at December 31, 2021		886,461		$	32.56
Granted		402,811		$	16.47
Forfeited		(28,824	)	$	23.20
Vested		(328,956	)	$	46.65
Unvested at March 31, 2022		931,492		$	21.01

As of March 31, 2022, total unrecognized compensation cost related to restricted stock units was $14,362, which is expected to be recognized over a weighted average period of 2.18 years.

Performance-Based Stock Options

The activity during the three months ended March 31, 2022 related to stock options that are subject to performance-based vesting conditions tied to the achievement of stock price goals by the Company was as follows:

				Weighted-Average
						Remaining		Aggregate
				Exercise		Contractual		Intrinsic
	Options			Price		Term		Value
Outstanding at December 31, 2021		3,834,441		$	11.05
Exercised		(21,713	)	$	5.55
Expired		(7,277	)	$	4.94
Outstanding at March 31, 2022		3,805,451		$	11.09		6.3	$	27,350
Exercisable at March 31, 2022		3,805,451		$	11.09		6.3	$	27,350

The aggregate intrinsic value of the options exercised during the three months ended March 31, 2022 and 2021 was $221 and $5,815, respectively. No performance-based stock options were granted during the three months ended March 31, 2022 and 2021 and no performance-based stock options vested during the three months ended March 31, 2022. During the three months ended March 31, 2021, the Company achieved all of the stock price milestones applicable to substantially all of the performance-based stock options and, as a result, such performance-based stock options vested and all associated unrecognized compensation was accelerated and recognized in full as a one-time expense of $16,268. 

Stock Options

The activity during the three months ended March 31, 2022 related to all other stock options was as follows:

				Weighted-Average
						Remaining		Aggregate
				Exercise		Contractual		Intrinsic
	Options			Price		Term		Value
Outstanding at December 31, 2021		5,508,608		$	15.10
Granted		291,850		$	16.13
Exercised		(20,222	)	$	7.33
Forfeited		(57,134	)	$	13.07
Expired		(8,425	)	$	21.61
Outstanding at March 31, 2022		5,714,677		$	15.23		6.2	$	25,419
Exercisable at March 31, 2022		4,289,264		$	13.76		5.4	$	20,201

The weighted average grant date fair value of stock options granted during the three months ended March 31, 2022 and 2021 was $11.36 and $32.68 per share, respectively. The aggregate intrinsic value of the stock options exercised during the three months ended March 31, 2022 and 2021 was $163 and $7,848, respectively. The total grant date fair value of stock options vested during the three months ended March 31, 2022 and 2021 was $1,085 and $733, respectively. At March 31, 2022, total unrecognized compensation expense related to stock options was $15,080 and is expected to be recognized over a weighted average period of 3.3 years.

The aggregate intrinsic values in the tables above represent the difference between the fair market value of the Company’s common stock and the average option exercise price of in-the-money options, multiplied by the number of such stock options.

Employee Stock Purchase Plan

During the three months ended March 31, 2022, a total of 67 shares of common stock were purchased under the Company’s ESPP. As of March 31, 2022, accrued employee contributions for future purchases under the ESPP totaled $191.

XML

Related Party Transactions

3 Months Ended

Mar. 31, 2022

Related Party Transactions [Abstract]

Related Party Transactions

NOTE 12. RELATED PARTY TRANSACTIONS

There were no related party transactions as of or during the three months ended March 31, 2022 and 2021.

XML

Presentation and Summary of Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2022

Accounting Policies [Abstract]

Basis of Presentation and Preparation

Basis of Presentation and Preparation

The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial statements and the rules and regulations of the SEC. Accordingly, they do not contain all information and footnotes required by GAAP for annual financial statements. Such unaudited condensed consolidated financial statements and accompanying notes are based on the representations of the Company’s management, who is responsible for their integrity and objectivity. The information included in this Form 10-Q/A should be read in conjunction with the information included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the SEC on March 17, 2022. Interim results for the three months ended March 31, 2022 are not necessarily indicative of the results the Company will have for the full year ending December 31, 2022.

The accompanying condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, which are normal, recurring and necessary to fairly state the Company’s financial position, results of operations and cash flows. All significant intercompany transactions have been eliminated in consolidation. The financial data and the other information disclosed in these notes to the condensed consolidated financial statements reflected in the three month periods presented are unaudited. The December 31, 2021 balance sheet included herein was derived from the audited financial statements but does not include all disclosures or notes required by GAAP for complete financial statements.

Restatement and Adjustment of Financial Statements

Restatement and Adjustment of Financial Statements

Restatement of Previously Issued Financial Statements

On August 9, 2022, the management of the Company and the Audit Committee of the Board of Directors of the Company, after consideration of the relevant facts and circumstances, determined that the Company’s previously issued financial statements as of and for the three months ended March 31, 2022 should be restated, and that such financial statements should no longer be relied upon due to an error related to the calculation of fair value of contingent consideration at the time of the acquisition of PandoLogic, which led to an understatement of goodwill, intangible assets and contingent consideration at the time of the acquisition, an overstatement of subsequent changes to the fair value of contingent consideration, and an understatement of subsequent intangible amortization expense. The restatement results in a non-cash charge that reduces general and administrative expenses and results in a favorable change to net loss for the three months ended March 31, 2022. The Company has restated its financial statements for the three months ended March 31, 2022 for such errors.

Adjustment of Previously Issued Financial Statements

The Company also evaluated the aggregate effects of the errors to its previously issued financial statements in accordance with SEC Staff Accounting Bulletins No. 99 and No. 108 and, based upon quantitative and qualitative factors, determined that the errors were not material to the previously issued financial statements included in its Annual Report on Form 10-K for the year ended December 31, 2021 or for any quarterly periods included therein. However, in order to correctly state equity in connection with the filing of this Form 10-Q/A, the December 31, 2021 consolidated balance sheet has been corrected to reflect the impact of this immaterial error.  The Company will adjust its consolidated financial statements for the year ended December 31, 2021 when it files its Form 10-K for the period ended December 31, 2022.

The following tables present the effects of the aforementioned restatement to the specific line items presented in the Company’s previously reported unaudited condensed consolidated financial statements as of and for the three months ended March 31, 2022 (in thousands, except per share amounts):

Condensed Consolidated Balance Sheet

	As of March 31, 2022
	As Reported			Adjustment		As Restated
Intangible assets, net	$	86,563		$	5,304	$	91,867
Goodwill		36,630			7,970		44,600
Total assets		469,004			13,274		482,278
Contingent consideration, non-current		35,416			265		35,681
Other non-current liabilities		16,440			776		17,216
Total liabilities		413,004			1,041		414,045
Accumulated deficit		(380,076	)		12,233		(367,843	)
Total stockholders' equity		56,000			12,233		68,233
Total liabilities and stockholders' equity		469,004			13,274		482,278

Condensed Consolidated Statement of Operations and Comprehensive Loss

	Three Months Ended
	March 31, 2022
	As Reported			Adjustment			As Restated
General and administrative	$	28,917		$	(6,596	)	$	22,321
Amortization		4,693			323			5,016
Total operating expenses		61,485			(6,273	)		55,212
Loss from operations		(27,078	)		6,273			(20,805	)
Loss before provision for income taxes		(28,264	)		6,273			(21,991	)
Provision for income taxes		177			(39	)		138
Net loss		(28,441	)		6,312			(22,129	)
Basic and diluted net loss per share		(0.80	)		0.18			(0.62	)
Total comprehensive loss		(28,251	)		6,312			(21,939	)

Condensed Consolidated Statement of Stockholders’ Equity

	Accumulated Deficit
	As Reported			Adjustment		As Restated
Balance as of December 31, 2021	$	(350,958	)	$	5,921	$	(345,037	)
Net loss		(28,441	)		6,312		(22,129	)
Balance as of March 31, 2022		(380,076	)		12,233		(367,843	)
	Total Stockholders' Equity
Balance as of December 31, 2021		80,579			5,921		86,500
Net loss		(28,441	)		6,312		(22,129	)
Balance as of March 31, 2022		56,000			12,233		68,233

Condensed Consolidated Statement of Cash Flows

	Three Months Ended
	March 31, 2022
	As Reported			Adjustment			As Restated
Cash flows from operating activities:
Net loss	$	(28,441	)	$	6,312		$	(22,129	)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization		4,891			323			5,214
Change in fair value of contingent consideration		11,641			(6,596	)		5,045
Change in deferred taxes		(426	)		(39	)		(465	)

There was no impact on cash flows from investing or financing activities.

The following tables reflect the impact of the adjustments to the specific line items presented in the Company’s previously reported consolidated financial statements as of and for the year-ended December 31, 2021 (in thousands, except per share amounts):

Consolidated Balance Sheet

	As of December 31, 2021
	As Reported			Adjustment		As Adjusted
Intangible assets, net	$	88,247		$	5,625	$	93,872
Goodwill		34,058			7,970	$	42,028
Total assets		504,752			13,595		518,347
Contingent consideration, current		19,988			65		20,053
Total current liabilities		191,276			65		191,341
Contingent consideration, non-current		24,737			6,796		31,533
Other non-current liabilities		13,078			813		13,891
Total liabilities		424,173			7,674		431,847
Accumulated deficit		(350,958	)		5,921		(345,037	)
Total stockholders' equity		80,579			5,921		86,500
Total liabilities and stockholders' equity		504,752			13,595		518,347

Consolidated Statement of Operations and Comprehensive Loss

	Year Ended
	December 31, 2021
	As Reported			Adjustment			As Adjusted
General and administrative	$	97,918		$	(6,251	)	$	91,667
Amortization		8,497			375			8,872
Total operating expenses		182,554			(5,876	)		176,678
Loss from operations		(67,249	)		5,876			(61,373	)
Loss before provision for income taxes		(67,849	)		5,876			(61,973	)
Provision for income taxes		2,744			(45	)		2,699
Net loss		(70,593	)		5,921			(64,672	)
Basic and diluted net loss per share		(2.12	)		0.18			(1.94	)
Total comprehensive loss		(70,763	)		5,921			(64,842	)

Consolidated Statement of Stockholders’ Equity

	Accumulated Deficit
	As Reported			Adjustment		As Adjusted
Net loss	$	(70,593	)	$	5,921	$	(64,672	)
Balance as of December 31, 2021		(350,958	)		5,921		(345,037	)
	Total Stockholders' Equity
Net loss		(70,593	)		5,921		(64,672	)
Balance as of December 31, 2021		80,579			5,921		86,500

Consolidated Statement of Cash Flows

	Year Ended
	December 31, 2021
	As Reported			Adjustment			As Adjusted
Cash flows from operating activities:
Net loss	$	(70,593	)	$	5,921		$	(64,672	)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization		9,035			375			9,410
Change in fair value of contingent consideration		18,325			(6,251	)		12,074
Change in deferred taxes		—			(45	)		(45	)

There was no impact on cash flows from investing or financing activities.

The accompanying applicable Notes to the Condensed Consolidated Financial Statements have been updated to reflect the restatement as of and for the three months ended March 31, 2022 and the revision for the year ended December 31, 2021.

Liquidity and Capital Resources

Liquidity and Capital Resources

During the years ended December 31, 2021 and 2020, the Company generated cash flows from operations of $7,234 and $1,433, respectively, and incurred net losses of $64,672 and $47,876, respectively. In the three months ended March 31, 2022, the Company generated cash flows from operations of $10,134 and incurred a net loss of $22,129. As of March 31, 2022, the Company had an accumulated deficit of $367,843. Historically, the Company has satisfied its capital needs with the net proceeds from sales of equity securities, issuances of convertible debt, and the exercise of common stock options and warrants. In the first three months of 2022, the Company received net proceeds of $569 from the issuance of common stock under the Company’s employee stock plans, and used $9,441 for taxes paid related to net share settlement of equity awards and $14,376 for payment of the 2021 earnout for PandoLogic.

In 2022, driven by the acquisition of PandoLogic in September 2021, the Company expects to generate positive consolidated cash flows from its operations. As a result, management believes that the Company’s existing balances of cash and cash equivalents, which totaled $237,553 as of March 31, 2021, will be sufficient to meet its anticipated cash requirements for the foreseeable future.

Use of Accounting Estimates

Use of Accounting Estimates

The preparation of the accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the accompanying condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The principal estimates relate to the accounting recognition and presentation of revenue, allowance for doubtful accounts, purchase accounting, impairment of long-lived assets, the valuation of contingent consideration, the valuation of stock awards and stock warrants and income taxes, where applicable.

There has been uncertainty and disruption in the global economy and financial markets due to the COVID-19 pandemic and the war in Ukraine. The Company is not aware of any specific event or circumstance that would require an update to its estimates or assumptions or a revision of the carrying value of its assets or liabilities as of the date of filing of this Quarterly Report on Form 10-Q/A.

These estimates and assumptions may change as new events occur and additional information is obtained. As a result, actual results could differ materially from these estimates and assumptions.

Significant Customers

Significant Customers

One individual customer accounted for 10% or more of the Company’s revenue for the three months ended March 31, 2022 and one individual customer accounted for 10% of the Company’s net revenues for the three months ended March 31, 2021. Two individual customers accounted for 10% or more of the Company’s accounts receivable as of March 31, 2022 and two individual customers accounted for 10% or more of the Company’s accounts receivable as December 31, 2021.

Remaining Performance Obligations

Remaining Performance Obligations

As of March 31, 2022, the aggregate amount of the transaction prices under the Company’s contracts allocated to the Company’s remaining performance obligations was $8,798, approximately 57% of which the Company expects to recognize as revenue over the next twelve months, and the remainder thereafter. This aggregate amount excludes amounts allocated to remaining performance obligations under contracts that have an original duration of one year or less and variable consideration that is allocated to remaining performance obligations. Excluded based on this policy are balances related to PandoLogic representing gross purchase orders to be satisfied in less than one year. Revenues will be recognized net of costs to fulfill these orders.

Significant Accounting Policies

Significant Accounting Policies

There have been no material changes in the Company’s significant accounting policies from those disclosed in its Annual Report on Form 10-K for the year ended December 31, 2021, other than those associated with the recently adopted leasing guidance as further described in Note 9.

Recently Issued Accounting Pronouncements

Recently Adopted Accounting Pronouncements

In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). The amendments under this pronouncement change the way all leases with duration of one year or more are treated. Under this guidance, lessees are required to capitalize virtually all leases on the balance sheet as a right-of-use asset and an associated financing lease liability or operating lease liability. On January 1, 2022, the Company adopted the new leasing standard using the modified retrospective transition method applied at the adoption date of the standard. See Note 9 for further details.

In December 2019, the FASB issued ASU No. 2019-12 to simplify the accounting in ASC 740, Income Taxes. This standard removes certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. This guidance also clarifies and simplifies other areas of ASC 740. The Company adopted this guidance on January 1, 2022 using the prospective transition method. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

Recently Issued Accounting Pronouncements

In September 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326) which requires measurement and recognition of expected credit losses for financial assets held. This standard will be effective for the Company beginning in the first quarter of fiscal year 2023, and early adoption is permitted. The Company is currently evaluating the impact that this standard will have on its consolidated financial statements and related disclosures as well as the timing of adoption.

In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires entities to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with ASC Topic 606, Revenue from Contracts with Customers, in order to align the recognition of a contract liability with the definition of a performance obligation. This standard will be effective for the Company beginning in the first quarter of fiscal year 2023, and early adoption is permitted. The Company is currently evaluating the impact that this standard will have on its financial statements and related disclosures as well as the timing of adoption.

XML

Presentation and Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2022

Accounting Policies [Abstract]

Summary of Restatement to Previously Reported Condensed Consolidated Financial Statements

The following tables present the effects of the aforementioned restatement to the specific line items presented in the Company’s previously reported unaudited condensed consolidated financial statements as of and for the three months ended March 31, 2022 (in thousands, except per share amounts):

Condensed Consolidated Balance Sheet

	As of March 31, 2022
	As Reported			Adjustment		As Restated
Intangible assets, net	$	86,563		$	5,304	$	91,867
Goodwill		36,630			7,970		44,600
Total assets		469,004			13,274		482,278
Contingent consideration, non-current		35,416			265		35,681
Other non-current liabilities		16,440			776		17,216
Total liabilities		413,004			1,041		414,045
Accumulated deficit		(380,076	)		12,233		(367,843	)
Total stockholders' equity		56,000			12,233		68,233
Total liabilities and stockholders' equity		469,004			13,274		482,278

Condensed Consolidated Statement of Operations and Comprehensive Loss

	Three Months Ended
	March 31, 2022
	As Reported			Adjustment			As Restated
General and administrative	$	28,917		$	(6,596	)	$	22,321
Amortization		4,693			323			5,016
Total operating expenses		61,485			(6,273	)		55,212
Loss from operations		(27,078	)		6,273			(20,805	)
Loss before provision for income taxes		(28,264	)		6,273			(21,991	)
Provision for income taxes		177			(39	)		138
Net loss		(28,441	)		6,312			(22,129	)
Basic and diluted net loss per share		(0.80	)		0.18			(0.62	)
Total comprehensive loss		(28,251	)		6,312			(21,939	)

Condensed Consolidated Statement of Stockholders’ Equity

	Accumulated Deficit
	As Reported			Adjustment		As Restated
Balance as of December 31, 2021	$	(350,958	)	$	5,921	$	(345,037	)
Net loss		(28,441	)		6,312		(22,129	)
Balance as of March 31, 2022		(380,076	)		12,233		(367,843	)
	Total Stockholders' Equity
Balance as of December 31, 2021		80,579			5,921		86,500
Net loss		(28,441	)		6,312		(22,129	)
Balance as of March 31, 2022		56,000			12,233		68,233

Condensed Consolidated Statement of Cash Flows

	Three Months Ended
	March 31, 2022
	As Reported			Adjustment			As Restated
Cash flows from operating activities:
Net loss	$	(28,441	)	$	6,312		$	(22,129	)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization		4,891			323			5,214
Change in fair value of contingent consideration		11,641			(6,596	)		5,045
Change in deferred taxes		(426	)		(39	)		(465	)

There was no impact on cash flows from investing or financing activities.

The following tables reflect the impact of the adjustments to the specific line items presented in the Company’s previously reported consolidated financial statements as of and for the year-ended December 31, 2021 (in thousands, except per share amounts):

Consolidated Balance Sheet

	As of December 31, 2021
	As Reported			Adjustment		As Adjusted
Intangible assets, net	$	88,247		$	5,625	$	93,872
Goodwill		34,058			7,970	$	42,028
Total assets		504,752			13,595		518,347
Contingent consideration, current		19,988			65		20,053
Total current liabilities		191,276			65		191,341
Contingent consideration, non-current		24,737			6,796		31,533
Other non-current liabilities		13,078			813		13,891
Total liabilities		424,173			7,674		431,847
Accumulated deficit		(350,958	)		5,921		(345,037	)
Total stockholders' equity		80,579			5,921		86,500
Total liabilities and stockholders' equity		504,752			13,595		518,347

Consolidated Statement of Operations and Comprehensive Loss

	Year Ended
	December 31, 2021
	As Reported			Adjustment			As Adjusted
General and administrative	$	97,918		$	(6,251	)	$	91,667
Amortization		8,497			375			8,872
Total operating expenses		182,554			(5,876	)		176,678
Loss from operations		(67,249	)		5,876			(61,373	)
Loss before provision for income taxes		(67,849	)		5,876			(61,973	)
Provision for income taxes		2,744			(45	)		2,699
Net loss		(70,593	)		5,921			(64,672	)
Basic and diluted net loss per share		(2.12	)		0.18			(1.94	)
Total comprehensive loss		(70,763	)		5,921			(64,842	)

Consolidated Statement of Stockholders’ Equity

	Accumulated Deficit
	As Reported			Adjustment		As Adjusted
Net loss	$	(70,593	)	$	5,921	$	(64,672	)
Balance as of December 31, 2021		(350,958	)		5,921		(345,037	)
	Total Stockholders' Equity
Net loss		(70,593	)		5,921		(64,672	)
Balance as of December 31, 2021		80,579			5,921		86,500

Consolidated Statement of Cash Flows

	Year Ended
	December 31, 2021
	As Reported			Adjustment			As Adjusted
Cash flows from operating activities:
Net loss	$	(70,593	)	$	5,921		$	(64,672	)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization		9,035			375			9,410
Change in fair value of contingent consideration		18,325			(6,251	)		12,074
Change in deferred taxes		—			(45	)		(45	)

XML

Business Combinations (Tables)

3 Months Ended

Mar. 31, 2022

March 2022 Acquisition [Member]

Summary of Preliminary Allocation of Purchase Consideration

The following table summarizes the fair value of the purchase price consideration (in thousands):

March Acquisition Consideration	Preliminary
Cash consideration at closing	$	1,500
Equity consideration at closing		1,929
Deferred consideration		2,707
Acquired cash		684
Settlement of pre-existing receivable		(976	)
Total	$	5,844

The preliminary allocation of the purchase consideration to tangible and intangible assets acquired and liabilities assumed is based on estimated fair values and is as follows (in thousands):

Preliminary allocation of March Acquisition Consideration**	Preliminary
Cash	$	715
Accounts receivable		1,088
Prepaid and other current assets		120
Property and equipment		53
Intangible assets		3,000
Other assets		247
Total assets acquired		5,223
Accounts payable		18
Accrued expenses and other current liabilities		1,793
Operating lease liabilities, non-current		140
Total liabilities assumed		1,951
Identifiable net assets acquired	$	3,272
Goodwill		2,572
Total purchase consideration	$	5,844

Summary of Valuation of Intangible Assets

The valuation of the intangible assets acquired along with their estimated useful lives, is as follows (in thousands):

	Estimated Fair Value		Estimated Useful Lives (in years)
Influencer network	$	1,500		5
Trade name		200		10
Brand relationships		1,300		5
Total intangible assets	$	3,000

Pandologic Ltd [Member]

Summary of Preliminary Allocation of Purchase Consideration

The following table summarizes the fair value of the purchase price consideration (in thousands):

Merger Consideration	Amount
Cash consideration at closing	$	58,733
Equity consideration at closing		31,500
Contingent earnout		39,512
Net working capital adjustment		5,818
Total	$	135,563

The preliminary allocation of the purchase consideration to tangible and intangible assets acquired and liabilities assumed is based on estimated fair values and is as follows (in thousands):

Allocation of Merger Consideration**	Amount
Cash	$	11,581
Accounts receivable		21,344
Prepaid and other current assets		8,710
Property and equipment		618
Intangible assets		92,000
Other assets		1,653
Total assets acquired		135,906
Accounts payable		13,183
Accrued expenses and other current liabilities		9,443
Deferred tax liability		12,686
Total liabilities assumed		35,312
Identifiable net assets acquired	$	100,594
Goodwill		34,969
Total purchase consideration	$	135,563

Summary of Valuation of Intangible Assets

The valuation of the intangible assets acquired from PandoLogic along with their estimated useful lives, is as follows (in thousands):

	Estimated Fair Value		Estimated Useful Lives (in years)
Customer relationships	$	70,000	5 - 7
Developed technology		20,000		4
Trade name		2,000		5
Total intangible assets	$	92,000

Summary of Unaudited Proforma Information

The unaudited pro forma financial information was as follows (in thousands):

	Three Months Ended
	March 31,
	2021
Net revenue	$	23,794
Loss before provision for income taxes	$	(36,392	)
Net loss	$	(35,755	)

XML

Net Loss Per Share (Tables)

3 Months Ended

Mar. 31, 2022

Earnings Per Share [Abstract]

Computation of Basic and Diluted Net Loss Per Common Share

The following table presents the computation of basic and diluted net loss per share:

	Three Months Ended
	March 31,
	2022
	(As Restated)			2021
Numerator
Net loss	$	(22,129	)	$	(30,567	)
Denominator
Weighted-average common shares outstanding		35,478,676			32,191,419
Less:  Weighted-average shares subject to repurchase		(1,728	)		(19,381	)
Denominator for basic and diluted net loss per share    attributable to common stockholders		35,476,948			32,172,038
Basic and diluted net loss per share	$	(0.62	)	$	(0.95	)

Effect of Anti-dilutive Securities

The table below presents the weighted-average securities (in common equivalent shares) outstanding during the periods presented that have been excluded from the calculation of diluted net loss per share because their effect would be anti-dilutive:

	Three Months Ended
	March 31,
	2022		2021
Common stock options and restricted stock units		10,025,447		10,274,878
Warrants to purchase common stock		496,612		639,169
Common stock issuable in connection with convertible senior notes		5,475,369		—
		15,997,428		10,914,047

XML

Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2022

Investments All Other Investments [Abstract]

Schedule of Cash and Cash Equivalents

As of March 31, 2022, the Company’s cash and cash equivalents were as follows:

			Gross				Cash and
			Unrealized		Fair		Cash
	Cost		Losses		Value		Equivalents
Cash	$	236,524	$	—	$	236,524	$	236,524
Level 1:
Money market funds		1,029		—		1,029		1,029
Total	$	237,553	$	—	$	237,553	$	237,553

As of December 31, 2021, the Company’s cash and cash equivalents balances were as follows:

			Gross				Cash and
			Unrealized		Fair		Cash
	Cost		Losses		Value		Equivalents
Cash	$	253,693	$	—	$	253,693	$	253,693
Level 1:
Money market funds		1,029		—		1,029		1,029
Total	$	254,722	$	—	$	254,722	$	254,722

Schedule of Contingent Consideration Liabilities Current and Non-current Balances

As of March 31, 2022, the Company’s contingent consideration liabilities current and non-current balances were as follows:

			Changes in					Fair		Contingent
	Cost		Fair Value		Amount Paid			Value		Consideration
	(As Restated)		(As Restated)		In Period			(As Restated)		(As Restated)
Level 3:
Contingent consideration, current	$	18,128	$	2,822	$	(20,816	)	$	134	$	134
Contingent consideration, non-current		21,384		14,297		—			35,681		35,681
Total	$	39,512	$	17,119	$	(20,816	)	$	35,815	$	35,815

As of December 31, 2021, the Company’s contingent consideration liabilities current and non-current balances were as follows:

			Changes in		Fair		Contingent
	Cost		Fair Value		Value		Consideration
Level 3:
Contingent consideration, current	$	18,128	$	1,925	$	20,053	$	20,053
Contingent consideration, non-current		21,384		10,149		31,533		31,533
Total	$	39,512	$	12,074	$	51,586	$	51,586

XML

Goodwill and Intangible Assets, Net (Tables)

3 Months Ended

Mar. 31, 2022

Goodwill And Intangible Assets Disclosure [Abstract]

Schedule of Carrying Amount of Goodwill

The carrying amount of goodwill was $44,600 as of March 31, 2022 and $42,028 December 31, 2021.

	Goodwill
Balance at December 31, 2021	$	42,028
March 2022 acquisition		2,572
Balance at March 31, 2022	$	44,600

Summary of Finite-Lived Intangible Assets Resulting from Business Acquisitions and Other Purchases

The following table sets forth the Company’s finite-lived intangible assets resulting from business acquisitions and other purchases, which continue to be amortized: 

			March 31, 2022
			(As Restated)							December 31, 2021
	Weighted Average Remaining Useful Life (in years)		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
Software and technology		0.0	$	3,582	$	(3,555	)	$	27	$	3,582	$	(3,515	)	$	67
Licensed technology		0.0		500		(500	)		—		500		(500	)		—
Developed technology		3.1		29,600		(9,201	)		20,399		29,600		(7,647	)		21,953
Customer and supplier relationships		5.9		82,100		(12,715	)		69,385		79,300		(9,449	)		69,851
Noncompete agreements		0.3		800		(727	)		73		800		(683	)		117
Trade names		4.6		2,300		(317	)		1,983		2,100		(216	)		1,884
Total		5.4	$	118,882	$	(27,015	)	$	91,867	$	115,882	$	(22,010	)	$	93,872

Summary of Future Amortization of Finite-Lived Intangible Assets

The following table presents future amortization of the Company’s finite-lived intangible assets at March 31, 2022:

	(As Restated)
2022 (9 months)	$	15,496
2023		19,177
2024		17,365
2025		14,074
2026		10,574
Thereafter		15,181
Total	$	91,867

XML

Consolidated Financial Statements Details (Tables)

3 Months Ended

Mar. 31, 2022

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Summary of Accounts Receivable, Net

Accounts receivable consisted of the following:

	As of
	March 31,			December 31,
	2022			2021
Accounts receivable — Managed Services(1)	$	35,648		$	21,347
Accounts receivable — Software Products & Services(2)		25,847			59,568
Accounts receivable — Other		6,452			4,926
		67,947			85,841
Less: allowance for doubtful accounts		(972	)		(778	)
Accounts receivable, net	$	66,975		$	85,063

⁽¹⁾ Accounts receivable – Managed Services reflects the amounts due from the Company’s advertising customers.

⁽²⁾ Accounts receivable – Software Products & Services reflects the amounts due from the Company’s PandoLogic customers.

Summary of Property Equipment and Improvements, Net

Property, equipment and improvements, net consisted of the following:

	As of
	March 31,			December 31,
	2022			2021
Property and equipment	$	5,088		$	4,262
Leasehold improvements		167			167
		5,255			4,429
Less: accumulated depreciation		(3,118	)		(2,873	)
Property, equipment and improvements, net	$	2,137		$	1,556

Summary of Accounts Payable

Accounts payable consisted of the following:

	As of
	March 31,		December 31,
	2022		2021
Accounts payable — Managed Services(1)	$	27,440	$	23,613
Accounts payable — Other		10,905		23,098
Total	$	38,345	$	46,711

⁽¹⁾ Accounts payable – Managed Services reflects the amounts due to media vendors for advertisements placed on behalf of the Company’s advertising clients.

Summary of Revenue

Revenue for the periods presented were comprised of the following:

	Three Months Ended
	March 31,
	2022		2021
Commercial Enterprise	$	33,626	$	17,005
Government & Regulated Entities		781		1,290
Total revenue	$	34,407	$	18,295

Summary of Presentation of Revenues

The table below illustrates the presentation of our revenues based on the above definitions:

	Three Months Ended
	March 31, 2022
			Government &
	Commercial		Regulated
	Enterprise		Industries		Total
Total Software Products & Services(1)	$	17,386	$	781	$	18,167
Managed Services
Advertising		10,968		—		10,968
Licensing		5,272		—		5,272
Total Managed Services		16,240		—		16,240
Total Revenue	$	33,626	$	781	$	34,407

⁽¹⁾ Software Products & Services consists of aiWARE revenues of $3,371 and PandoLogic revenues of $14,796.

	Three Months Ended
	March 31, 2021
			Government &
	Commercial		Regulated
	Enterprise		Industries		Total
Total Software Products & Services	$	3,395	$	1,290	$	4,685
Managed Services
Advertising		10,327		—		10,327
Licensing		3,283		—		3,283
Total Managed Services		13,610		—		13,610
Total Revenue	$	17,005	$	1,290	$	18,295

Schedule of Other Expense, Net

Other expense, net for the periods presented was comprised of the following:

	Three Months Ended
	March 31,
	2022			2021
Interest (expense) income, net	$	(1,182	)	$	2
Other		(4	)		(11	)
Other expense, net	$	(1,186	)	$	(9	)

XML

Leases, Commitments and Contingencies (Tables)

3 Months Ended

Mar. 31, 2022

Leases Commitments And Contingencies [Abstract]

Schedule of Cumulative Effects of Changes Made to the Company

The cumulative effects of the changes made to the Company’s January 1, 2022 consolidated balance sheet were as follows:

	December 31, 2021			Adjustments Due to Adoption of New Leasing Standard			January 1, 2022
Assets
Prepaid expenses and other current assets	$	12,117		$	71		$	12,188
Other assets		954			1,983			2,937
								-
Liabilities								-
Other accrued liabilities	$	27,093		$	1,675		$	28,768
Other non-current liabilities		13,891			1,057			14,948
								-
Stockholders' Equity								-
Accumulated deficit	$	(345,037	)	$	(678	)	$	(345,715	)

Summary of Future Minimum Lease Payments

Future undiscounted lease payments for the Company’s operating lease liabilities, a reconciliation of these payments to its operating lease liabilities, and related sublease income at December 31, 2021 are as follows:

Years ended December 31,
2022 (nine months)	$	2,095
2023		2,241
2024		1,792
Total future minimum lease payments, including short-term leases		6,128
Less: future minimum lease payments for short-term leases		(602	)
Less: imputed interest		(569	)
Present value of future minimum lease payments, excluding short-term leases	$	4,957
Less: current portion of operating lease liabilities		(2,106	)
Non-current portion of operating lease liabilities		2,851
Years ended December 31,	Sublease Income
2022 (nine months)	$	782
2023		1,297
2024		1,034
Total sublease income	$	3,113

As previously disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 under the previous lease accounting standard, future minimum lease payments at December 31, 2021, on an undiscounted basis, were as follows:    

2022	$	2,532
2023		2,091
2024		1,730
Total minimum payments	$	6,353

XML

Stock Plans (Tables)

3 Months Ended

Mar. 31, 2022

Schedule of Stock-based Compensation Expense

The Company’s stock-based compensation expense by type of award and by operating expense grouping are presented below:

	Three Months Ended
	March 31,
	2022		2021
Stock-based compensation expense by type of award:
Restricted stock units	$	3,432	$	4,171
Stock awards		—		19
Performance-based stock options		—		16,314
Stock options		1,273		837
Employee stock purchase plan		92		150
Common stock issued for services		19		119
Total	$	4,816	$	21,610
Stock-based compensation expense by operating expense grouping:
Cost of revenue	$	20	$	-
Sales and marketing		463		898
Research and development		1,004		1,019
General and administrative		3,329		19,693
	$	4,816	$	21,610

Schedule of Restricted Stock Unit Activity

The Company’s restricted stock unit activity for the three months ended March 31, 2022 was as follows:

				Weighted
				Average Grant
	Shares			Date Fair Value
Unvested at December 31, 2021		886,461		$	32.56
Granted		402,811		$	16.47
Forfeited		(28,824	)	$	23.20
Vested		(328,956	)	$	46.65
Unvested at March 31, 2022		931,492		$	21.01

Schedule of Stock Option Activity

The activity during the three months ended March 31, 2022 related to all other stock options was as follows:

				Weighted-Average
						Remaining		Aggregate
				Exercise		Contractual		Intrinsic
	Options			Price		Term		Value
Outstanding at December 31, 2021		5,508,608		$	15.10
Granted		291,850		$	16.13
Exercised		(20,222	)	$	7.33
Forfeited		(57,134	)	$	13.07
Expired		(8,425	)	$	21.61
Outstanding at March 31, 2022		5,714,677		$	15.23		6.2	$	25,419
Exercisable at March 31, 2022		4,289,264		$	13.76		5.4	$	20,201

Employee Stock Purchase Plan [Member]

Summary of Fair Value Assumptions of Stock Purchase Plan

The assumptions used in calculating the fair values of purchase rights granted under the ESPP during the three months ended March 31, 2022 are set forth in the table below:

Expected term (in years)	0.5 - 2.0
Expected volatility	71% - 88%
Risk-free interest rate	0.2% - 2.4%
Expected dividend yield		—

Stock Options [Member]

Schedule of Fair Value Assumptions

The following assumptions were used to compute the grant date fair values of the stock options granted during the three months ended March 31, 2022:

Expected term (in years)	6.1
Expected volatility	82	%
Risk-free interest rate	1.8	%
Expected dividend yield	—

Performance-based Stock Options [Member]

Schedule of Stock Option Activity

The activity during the three months ended March 31, 2022 related to stock options that are subject to performance-based vesting conditions tied to the achievement of stock price goals by the Company was as follows:

				Weighted-Average
						Remaining		Aggregate
				Exercise		Contractual		Intrinsic
	Options			Price		Term		Value
Outstanding at December 31, 2021		3,834,441		$	11.05
Exercised		(21,713	)	$	5.55
Expired		(7,277	)	$	4.94
Outstanding at March 31, 2022		3,805,451		$	11.09		6.3	$	27,350
Exercisable at March 31, 2022		3,805,451		$	11.09		6.3	$	27,350

XML

Presentation and Summary of Significant Accounting Policies - Summary of Restatement to Previously Reported Condensed Consolidated Balance Sheet (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Jan. 01, 2022	Dec. 31, 2021	Mar. 31, 2021	Dec. 31, 2020
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Intangible assets, net	$ 91,867		$ 93,872
Goodwill	44,600		42,028
Total assets	482,278		518,347
Contingent consideration, current	134		20,053
Total current liabilities	165,767		191,341
Contingent consideration, non-current	35,681		31,533
Other non-current liabilities	17,216	$ 14,948	13,891
Total liabilities	414,045		431,847
Accumulated deficit	(367,843)	$ (345,715)	(345,037)
Total stockholders' equity	68,233		86,500	$ 85,793	$ 88,210
Total liabilities and stockholders' equity	482,278		518,347
As Reported [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Intangible assets, net	86,563		88,247
Goodwill	36,630		34,058
Total assets	469,004		504,752
Contingent consideration, current			19,988
Total current liabilities			191,276
Contingent consideration, non-current	35,416		24,737
Other non-current liabilities	16,440		13,078
Total liabilities	413,004		424,173
Accumulated deficit	(380,076)		(350,958)
Total stockholders' equity	56,000		80,579
Total liabilities and stockholders' equity	469,004		504,752
Adjustment [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Intangible assets, net	5,304		5,625
Goodwill	7,970		7,970
Total assets	13,274		13,595
Contingent consideration, current			65
Total current liabilities			65
Contingent consideration, non-current	265		6,796
Other non-current liabilities	776		813
Total liabilities	1,041		7,674
Accumulated deficit	12,233		5,921
Total stockholders' equity	12,233		5,921
Total liabilities and stockholders' equity	$ 13,274		$ 13,595

XML

Presentation and Summary of Significant Accounting Policies - Summary of Restatement to Previously Reported Condensed Consolidated Statement of Operations and Comprehensive Loss (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Error Corrections And Prior Period Adjustments Restatement [Line Items]
General and administrative	$ 22,321	$ 31,543	$ 91,667
Amortization	5,016	1,078	8,872
Total operating expenses	55,212	48,831	176,678
Loss from operations	(20,805)	(30,536)	(61,373)
Loss before provision for income taxes	(21,991)	(30,545)	(61,973)
Provision for income taxes	138	22	2,699
Net loss	$ (22,129)	$ (30,567)	$ (64,672)	$ (47,876)
Basic and diluted net loss per share	$ (0.62)	$ (0.95)	$ (1.94)
Total comprehensive loss	$ (21,939)	$ (30,560)	$ (64,842)
As Reported [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
General and administrative	28,917		97,918
Amortization	4,693		8,497
Total operating expenses	61,485		182,554
Loss from operations	(27,078)		(67,249)
Loss before provision for income taxes	(28,264)		(67,849)
Provision for income taxes	177		2,744
Net loss	$ (28,441)		$ (70,593)
Basic and diluted net loss per share	$ (0.80)		$ (2.12)
Total comprehensive loss	$ (28,251)		$ (70,763)
Adjustment [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
General and administrative	(6,596)		(6,251)
Amortization	323		375
Total operating expenses	(6,273)		(5,876)
Loss from operations	6,273		5,876
Loss before provision for income taxes	6,273		5,876
Provision for income taxes	(39)		(45)
Net loss	$ 6,312		$ 5,921
Basic and diluted net loss per share	$ 0.18		$ 0.18
Total comprehensive loss	$ 6,312		$ 5,921

XML

Presentation and Summary of Significant Accounting Policies - Summary of Restatement to Previously Reported Condensed Consolidated Statement of Stockholders' Equity (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Beginning balance	$ 86,500	$ 88,210	$ 88,210
Net loss	(22,129)	(30,567)	(64,672)	$ (47,876)
Ending balance	68,233	85,793	86,500	88,210
Accumulated Deficit [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Beginning balance	(345,037)	(280,365)	(280,365)
Net loss	(22,129)	(30,567)	(64,672)
Ending balance	(367,843)	$ (310,932)	(345,037)	$ (280,365)
As Reported [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Beginning balance	80,579
Net loss	(28,441)		(70,593)
Ending balance	56,000		80,579
As Reported [Member] | Accumulated Deficit [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Beginning balance	(350,958)
Net loss	(28,441)		(70,593)
Ending balance	(380,076)		(350,958)
Adjustment [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Beginning balance	5,921
Net loss	6,312		5,921
Ending balance	12,233		5,921
Adjustment [Member] | Accumulated Deficit [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Beginning balance	5,921
Net loss	6,312		5,921
Ending balance	$ 12,233		$ 5,921

XML

Presentation and Summary of Significant Accounting Policies - Summary of Restatement to Previously Reported Condensed Consolidated Statement of Cash Flows (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Cash flows from operating activities:
Net loss	$ (22,129)	$ (30,567)	$ (64,672)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	5,214	$ 1,253	9,410
Change in fair value of contingent consideration	5,045		12,074
Change in deferred taxes	(465)		(45)
As Reported [Member]
Cash flows from operating activities:
Net loss	(28,441)		(70,593)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	4,891		9,035
Change in fair value of contingent consideration	11,641		18,325
Change in deferred taxes	(426)
Adjustment [Member]
Cash flows from operating activities:
Net loss	6,312		5,921
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	323		375
Change in fair value of contingent consideration	(6,596)		(6,251)
Change in deferred taxes	$ (39)		$ (45)

XML

Presentation and Summary of Significant Accounting Policies - Additional Information (Details) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2022 USD ($) Customer	Mar. 31, 2021 USD ($) Customer	Dec. 31, 2021 USD ($) Customer	Dec. 31, 2020 USD ($)	Jan. 01, 2022 USD ($)
Significant Accounting Policies [Line Items]
Positive (negative) cash flows from operations	$ 10,134	$ 6,209	$ 7,234	$ 1,433
Net loss	22,129	30,567	64,672	$ 47,876
Accumulated deficit	367,843		345,037		$ 345,715
Proceeds from issuances of stock under employee stock plans, net	569	4,254
Tax paid related to net share settlement of equity awards	9,441
Cash and cash equivalents	237,553	$ 237,553	$ 254,722
Transaction price remaining performance obligations	$ 8,798
Transaction price remaining performance obligations percentage	57.00%
Sales Revenue, Net [Member] | Customer Concentration Risk [Member]
Significant Accounting Policies [Line Items]
Number of major customers | Customer	1	1
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Minimum [Member]
Significant Accounting Policies [Line Items]
Concentration risk percentage	10.00%	10.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Commercial Enterprise [Member]
Significant Accounting Policies [Line Items]
Number of major customers | Customer		2	2
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Commercial Enterprise [Member] | Minimum [Member]
Significant Accounting Policies [Line Items]
Concentration risk percentage		10.00%	10.00%
Pandologic Ltd [Member]
Significant Accounting Policies [Line Items]
Earnout payment	$ 14,376

XML

Presentation and Summary of Significant Accounting Policies - Additional Information (Details 1)	Mar. 31, 2022
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2022-04-01
Significant Accounting Policies [Line Items]
Expected Recognition of revenue over remaining contract terms	12 months

XML

Business Combinations - Additional Information (Detail) - USD ($)			3 Months Ended	12 Months Ended
	Mar. 01, 2022	Sep. 14, 2021	Mar. 31, 2022	Dec. 31, 2021
March 2022 Acquisition [Member]
Business Acquisition [Line Items]
Total consideration	$ 5,844,000
Equity consideration at closing	1,929,000
Deferred consideration	2,707,000
Settlement of pre-existing receivable	976,000
Acquired cash	684,000
Contingent earnout	3,015,000
Tax deductible goodwill, acquisition	2,842,000
Transaction cost	270,000
March 2022 Acquisition [Member] | General and Administrative Expense [Member]
Business Acquisition [Line Items]
Acquisition related expenses	$ 270,000
March 2022 Acquisition [Member] | Maximum [Member]
Business Acquisition [Line Items]
Estimated useful lives	10 years
March 2022 Acquisition [Member] | Minimum [Member]
Business Acquisition [Line Items]
Estimated useful lives	2 years
Pandologic Ltd [Member]
Business Acquisition [Line Items]
Contingent earnout		$ 44,900,000
Pandologic Ltd [Member] | Contingent Consideration
Business Acquisition [Line Items]
Contingent earnout		39,512,000
Pandologic Ltd [Member] | General and Administrative Expense [Member]
Business Acquisition [Line Items]
Acquisition related expenses				$ 2,161,000
Pandologic Ltd [Member] | Recognized in Compensation Expense Within General and Administrative Expense [Member]
Business Acquisition [Line Items]
Contingent earnout		5,388,000
Pandologic Ltd [Member]
Business Acquisition [Line Items]
Total consideration		135,563,000
Equity consideration at closing		31,500,000
Deferred tax liability		$ 12,686,000	$ 0
Deferred tax assets			0
Goodwill not deductible for tax purposes			33,111,000
Deferred tax assets, valuation allowance			$ 0
Pandologic Ltd [Member] | Israeli [Member]
Business Acquisition [Line Items]
Tax rate		23.00%	12.00%
Pandologic Ltd [Member] | Maximum [Member]
Business Acquisition [Line Items]
Estimated useful lives			7 years
Pandologic Ltd [Member] | Minimum [Member]
Business Acquisition [Line Items]
Estimated useful lives			4 years
Pandologic Ltd [Member] | Common Stock [Member]
Business Acquisition [Line Items]
Consideration equity interest issued number of shares			352,330
Purchase Agreement [Member] | March 2022 Acquisition [Member]
Business Acquisition [Line Items]
Business acquisition, effective date of acquisition	Mar. 01, 2022
Business acquisition, percentage of ownership interests acquired	100.00%
Business acquisition, date of acquisition agreement	Mar. 01, 2022
Total consideration	$ 5,844,000
Consideration upfront payment in cash	1,500,000
Deferred cash payment	3,000,000
Deferred consideration	2,707,000
Settlement of pre-existing receivable	(976,000)
Acquired cash	684,000
Purchase Agreement [Member] | March 2022 Acquisition [Member] | Maximum [Member]
Business Acquisition [Line Items]
Contingent earnout consideration	4,500,000
Purchase Agreement [Member] | March 2022 Acquisition [Member] | Common Stock [Member]
Business Acquisition [Line Items]
Equity consideration at closing	$ 1,929,000
Consideration equity interest issued number of shares	116,550
Merger Agreement [Member] | Pandologic Ltd [Member]
Business Acquisition [Line Items]
Business acquisition, effective date of acquisition		Sep. 14, 2021
Business acquisition, percentage of ownership interests acquired		100.00%
Business acquisition, date of acquisition agreement		Jul. 21, 2021
Total consideration		$ 135,563,000
Consideration upfront payment in cash		$ 58,733,000
Business acquisition, name of acquired entity		PandoLogic.
Merger Agreement [Member] | Pandologic Ltd [Member] | Maximum [Member]
Business Acquisition [Line Items]
Contingent earnout consideration		$ 65,000,000
Merger Agreement [Member] | Pandologic Ltd [Member] | Common Stock [Member]
Business Acquisition [Line Items]
Equity consideration at closing		$ 31,500,000
Consideration equity interest issued number of shares		1,704,822

XML

Business Combinations - Summary of Fair Value of Purchase Price Consideration (Details) - USD ($) $ in Thousands	Mar. 01, 2022	Sep. 14, 2021
March 2022 Acquisition [Member]
Business Acquisition [Line Items]
Cash consideration at closing	$ 1,500
Equity consideration at closing	1,929
Deferred consideration	2,707
Acquired cash	684
Settlement of pre-existing receivable	(976)
Total	$ 5,844
Pandologic Ltd [Member]
Business Acquisition [Line Items]
Cash consideration at closing		$ 58,733
Equity consideration at closing		31,500
Net working capital adjustment		5,818
Total		135,563
Pandologic Ltd [Member] | Contingent Consideration
Business Acquisition [Line Items]
Contingent earnout		$ 39,512

XML

Business Combinations - Summary of Preliminary Allocation of Purchase Consideration (Details) - USD ($)	Mar. 31, 2022	Mar. 01, 2022	Dec. 31, 2021	Sep. 14, 2021
Business Acquisition [Line Items]
Goodwill	$ 44,600,000		$ 42,028,000
March 2022 Acquisition [Member]
Business Acquisition [Line Items]
Cash		$ 715,000
Accounts receivable		1,088,000
Prepaid and other current assets		120,000
Property and equipment		53,000
Intangible assets		3,000,000
Other assets		247,000
Total assets acquired		5,223,000
Accounts payable		18,000
Accrued expenses and other current liabilities		1,793,000
Operating lease liabilities, non-current		140,000
Total liabilities assumed		1,951,000
Identifiable net assets acquired		3,272,000
Goodwill		2,572,000
Total purchase consideration		$ 5,844,000
Pandologic Ltd [Member]
Business Acquisition [Line Items]
Cash				$ 11,581,000
Accounts receivable				21,344,000
Prepaid and other current assets				8,710,000
Property and equipment				618,000
Intangible assets				92,000,000
Other assets				1,653,000
Total assets acquired				135,906,000
Accounts payable				13,183,000
Accrued expenses and other current liabilities				9,443,000
Deferred tax liability	$ 0			12,686,000
Total liabilities assumed				35,312,000
Identifiable net assets acquired				100,594,000
Goodwill				34,969,000
Total purchase consideration				$ 135,563,000

XML

Business Combinations - Summary of Valuation of Intangible Assets (Details) - USD ($) $ in Thousands			3 Months Ended
	Mar. 01, 2022	Sep. 14, 2021	Mar. 31, 2022
March 2022 Acquisition [Member]
Business Acquisition [Line Items]
Total intangible assets	$ 3,000
March 2022 Acquisition [Member] | Minimum [Member]
Business Acquisition [Line Items]
Estimated useful lives	2 years
March 2022 Acquisition [Member] | Maximum [Member]
Business Acquisition [Line Items]
Estimated useful lives	10 years
Pandologic Ltd [Member]
Business Acquisition [Line Items]
Total intangible assets		$ 92,000
Pandologic Ltd [Member] | Minimum [Member]
Business Acquisition [Line Items]
Estimated useful lives			4 years
Pandologic Ltd [Member] | Maximum [Member]
Business Acquisition [Line Items]
Estimated useful lives			7 years
Influencer Network [Member] | March 2022 Acquisition [Member]
Business Acquisition [Line Items]
Total intangible assets	$ 1,500
Estimated useful lives	5 years
Customer Relationships [Member] | Pandologic Ltd [Member]
Business Acquisition [Line Items]
Total intangible assets		$ 70,000
Customer Relationships [Member] | Pandologic Ltd [Member] | Minimum [Member]
Business Acquisition [Line Items]
Estimated useful lives		5 years
Customer Relationships [Member] | Pandologic Ltd [Member] | Maximum [Member]
Business Acquisition [Line Items]
Estimated useful lives		7 years
Trade Name [Member] | March 2022 Acquisition [Member]
Business Acquisition [Line Items]
Total intangible assets	$ 200
Estimated useful lives	10 years
Trade Name [Member] | Pandologic Ltd [Member]
Business Acquisition [Line Items]
Total intangible assets		$ 2,000
Estimated useful lives		5 years
Developed Technology [Member] | Pandologic Ltd [Member]
Business Acquisition [Line Items]
Total intangible assets		$ 20,000
Estimated useful lives		4 years
Brand Relationships [Member] | March 2022 Acquisition [Member]
Business Acquisition [Line Items]
Total intangible assets	$ 1,300
Estimated useful lives	5 years

XML

Business Combinations - Summary of Unaudited Proforma Information (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2021 USD ($)
Business Combinations [Abstract]
Net revenue	$ 23,794
Loss before provision for income taxes	(36,392)
Net loss	$ (35,755)

XML

Debt - Additional Information (Detail)	1 Months Ended	3 Months Ended
	Nov. 30, 2021 USD ($) Day $ / shares	Mar. 31, 2022 USD ($) $ / Derivative	Nov. 16, 2021 $ / shares
Debt Instrument [Line Items]
Amortization of debt issuance costs		$ 299,000
Payment for capped call transactions	$ 18,600,000
Initial cap price | $ / Derivative		48.55
Premium over last reported sale price, percentage	75.00%
Sale price of common stock | $ / shares			$ 27.74
Strike price | $ / Derivative		35.76
1.75% Convertible Senior Notes Due 2026 [Member]
Debt Instrument [Line Items]
Aggregate principal amount	$ 201,300
Debt instrument, interest rate	1.75%	1.75%
Additional principal amount	$ 26,250,000
Debt instrument, frequency of periodic payment		semi-annually
Debt instrument, payment terms		is payable semi-annually in arrears on May 15 and November 15 of each year, beginning on May 15, 2022.
Debt Instrument, maturity date, description		The Convertible Notes will mature on November 15, 2026, unless earlier converted, redeemed, or repurchased in accordance with the terms of the Convertible Notes.
Debt Instrument, maturity date		Nov. 15, 2026
Number of trading days (whether or not consecutive) | Day	20
Number of consecutive trading days | Day	30
Percentage of conversion price	130.00%
Debt instrument convertible measurement period	5 years
Debt instrument convertible business period	5 years
Debt instrument convertible principal amount	$ 1,000,000
Debt instrument convertible measurement period percentage	98.00%
Debt instrument, convertible, Date	May 15, 2026
Initial conversion rate	0.0272068
Initial conversion price | $ / shares	$ 36.76
Redemption date	Nov. 20, 2024
Percentage of conversion stock price, Redemption	130.00%
Debt instrument, Redeemable, Number of trading days | Day	20
Debt instrument, Redeemable, Number of consecutive trading days | Day	30
Redemption price, Percentage of principal amount to be redeemed	100.00%
Sinking fund	$ 0
Debt instrument repurchase price due to fundamental change	100.00%
Net proceeds from issuance of notes		$ 194,900,000
Debt issuance costs		6,300,000
Amortization of debt issuance costs		1,200,000
Interest expense		$ 1,200,000
Effective annual interest rate		2.42%
Convertible debt, if-converted value in excess of principal		$ 0
Estimated fair value of convertible notes		$ 176,300,000

XML

Net Loss Per Share - Computation of Basic and Diluted Net Loss Per Common Share (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020
Numerator
Net loss	$ (22,129)	$ (30,567)	$ (64,672)	$ (47,876)
Denominator
Weighted-average common shares outstanding	35,478,676	32,191,419
Less: Weighted-average shares subject to repurchase	(1,728)	(19,381)
Denominator for basic and diluted net loss per share attributable to common stockholders	35,476,948	32,172,038
Basic and diluted net loss per share	$ (0.62)	$ (0.95)	$ (1.94)

XML

Net Loss Per Share - Effect of Anti-dilutive Securities (Detail) - shares	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Effect of Anti-dilutive Securities	15,997,428	10,914,047
Employee Stock Option and Restricted Stock Units [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Effect of Anti-dilutive Securities	10,025,447	10,274,878
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Effect of Anti-dilutive Securities	496,612	639,169
Common Stock Issuable in Connection with Convertible Senior Notes [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Effect of Anti-dilutive Securities	5,475,369

XML

Financial Instruments - Schedule of Cash and Cash Equivalents (Detail) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021
Schedule Of Available For Sale Securities [Line Items]
Total Cash and Debt Securities	$ 237,553	$ 254,722
Total Fair Value, Cash and Debt Securities	237,553	254,722
Cash and cash equivalents	237,553	254,722	$ 237,553
Cash [Member]
Schedule Of Available For Sale Securities [Line Items]
Cash and cash equivalents	236,524	253,693
Fair Value, Cash	236,524	253,693
Level 1 [Member] | Money Market Funds [Member]
Schedule Of Available For Sale Securities [Line Items]
Cash and cash equivalents	1,029	1,029
Cash and cash equivalents gross before unrealized losses	1,029	1,029
Fair Value, Cash	$ 1,029	$ 1,029

XML

Financial Instruments - Schedule of Contingent Consideration Liabilities Current and Non-current Balances (Details) - Level 3 [Member] - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Contingent Consideration Liabilities [Line Items]
Cost	$ 39,512	$ 39,512
Changes in Fair Value	17,119	12,074
Amount Paid In Period	(20,816)
Fair Value	35,815	51,586
Contingent Consideration	35,815	51,586
Contingent Consideration, Current [Member]
Contingent Consideration Liabilities [Line Items]
Cost	18,128	18,128
Changes in Fair Value	2,822	1,925
Amount Paid In Period	(20,816)
Fair Value	134	20,053
Contingent Consideration	134	20,053
Contingent Consideration, Noncurrent [Member]
Contingent Consideration Liabilities [Line Items]
Cost	21,384	21,384
Changes in Fair Value	14,297	10,149
Fair Value	35,681	31,533
Contingent Consideration	$ 35,681	$ 31,533

XML

Financial Instruments - Additional Information (Detail) $ in Thousands	Mar. 31, 2022 USD ($)
Other Assets
Schedule Of Available For Sale Securities [Line Items]
Strategic investment	$ 2,000

XML

Goodwill and Intangible Assets, Net - Additional Information (Detail) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Goodwill And Intangible Assets Disclosure [Abstract]
Carrying amount of goodwill	$ 44,600	$ 42,028

XML

Goodwill and Intangible Assets, Net - Schedule of Carrying Amount of Goodwill (Detail) $ in Thousands	3 Months Ended
	Mar. 31, 2022 USD ($)
Impairment Of Intangible Assets Excluding Goodwill [Abstract]
Beginning balance	$ 42,028
March 2022 acquisition	2,572
Ending balance	$ 44,600

XML

Goodwill and Intangible Assets, Net - Summary of Finite-Lived Intangible Assets Resulting from Business Acquisitions and Other Purchases (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	5 years 4 months 24 days
Gross Carrying Amount	$ 118,882	$ 115,882
Accumulated Amortization	(27,015)	(22,010)
Net Carrying Amount	$ 91,867	93,872
Software and Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	0 years
Gross Carrying Amount	$ 3,582	3,582
Accumulated Amortization	(3,555)	(3,515)
Net Carrying Amount	$ 27	67
Licensed Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	0 years
Gross Carrying Amount	$ 500	500
Accumulated Amortization	$ (500)	(500)
Developed Technology [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	3 years 1 month 6 days
Gross Carrying Amount	$ 29,600	29,600
Accumulated Amortization	(9,201)	(7,647)
Net Carrying Amount	$ 20,399	21,953
Customer and Supplier Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	5 years 10 months 24 days
Gross Carrying Amount	$ 82,100	79,300
Accumulated Amortization	(12,715)	(9,449)
Net Carrying Amount	$ 69,385	69,851
Noncompete Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	3 months 18 days
Gross Carrying Amount	$ 800	800
Accumulated Amortization	(727)	(683)
Net Carrying Amount	$ 73	117
Trade Name [Member]
Finite-Lived Intangible Assets [Line Items]
Weighted Average Remaining Useful Life (in years)	4 years 7 months 6 days
Gross Carrying Amount	$ 2,300	2,100
Accumulated Amortization	(317)	(216)
Net Carrying Amount	$ 1,983	$ 1,884

XML

Goodwill and Intangible Assets, Net - Summary of Future Amortization of Finite-Lived Intangible Assets (Detail) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Finite Lived Intangible Assets Future Amortization Expense [Abstract]
2022 (9 months)	$ 15,496
2023	19,177
2024	17,365
2025	14,074
2026	10,574
Thereafter	15,181
Net Carrying Amount	$ 91,867	$ 93,872

XML

Consolidated Financial Statements Details - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Condensed Financial Statements, Captions [Line Items]
Cash and cash equivalents	$ 237,553	$ 237,553	$ 254,722
Depreciation Expense	$ 198	$ 175
Effective tax rate	(0.60%)	(0.10%)
Provision for income taxes	$ 138	$ 22	2,699
Advertising Customers and Content Licensees [Member]
Condensed Financial Statements, Captions [Line Items]
Cash received	$ 69,496		$ 66,401

XML

Consolidated Financial Statements Details - Summary of Accounts Receivable,Net (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Accounts receivable, gross	$ 67,947	$ 85,841
Less: allowance for doubtful accounts	(972)	(778)
Accounts receivable, net	66,975	85,063
Managed Services [Member]
Accounts receivable, gross	35,648	21,347
Software Products & Services [Member]
Accounts receivable, gross	25,847	59,568
Other [Member]
Accounts receivable, gross	$ 6,452	$ 4,926

XML

Consolidated Financial Statements Details - Summary of Property Equipment and Improvements, Net (Detail) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Property Plant And Equipment [Abstract]
Property and equipment	$ 5,088	$ 4,262
Leasehold improvements	167	167
Property, equipment and improvements, gross	5,255	4,429
Less: accumulated depreciation	(3,118)	(2,873)
Property, equipment and improvements, net	$ 2,137	$ 1,556

XML

Consolidated Financial Statements Details - Accounts Payable (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Statement Of Financial Position [Abstract]
Accounts payable — Managed Services	$ 27,440	$ 23,613
Accounts payable — Other	10,905	23,098
Total	$ 38,345	$ 46,711

XML

Consolidated Financial Statements Details - Summary of Revenue (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Segment Reporting Revenue Reconciling Item [Line Items]
Total revenue	$ 34,407	$ 18,295
Commercial Enterprise [Member]
Segment Reporting Revenue Reconciling Item [Line Items]
Total revenue	33,626	17,005
Government and Regulated Entities [Member]
Segment Reporting Revenue Reconciling Item [Line Items]
Total revenue	$ 781	$ 1,290

XML

Consolidated Financial Statements Details - Summary of Presentation of Revenues (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenue	$ 34,407	$ 18,295
Commercial Enterprise [Member]
Revenue	33,626	17,005
Government and Regulated Industries [Member]
Revenue	781	1,290
Software Products & Services [Member]
Revenue	18,167	4,685
Software Products & Services [Member] | Commercial Enterprise [Member]
Revenue	17,386	3,395
Software Products & Services [Member] | Government and Regulated Industries [Member]
Revenue	781	1,290
Advertising [Member]
Revenue	10,968	10,327
Advertising [Member] | Commercial Enterprise [Member]
Revenue	10,968	10,327
Licensing [Member]
Revenue	5,272	3,283
Licensing [Member] | Commercial Enterprise [Member]
Revenue	5,272	3,283
Total Managed Services [Member]
Revenue	16,240	13,610
Total Managed Services [Member] | Commercial Enterprise [Member]
Revenue	$ 16,240	$ 13,610

XML

Consolidated Financial Statements Details - Summary of Presentation of Revenues (Parenthetical) (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenue	$ 34,407	$ 18,295
Software Products or Services Consists of aiWARE Revenues [Member]
Revenue	3,371
Software Products & Services [Member]
Revenue	18,167	$ 4,685
Software Products & Services [Member] | Pandologic Ltd [Member]
Revenue	$ 14,796

XML

Consolidated Financial Statements Details - Schedule of Other Expense, Net (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Other Income And Expenses [Abstract]
Interest (expense) income, net	$ (1,182)	$ 2
Other	(4)	(11)
Other expense, net	$ (1,186)	$ (9)

XML

Leases, Commitments and Contingencies - Schedule of Cumulative Effects of Changes Made to the Company (Detail) - USD ($) $ in Thousands	Mar. 31, 2022	Jan. 01, 2022	Dec. 31, 2021
ASSETS
Prepaid expenses and other current assets	$ 12,519	$ 12,188	$ 12,117
Other assets	6,078	2,937	954
Total assets	482,278		518,347
Liabilities
Other accrued liabilities	22,993	28,768	27,093
Other non-current liabilities	17,216	14,948	13,891
Total liabilities	414,045		431,847
Stockholders' equity
Accumulated deficit	$ (367,843)	(345,715)	$ (345,037)
Adjustments Due to Adoption of New Leasing Standard [Member]
ASSETS
Prepaid expenses and other current assets		71
Other assets		1,983
Liabilities
Other accrued liabilities		1,675
Other non-current liabilities		1,057
Stockholders' equity
Accumulated deficit		$ (678)

XML

Leases, Commitments and Contingencies - Additional Information (Detail) $ in Thousands	1 Months Ended	3 Months Ended		12 Months Ended
	Feb. 28, 2021 ft²	Mar. 31, 2022 USD ($)	Mar. 31, 2021 USD ($)	Dec. 31, 2021 USD ($)
Other Commitments [Line Items]
Operating lease, cash payments		$ 652
Operating lease, weighted average remaining lease term		2 years 8 months 12 days
Operating lease, weighted average discount rate		780.00%
Loss on disposal of property and equipment and leasehold improvements			$ (1,894)
Loss on sublease			1,211
Rent expense				$ 4,668
Minimum sublease rental income to be received in the future under noncancelable subleases				$ 3,402
Liability for potential exposure		$ 134	138
Purchase consideration payment within ten days of first anniversary of acquisition		1,500
Purchase consideration payment within ten days of second anniversary of acquisition		1,500
Office Sublease [Member]
Other Commitments [Line Items]
Area of Office Space Subleased | ft²	37,875
Lease Expiration Date	Dec. 31, 2024
Sublease charges			3,367
Loss on disposal of property and equipment and leasehold improvements			(1,894)
Loss on sublease			1,211
Initial direct costs			262
Rent expense		506	$ 571
Sublease income		277
Other Non-Current Liabilities [Member]
Other Commitments [Line Items]
Non-current portion of operating lease liabilities		$ 2,851
Minimum [Member]
Other Commitments [Line Items]
Operating lease, remaining lease term		1 year
Operating lease, renewal term		1 year
Minimum [Member] | Other Assets
Other Commitments [Line Items]
Operating lease right-of-use assets		$ 2,556
Minimum [Member] | Other Accrued Liabilities [Member]
Other Commitments [Line Items]
Current portion of operating lease liabilities		$ 2,106
Maximum [Member]
Other Commitments [Line Items]
Operating lease, remaining lease term		5 years
Operating lease, renewal term		5 years

XML

Leases, Commitments and Contingencies - Summary of Future Minimum Lease Payments (Detail) - Building Lease Agreement [Member] $ in Thousands	Dec. 31, 2021 USD ($)
Other Commitments [Line Items]
2022 (nine months)	$ 2,095
2023	2,241
2024	1,792
Total future minimum lease payments, including short-term leases	6,128
Less: future minimum lease payments for short-term leases	(602)
Less: imputed interest	(569)
Present value of future minimum lease payments, excluding short-term leases	4,957
Less: current portion of operating lease liabilities	(2,106)
Non-current portion of operating lease liabilities	2,851
2022 (nine months)	782
2023	1,297
2024	1,034
Total sublease income	$ 3,113

XML

Commitments and Contingencies - Summary of Future Minimum Lease Payments Under Previous Lease Accounting Standard (Detail) - Building Lease Agreement [Member] $ in Thousands	Dec. 31, 2021 USD ($)
Other Commitments [Line Items]
2022	$ 2,532
2023	2,091
2024	1,730
Total minimum payments	$ 6,353

XML

Stockholders' Equity - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Class of Stock [Line Items]
Exercise of warrants		$ 2,279
Common Stock [Member]
Class of Stock [Line Items]
Exercise of warrants		$ 2,279
Exercise of warrants issued, shares for cash consideration		167,495
Aggregate exercise of warrants issued, shares		84,723
Issued warrants to purchase shares upon exercises		91,833
Shares issued to outside service provider, shares		15,828
Common Stock [Member] | March 2022 Acquisition [Member]
Class of Stock [Line Items]
Business acquisition, shares issued or issuable	116,550
Common Stock [Member] | Pandologic Ltd [Member]
Class of Stock [Line Items]
Business acquisition, shares issued or issuable	352,330
Common Stock and Employee Stock Purchase Plan [Member]
Class of Stock [Line Items]
Shares issued in connection with stock option exercise	615,703	608,886

XML

Stock Plans - Additional Information (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Employee Stock Purchase Plan [Member]
Class of Stock [Line Items]
Common stock were purchased under ESPP	67
Accrued employee contributions	$ 191,000
Timebased Stock Option [Member]
Class of Stock [Line Items]
Options granted	480,850
Restricted Stock Units [Member]
Class of Stock [Line Items]
Unrecognized cost of share-based compensation awards	$ 14,362,000
Cost of share-based compensation awards, recognition period	2 years 2 months 4 days
Performance-based Stock Options [Member]
Class of Stock [Line Items]
Total grant date fair value of stock options granted	$ 0	$ 0
Total grant date fair value of stock options vested	0
Unrecognized compensation expense related to stock options	16,268,000
Aggregate intrinsic value of the options exercised	$ 221,000	5,815,000
Stock Options [Member]
Class of Stock [Line Items]
Options granted	291,850
Cost of share-based compensation awards, recognition period	3 years 3 months 18 days
Total grant date fair value of stock options vested	$ 1,085,000	733,000
Unrecognized compensation expense related to stock options	15,080,000
Aggregate intrinsic value of the options exercised	$ 163,000	$ 7,848,000
Weighted Average Grant Date Fair Value, Granted	$ 11.36	$ 32.68

XML

Stock Plans - Schedule of Fair Value Assumptions (Detail) - Stock Options [Member]	3 Months Ended
	Mar. 31, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected term (in years)	6 years 1 month 6 days
Expected volatility	82.00%
Risk-free interest rate	1.80%

XML

Stock Plans - Summary of Fair Value Assumptions of Stock Purchase Plan (Detail) - Employee Stock Purchase Plan [Member]	3 Months Ended
	Mar. 31, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected volatility, minimum	71.00%
Expected volatility, maximum	88.00%
Risk-free interest rate, minimum	0.20%
Risk-free interest rate, maximum	2.40%
Minimum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected term (in years)	6 months
Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected term (in years)	2 years

XML

Stock Plans - Schedule of Stock-based Compensation Expense (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	$ 4,816	$ 21,610
Cost of Revenue [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	20
Sales and Marketing [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	463	898
Research and Development [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	1,004	1,019
General and Administrative [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	3,329	19,693
Restricted Stock Units [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	3,432	4,171
Stock Awards [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense		19
Performance-based Stock Options [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense		16,314
Stock Options [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	1,273	837
Common Stock Issued for Services [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	19	119
Employee Stock Purchase Plan [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	$ 92	$ 150

XML

Stock Plans - Schedule of Restricted Stock Unit Activity (Detail) - Restricted Stock Units [Member]	3 Months Ended
	Mar. 31, 2022 $ / shares shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares, Unvested, Beginning Balance | shares	886,461
Shares, Granted | shares	402,811
Shares, Forfeited | shares	(28,824)
Shares, Vested | shares	(328,956)
Shares, Unvested, Ending Balance | shares	931,492
Weighted Average Grant Date Fair Value, Unvested, Beginning Balance | $ / shares	$ 32.56
Weighted Average Grant Date Fair Value, Granted | $ / shares	16.47
Weighted Average Grant Date Fair Value, Forfeited | $ / shares	23.20
Weighted Average Grant Date Fair Value, Vested | $ / shares	46.65
Weighted Average Grant Date Fair Value, Unvested, Ending Balance | $ / shares	$ 21.01

XML

Stock Plans - Schedule of Performance-Based Stock Options Activity (Detail) - Performance-based Stock Options [Member] $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2022 USD ($) $ / shares shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options, Outstanding, Beginning Balance | shares	3,834,441
Options Exercised | shares	(21,713)
Options Expired | shares	(7,277)
Options, Outstanding, Ending Balance | shares	3,805,451
Options Exercisable at March 31, 2021 | shares	3,805,451
Weighted-Average Exercise Price, Outstanding, Beginning Balance | $ / shares	$ 11.05
Weighted-Average Exercise Price, Options Exercised | $ / shares	5.55
Weighted-Average Exercise Price, Options Expired | $ / shares	4.94
Weighted-Average Exercise Price, Outstanding, Ending Balance | $ / shares	11.09
Weighted-Average Exercise Price, Exercisable | $ / shares	$ 11.09
Weighted-Average Remaining Contractual Term, Outstanding	6 years 3 months 18 days
Weighted-Average Remaining Exercisable	6 years 3 months 18 days
Weighted-Average Aggregate Intrinsic Value | $	$ 27,350
Weighted-Average Aggregate Intrinsic Value, Exercisable | $	$ 27,350

XML

Stock Plans - Schedule of Stock Option Activity (Detail) - Stock Options [Member] $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2022 USD ($) $ / shares shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options, Outstanding, Beginning Balance | shares	5,508,608
Options Granted | shares	291,850
Options Exercised | shares	(20,222)
Options Forfeited | shares	(57,134)
Options Expired | shares	(8,425)
Options, Outstanding, Ending Balance | shares	5,714,677
Options Exercisable at March 31, 2021 | shares	4,289,264
Weighted-Average Exercise Price, Outstanding, Beginning Balance | $ / shares	$ 15.10
Weighted-Average Exercise Price, Options Granted | $ / shares	16.13
Weighted-Average Exercise Price, Options Exercised | $ / shares	7.33
Weighted-Average Exercise Price, Options Forfeited | $ / shares	13.07
Weighted-Average Exercise Price, Options Expired | $ / shares	21.61
Weighted-Average Exercise Price, Outstanding, Ending Balance | $ / shares	15.23
Weighted-Average Exercise Price, Exercisable | $ / shares	$ 13.76
Weighted-Average Remaining Contractual Term, Outstanding	6 years 2 months 12 days
Weighted-Average Remaining Exercisable	5 years 4 months 24 days
Weighted-Average Aggregate Intrinsic Value | $	$ 25,419
Weighted-Average Aggregate Intrinsic Value, Exercisable | $	$ 20,201

XML

Related Party Transactions - Additional Information (Detail) - USD ($)	Mar. 31, 2022	Mar. 31, 2021
Related Party Transactions [Abstract]
Due to related party transactions	$ 0	$ 0